0001213900-25-117512 | S-4 | XBRL Viewer

Nature of the Organization and Business (Details)											1 Months Ended	3 Months Ended						9 Months Ended		12 Months Ended
Nature of the Organization and Business (Details)	Nov. 10, 2025 shares	Sep. 02, 2025 USD ($) $ / shares shares	Jul. 25, 2025 USD ($) shares	May 12, 2025 USD ($) $ / shares shares	Mar. 10, 2025 USD ($) $ / shares shares	Mar. 05, 2025 USD ($) $ / shares shares	Oct. 11, 2024 $ / shares	Jun. 14, 2024 $ / shares shares	Aug. 16, 2021 $ / shares shares	Dec. 31, 2020 USD ($)	Jul. 31, 2025 shares	Sep. 30, 2025 USD ($) $ / shares shares	Jun. 30, 2025 USD ($)	Mar. 31, 2025 USD ($) shares	Sep. 30, 2024 USD ($)	Jun. 30, 2024 USD ($)	Mar. 31, 2024 USD ($)	Sep. 30, 2025 USD ($) $ / shares shares	Sep. 30, 2024 USD ($) shares	Dec. 31, 2024 USD ($) $ / shares shares	Dec. 31, 2023 USD ($) $ / shares	Jul. 24, 2025 $ / shares	Feb. 22, 2022 $ / shares	Dec. 03, 2021 $ / shares	Aug. 16, 2021 £ / shares
Nature of the Organization and Business [Line Items]
Acquired shares \| shares											15,000
Preferred stock, par value (in Dollars per share) \| $ / shares												$ 0.0001						$ 0.0001		$ 0.0001	$ 0.0001
Common stock, par value (in Dollars per share) \| $ / shares												0.0001						$ 0.0001		$ 0.0001	$ 0.0001
Sale of shares \| shares					221,250														208,010
Offering price per share (in Dollars per share) \| $ / shares				$ 4
Other related expenses (in Dollars)																		$ 133,331
Shares issued rate																		3.00%		3.00%
Initial exercise price per share (in Dollars per share) \| $ / shares												$ 2.96						$ 2.96
Offering price rate																		100.00%		100.00%
Accumulated deficit (in Dollars)												$ (14,879,956)						$ (14,879,956)		$ (14,647,702)	$ (11,359,183)
Net Income (Loss) (in Dollars)												$ 2,540,636	$ (1,705,217)	$ (1,067,673)	$ (1,010,058)	$ (956,963)	$ (1,034,161)	(232,254)	$ (3,001,182)	(3,288,519)	(4,672,348)
Net cash flows provided by (used in) operating activities (in Dollars)																		(4,215,961)	(528,504)	(571,681)	(776,996)
Gross proceeds amount (in Dollars)						$ 5,900,000				$ 22									$ 100,000	$ 100,000
Other related expenses (in Dollars)						$ 1,100,000
Gross proceeds (in Dollars)				$ 225,000
Warrants exercise price per share (in Dollars per share) \| $ / shares		$ 0.0001
Warrant share \| shares												4,000,000						4,000,000
Warrant [Member]
Nature of the Organization and Business [Line Items]
Purchase an aggregate shares \| shares																		44,250		44,250
Pre-Funded Warrants [Member]
Nature of the Organization and Business [Line Items]
Purchase of warrants (in Dollars)		$ 4,000,000
Purchase price per warrant share (in Dollars)		$ 1
Preferred Stock [Member]
Nature of the Organization and Business [Line Items]
Preferred stock, par value (in Dollars per share) \| $ / shares																							$ 0.0001	$ 0.0001
Net Income (Loss) (in Dollars)
Common Stock [Member]
Nature of the Organization and Business [Line Items]
Common stock, par value (in Dollars per share) \| $ / shares								$ 0.0001														$ 0.0001	$ 0.0001	$ 0.0001
Purchase an aggregate shares \| shares				234,375										56
Net Income (Loss) (in Dollars)
Gross proceeds amount (in Dollars)																				$ 25,000
Original Reverse Stock Split [Member] \| Common Stock [Member]
Nature of the Organization and Business [Line Items]
Reverse split shares							1 for 2.43615
BHL [Member]
Nature of the Organization and Business [Line Items]
Acquired shares \| shares									10,000,000
Price per share \| (per share)									$ 14.07																£ 0.0001
Ordinary shares, exchange \| shares									140,700,000
Subsequent Event [Member]
Nature of the Organization and Business [Line Items]
Sale of shares \| shares						1,475,000
Offering price per share (in Dollars per share) \| $ / shares					$ 4
Other related expenses (in Dollars)					$ 885,000	$ 5,900,000
Purchase an aggregate shares \| shares					221,250
Subsequent Event [Member] \| Pre-Funded Warrants [Member]
Nature of the Organization and Business [Line Items]
Purchase an aggregate shares \| shares	4,000,000
Common Stock [Member]
Nature of the Organization and Business [Line Items]
Reverse stock split received \| shares								1
Offering price per share (in Dollars per share) \| $ / shares						$ 4
Purchase an aggregate shares \| shares					221,250
Initial exercise price per share (in Dollars per share) \| $ / shares												$ 4						$ 4		$ 4
Common Stock [Member] \| Original Reverse Stock Split [Member]
Nature of the Organization and Business [Line Items]
Reverse split shares							1 for 2.43615
Common Stock [Member] \| Subsequent Event [Member]
Nature of the Organization and Business [Line Items]
Offering price per share (in Dollars per share) \| $ / shares						$ 4
Series A Preferred Stock [Member]
Nature of the Organization and Business [Line Items]
Reverse stock split received \| shares								1
Reverse split shares																		1 for 2.43615		1 for 2.43615
Preferred stock, par value (in Dollars per share) \| $ / shares												$ 0.0001						$ 0.0001		$ 0.0001	$ 0.0001
Series A Preferred Stock [Member] \| Preferred Stock [Member]
Nature of the Organization and Business [Line Items]
Reverse stock split received \| shares								5.1287
Preferred stock, par value (in Dollars per share) \| $ / shares								$ 0.0001
Net Income (Loss) (in Dollars)
Series A Preferred Stock [Member]
Nature of the Organization and Business [Line Items]
Preferred stock, par value (in Dollars per share) \| $ / shares							$ 0.0001
Series A Preferred Stock [Member] \| Preferred Stock [Member]
Nature of the Organization and Business [Line Items]
Preferred stock, par value (in Dollars per share) \| $ / shares							$ 0.0001
Class B Common Stock [Member]
Nature of the Organization and Business [Line Items]
Warrant share \| shares		1
Over-Allotment Option [Member]
Nature of the Organization and Business [Line Items]
Sale of shares \| shares						1,475,000
Offering price per share (in Dollars per share) \| $ / shares					$ 4
Other related expenses (in Dollars)																		$ 95,800
Gross proceeds amount (in Dollars)					$ 885,000
Other related expenses (in Dollars)					$ 95,800
Series B Convertible Preferred Stock [Member]
Nature of the Organization and Business [Line Items]
Sale of shares \| shares			15,000
Gross proceeds (in Dollars)			$ 15,000,000

Debt (Details) - USD ($)															1 Months Ended						2 Months Ended	3 Months Ended			6 Months Ended	9 Months Ended		12 Months Ended
Debt (Details) - USD ($)	Apr. 30, 2025	Mar. 31, 2025	Mar. 07, 2025	Mar. 05, 2025	Feb. 05, 2025	Dec. 31, 2024	Nov. 30, 2024	Sep. 30, 2024	May 30, 2024	May 01, 2024	Apr. 30, 2024	Apr. 15, 2024	Mar. 01, 2024	Jun. 05, 2023	Feb. 15, 2025	Aug. 31, 2024	May 31, 2024	Apr. 30, 2024	Jan. 31, 2024	Nov. 30, 2023	Sep. 30, 2024	Sep. 30, 2025	Mar. 31, 2025	Sep. 30, 2024	Jun. 30, 2025	Sep. 30, 2025	Sep. 30, 2024	Dec. 31, 2024	Dec. 31, 2023	Nov. 01, 2025	Jul. 24, 2025	May 12, 2025	Mar. 10, 2025	Feb. 28, 2025	Feb. 10, 2025	Nov. 13, 2024	Jun. 30, 2024	Jun. 14, 2024	Jan. 16, 2024	Dec. 31, 2022	Feb. 22, 2022	Dec. 03, 2021
Debt [Line Items]
Convertible debt						$ 5,722,511																						$ 5,722,511	$ 4,527,228
Unamortized debt issuance costs and debt discount
Investment discount rate														10.00%														10.00%
Debt discount
Common stock, per share (in Dollars per share)						$ 0.0001																$ 0.0001				$ 0.0001		$ 0.0001	$ 0.0001
Percentage of purchase price per shares						5.00%																						5.00%
Common stock shares (in Shares)						250,000,000																250,000,000				250,000,000		250,000,000	250,000,000
Debt discount amount																										$ 100,781	$ 46,410	$ 50,629	$ 462,170
Amortization of debt discount																													143,906
Additional debt discount																								$ 704,239		438,709	1,985,213	$ 2,179,122	$ 2,769,208
Anticipated price per share (in Dollars per share)						$ 125																						$ 125
IPO valuation																										$ 6,785,000
Short term						$ 25,000																						$ 25,000
Common stock shares issued (in Shares)						7,033,330																10,972,588				10,972,588		7,033,330	5,744,929
Interest expense																$ 80,000												$ 111,117
Price per share (in Dollars per share)																																$ 4
Repayment of the loan principal																										$ 399,126	25,000	25,000
Loan extension fees																											997,253	997,253	1,864,153
Market Risk Benefit, Change in Fair Value, Gain (Loss)																													31,956
Additional debt discount																								0			6,819
Total debt converted																										$ 6,765,772
Shares issued																												(351,405)
Remaining shares (in Shares)																										355
Foreign currency exchange																										$ 13
Repayment of debt																												206,617
Principal																												95,500
Repayment of principal amount																$ 80,000
Total proceeds																										101,650	$ 292,900	322,900
Principal total						$ 187,900																						187,900
Total payment		$ 650,000																					650,000
Additional interest expense																							$ 201,374
Percentage of principal amount																							30.00%
Share payable	$ 45,000	$ 45,000				45,000																	$ 45,000					45,000
Forecast [Member]
Debt [Line Items]
Repayment of the loan principal	29,223
Original Issue Discount Convertible Promissory Notes [Member]
Debt [Line Items]
Convertible debt						5,722,511																						$ 5,722,511												$ 2,300,575
Unamortized debt issuance costs and debt discount																																								$ 469,082
Investment discount rate																												20.00%
Number of purchase price per share (in Dollars per share)																												$ 0.8
Original issued discount																												20.00%
Debt discount						$ 6,819																						$ 6,819	$ 179,956
Common stock, per share (in Dollars per share)						$ 0.0001																						$ 0.0001
Percentage of purchase price per shares						20.00%																						20.00%
Equity securities amount																												$ 20,000,000
Capitalization shares (in Shares)																												5,819,896
Fair market value price (in Dollars per share)																											$ 2,302		$ 2.44
Debt issuance shares (in Shares)																												2,304
Debt discount amount																							45,000
Amortization of debt discount																													$ 143,905
Additional principal amount																												$ 532,615	798,923
Principal amount						$ 2,663,075							$ 266,307							$ 156,749								$ 2,663,075	$ 266,308										$ 266,308
Percentage of principal amount																												15.00%
Debt amended rate																				15.00%
Outstanding principal amount increase rate																			10.00%	20.00%
Maturity date													May 30, 2024																Sep. 03, 2023
Debt fee rate																				25.00%									20.00%
Additional principal amount																													$ 532,615
Additional debt discount																							$ 90,000
Accrued interest remained outstanding																												$ 888,894	$ 363,120
Original issue discount percentage																							30.00%
Extension Note [Member]
Debt [Line Items]
Original issued discount																												20.00%
Additional principal amount												$ 281,977
Principal amount						25,912																						$ 25,912
Debt fee rate												25.00%
Accrued interest remained outstanding																						$ 144,239				381,535
Debt Discount [Member]
Debt [Line Items]
Debt discount amount																												46,410
Convertible Promissory Notes [Member]
Debt [Line Items]
Capitalization shares (in Shares)																	5,819,896	5,819,896
Fair market value price (in Dollars per share)																	$ 3.43	$ 3.43
Debt issuance shares (in Shares)			103,101							1,204	1,204
Principal amount											$ 103,650						$ 103,650	$ 103,650
Debt issuance cost																	82,920	82,920						0			$ 158,424
Additional debt discount																	20,730	20,730									39,606
Loan extension fees																								0			997,253
Convertible to shares of common stock (in Shares)			1,912,176
Converted amount																						$ 6,713,272				6,713,272
Notes Payable [Member]
Debt [Line Items]
Additional principal amount	80,000
Anticipated price per share (in Dollars per share)		$ 4																					$ 4
Accrued interest remained outstanding																										29,223
Loan amount						$ 12,900																						12,900									$ 12,198
Interest expense	80,000
Foreign currency exchange																									$ 424
Repayment of debt																										29,223
Debt extinguishment																										1,554
Notes Payable [Member] \| Forecast [Member]
Debt [Line Items]
Accrued interest remained outstanding	29,223
Principal	$ 30,000
Original Issue Discount Convertible Promissory Note - December 2024 [Member]
Debt [Line Items]
Additional principal amount																												5,722,511
Accrued interest remained outstanding																												$ 888,894
Original Issue Discount Convertible Promissory Note - December 2024 [Member] \| Forecast [Member]
Debt [Line Items]
Maturity date	Feb. 15, 2025
Common stock shares issued (in Shares)	1,875
Loan Agreement [Member]
Debt [Line Items]
Principal amount					$ 9,314																													$ 15,500
Percentage of principal amount					200.00%
Percentage of repayment of additional fees					100.00%
Interest expense																										111,117
Repayment of debt																										206,617
Additional loan																																			$ 6,186
Principal																										95,500
Confidential Release and Final Agreement [Member]
Debt [Line Items]
Debt discount amount																										90,000
Accrued interest remained outstanding																							$ 45,000
Repayment of the loan principal																							150,000
Total proceeds																							86,150
Borrowings [Member]
Debt [Line Items]
Additional principal amount																							273,626
Accrued interest remained outstanding																							$ 175,000
Short-Term Promissory Notes [Member]
Debt [Line Items]
Maturity date																							Apr. 10, 2025
Second Amendment [Member] \| Original Issue Discount Convertible Promissory Notes [Member]
Debt [Line Items]
Debt fee rate																				20.00%
Common Stock [Member]
Debt [Line Items]
Common stock, per share (in Dollars per share)																															$ 0.0001							$ 0.0001			$ 0.0001	$ 0.0001
Common stock shares (in Shares)																																									250,000,000	50,000,000
Common stock shares issued (in Shares)						6,296,434	937,500																					6,296,434	5,744,929							937,500
Shares issued
Common Stock [Member] \| Original Issue Discount Convertible Promissory Notes [Member]
Debt [Line Items]
Common stock shares (in Shares)																													73,869
Convertible Debt [Member]
Debt [Line Items]
Debt discount						$ 39,606																						$ 39,606	$ 72,500
Debt issuance shares (in Shares)																												2,304
Percentage of due						30.00%																						30.00%
Convertible Debt [Member] \| Convertible Promissory Notes [Member]
Debt [Line Items]
Additional debt discount																	$ 4,159	$ 4,159
Convertible Debt [Member] \| Common Stock [Member]
Debt [Line Items]
Percentage of common stock																												30.00%
Repayment of the loan principal																												$ 25,000
Bridge Loan [Member]
Debt [Line Items]
Fair market value price (in Dollars per share)																$ 1.41
Principal amount						$ 30,000																						30,000
Accrued interest remained outstanding																										175,000		30,000
Short term								$ 280,000								$ 280,000					$ 280,000			280,000			280,000
Short-term loan interest rate								100.00%								100.00%					100.00%
Percentage of repayment of additional fees																100.00%
Common stock shares issued (in Shares)							24,500
Repayment of debt																										175,000
Bridge Loan [Member] \| Original Issue Discount Convertible Promissory Notes [Member]
Debt [Line Items]
Fair market value price (in Dollars per share)								$ 1.41													$ 1.41
Principal amount						255,000																						255,000
Accrued interest remained outstanding																												255,000
Loan amount								$ 280,000													$ 280,000			$ 280,000			$ 280,000
Short-term loan interest rate							100.00%
Percentage of repayment of additional fees								100.00%
Common stock shares issued (in Shares)								198,454													198,454			198,454			198,454
Repaid the short-term loans								$ 25,000
Short-term loan							$ 30,000	25,000													$ 25,000			$ 25,000			$ 25,000
Interest expense																								560,000			560,000	560,000
Bridge Loan [Member] \| Notes Payable [Member]
Debt [Line Items]
Accrued interest remained outstanding						30,000
Original Issue Discount Promissory Note [Member]
Debt [Line Items]
Debt discount amount																												7,500
Amortization of debt discount																												15,000
Additional principal amount																												7,500
Principal amount						32,500																						32,500
Additional debt discount																												4,219
Short term						$ 25,000																						$ 25,000
Common stock shares issued (in Shares)		11,250				1,875																	11,250					1,875
Percentage of due						30.00%																						30.00%
Unamortized debt discount						$ 10,781																						$ 10,781
Convertible Debt December 2024 [Member]
Debt [Line Items]
Debt discount amount																										10,781		7,500
Amortization of debt discount																										$ 15,000
Additional principal amount																												7,500
Principal amount						32,500																						32,500
Additional debt discount																												4,219
Short term						$ 25,000																						$ 25,000
Common stock shares issued (in Shares)						1,875																						1,875
Percentage of due																						30.00%				30.00%
Percentage of common stock															30.00%
Unamortized debt discount						$ 10,781																						$ 10,781
Amortization																						$ 0
Combination [Member]
Debt [Line Items]
Percentage of voting power						50.00%																						50.00%
Subsequent Event [Member]
Debt [Line Items]
Additional principal amount																							$ 273,626
Accrued interest remained outstanding		$ 45,000																					175,000
Loan amount					$ 9,314																									$ 779,000
Price per share (in Dollars per share)																																	$ 4
Repayment of the loan principal		25,000
Additional loan																																			$ 6,186
Principal total																																		$ 80,000
Total payment		650,000																					650,000
Additional interest expense																							201,374
Share payable		45,000																					45,000
Subsequent Event [Member] \| Original Issue Discount Convertible Promissory Note - December 2024 [Member]
Debt [Line Items]
Accrued interest remained outstanding		7,500
Principal		150,000
Subsequent Event [Member] \| Original Issue Discount Promissory Note [Member]
Debt [Line Items]
Percentage of common stock															30.00%
Minimum [Member] \| Original Issue Discount Convertible Promissory Notes [Member]
Debt [Line Items]
Common stock, per share (in Dollars per share)																													$ 3.43
Market Risk Benefit, Change in Fair Value, Gain (Loss)																											2.42
Minimum [Member] \| Convertible Promissory Notes [Member]
Debt [Line Items]
Anticipated price per share (in Dollars per share)										$ 3.43	$ 3.43							$ 3.43
Minimum [Member] \| Convertible Debt [Member]
Debt [Line Items]
Debt discount amount																											46,410
Minimum [Member] \| Subsequent Event [Member] \| Original Issue Discount Convertible Promissory Note - December 2024 [Member]
Debt [Line Items]
Principal		25,000
Maximum [Member] \| Original Issue Discount Convertible Promissory Notes [Member]
Debt [Line Items]
Common stock, per share (in Dollars per share)																													$ 3.48
Market Risk Benefit, Change in Fair Value, Gain (Loss)																								3.46
Maximum [Member] \| Convertible Promissory Notes [Member]
Debt [Line Items]
Principal amount								$ 198,030													$ 198,030			198,030			$ 198,030
Anticipated price per share (in Dollars per share)										$ 3.46	$ 3.46							$ 3.46
Maximum [Member] \| Convertible Debt [Member]
Debt [Line Items]
Debt discount amount																								$ 0
Maximum [Member] \| Subsequent Event [Member] \| Original Issue Discount Convertible Promissory Note - December 2024 [Member]
Debt [Line Items]
Accrued interest remained outstanding		7,500
IPO [Member]
Debt [Line Items]
Principal amount						$ 5,722,511																						$ 5,722,511
Maturity date																												Feb. 15, 2025
Anticipated price per share (in Dollars per share)				$ 4		$ 4																						$ 4
IPO valuation																										$ 1,351,098
Short term						$ 150,000																						$ 150,000
Common stock shares issued (in Shares)	29,305
Price per share (in Dollars per share)						$ 4	$ 4																					$ 4								$ 4
Total debt converted																												$ 6,611,405
Shares issued																										1,234
Original issue discount percentage																												30.00%
Percentage of principal amount																												30.00%
IPO [Member] \| Original Issue Discount Convertible Promissory Notes [Member]
Debt [Line Items]
IPO valuation									$ 20,000,000
Short-term loan		150,000																					150,000
IPO [Member] \| Convertible Promissory Notes [Member]
Debt [Line Items]
IPO valuation									$ 20,000,000
Accrued interest remained outstanding																												$ 888,894
IPO [Member] \| Common Stock [Member]
Debt [Line Items]
Debt issuance shares (in Shares)																												6,250
Shares issued																										$ 101,867
IPO [Member] \| Convertible Debt December 2024 [Member]
Debt [Line Items]
Maturity date	Feb. 15, 2025
Accrued interest remained outstanding																							7,500
Common stock shares issued (in Shares)	1,875
Price per share (in Dollars per share)															$ 4
Repayment of the loan principal																							25,000
IPO [Member] \| Subsequent Event [Member]
Debt [Line Items]
Total proceeds																							86,150
Principal total		$ 187,900																					$ 187,900
IPO [Member] \| Subsequent Event [Member] \| Common Stock [Member]
Debt [Line Items]
IPO valuation				$ 4
IPO [Member] \| Subsequent Event [Member] \| Original Issue Discount Promissory Note [Member]
Debt [Line Items]
Price per share (in Dollars per share)															$ 4
IPO [Member] \| Minimum [Member]
Debt [Line Items]
Convertible to shares of common stock (in Shares)			29,660

Subsequent Events (Details) - USD ($)											1 Months Ended					3 Months Ended			9 Months Ended		12 Months Ended
Subsequent Events (Details) - USD ($)	Nov. 10, 2025	Oct. 30, 2025	May 12, 2025	Apr. 30, 2025	Mar. 31, 2025	Mar. 10, 2025	Mar. 07, 2025	Mar. 05, 2025	Mar. 01, 2024	Dec. 31, 2020	Nov. 28, 2025	Jun. 30, 2025	Mar. 31, 2025	Aug. 31, 2024	Mar. 31, 2024	Sep. 30, 2025	Jun. 30, 2025	Mar. 31, 2025	Sep. 30, 2025	Sep. 30, 2024	Dec. 31, 2024	Dec. 31, 2023	Nov. 01, 2025	Oct. 14, 2025	Feb. 28, 2025	Feb. 10, 2025	Feb. 05, 2025	Nov. 30, 2024	Nov. 13, 2024	Jun. 30, 2024
Subsequent Events [Line Items]
Public offering price per share																			$ 6,785,000
Other related expenses																			$ 133,331
Exercised option (in Shares)																			1,950,000
Total proceeds received																			$ 101,650	292,900	$ 322,900
Notes payable principal																					$ 187,900
Interest payable					$ 650,000								$ 650,000					$ 650,000
Interest expense																		$ 201,374
Converted shares of common stock (in Shares)																					1,912,176
Loan repaid																					$ 95,500
Noteholder repaid principal																			$ 399,126	25,000	25,000
Total repayment																					206,617
Principal interest														$ 80,000							$ 111,117
Common stock shares issued (in Shares)																10,972,588			10,972,588		7,033,330	5,744,929
Short-term loans																					$ 25,000
Percentage of common stock value																		30.00%
Price per share (in Dollars per share)			$ 4
Original issue discount																					45,000
Discount on debt																			$ 100,781	$ 46,410	50,629	$ 462,170
Share payable				$ 45,000	45,000								45,000					$ 45,000			45,000
Additional common shares																					$ (351,405)
IPO price per share (in Dollars per share)																					$ 125
Share price (in Dollars per share)																$ 1			$ 1	$ 0.73
Issuance of shares of common stock (in Shares)																312,500			312,500
Cash proceeds								$ 5,900,000		$ 22										$ 100,000	$ 100,000
Cash payments												$ 50,000					$ 506,819	$ 164,647			$ 125
Exercise price per share (in Dollars per share)																$ 2.96			$ 2.96
Warrant [Member]
Subsequent Events [Line Items]
Issued shares of common stock (in Shares)																			44,250		44,250
Forecast [Member]
Subsequent Events [Line Items]
Shares were granted (in Shares)				29,305
Number of shares pending to be issued (in Shares)				355
Share payable				$ 1,234
Noteholder repaid principal				29,223
Gain on debt extinguishment				1,554
Payments				$ 50,000
Issuance of shares of common stock (in Shares)				6,250
Cash proceeds				$ 25,000
Forecast [Member] \| Warrant [Member]
Subsequent Events [Line Items]
Warrants shares (in Shares)											500,000
Exercise price per share (in Dollars per share)											$ 0.817
Proceeds of warrants											$ 408,500
Chief Executive Officer [Member]
Subsequent Events [Line Items]
Issued shares of common stock (in Shares)																			9,000,000
Common Stock [Member]
Subsequent Events [Line Items]
Issued shares of common stock (in Shares)			234,375															56
Common stock shares issued (in Shares)																					6,296,434	5,744,929						937,500	937,500
Additional common shares
Cash proceeds																					$ 25,000
Cash payments																	$ 5				$ 125
Shares issued (in Shares)																	50,000				1,250,000
Common Stock [Member] \| Warrant [Member]
Subsequent Events [Line Items]
Converted shares of common stock (in Shares)																			17,517,203
Marketing Agreement [Member]
Subsequent Events [Line Items]
Issued shares of common stock (in Shares)									50,000										50,000
IPO price per share (in Dollars per share)																$ 9			$ 9
Cash payments															$ 100,000				$ 100,000		$ 100,000
Common Stock Awards [Member]
Subsequent Events [Line Items]
Aggregate shares of common stock (in Shares)																			663,250,176
Subsequent Event [Member]
Subsequent Events [Line Items]
Issued shares of common stock (in Shares)						221,250
Other related expenses						$ 885,000		$ 5,900,000
Offering costs						$ 885,000
Notes payable principal																									$ 80,000
Interest payable					650,000								650,000					650,000
Principal amount paid																		273,626
Accrued interest					45,000													175,000
Interest expense																		201,374
Noteholder repaid principal					25,000
Loan																							$ 779,000				$ 9,314
Interest fee percentage																											200.00%
Principal loan percentage																											100.00%
Additional loan																										$ 6,186
Price per share (in Dollars per share)						$ 4
Share payable					$ 45,000								$ 45,000					$ 45,000
Cash payments		$ 51,000
Shares issued (in Shares)		175,000
Remaining balance		$ 30,000
Subsequent Event [Member] \| Pre-Funded Warrants [Member]
Subsequent Events [Line Items]
Issued shares of common stock (in Shares)	4,000,000
Subsequent Event [Member] \| Common Stock [Member]
Subsequent Events [Line Items]
Converted amount							$ 103,101
Converted shares of common stock (in Shares)							29,660
Issuance of shares of common stock (in Shares)					56								56					56
Subsequent Event [Member] \| Marketing Agreement [Member]
Subsequent Events [Line Items]
Common stock shares issued (in Shares)					50,000								50,000					50,000
Compensation amount					$ 100,000								$ 100,000					$ 100,000
Payment of compensation amount					$ 50,000								$ 50,000					$ 50,000
Share price (in Dollars per share)					$ 9								$ 9					$ 9
IPO [Member]
Subsequent Events [Line Items]
Public offering price per share																			$ 1,351,098
Other related expenses																			$ 1,100,000
Converted shares of common stock (in Shares)																			44,250
Common stock shares issued (in Shares)				29,305
Maturity date																					Feb. 15, 2025
Short-term loans																					$ 150,000
Original issue discount																					30.00%
Percentage of common stock value																					30.00%
Price per share (in Dollars per share)																					$ 4							$ 4	$ 4
Additional common shares																			$ 1,234
IPO price per share (in Dollars per share)								$ 4													$ 4
IPO [Member] \| Common Stock [Member]
Subsequent Events [Line Items]
Additional common shares																			101,867
IPO [Member] \| Marketing Agreement [Member]
Subsequent Events [Line Items]
Issued shares of common stock (in Shares)															50,000
Additional common shares															$ 200,000				200,000
Cash payments																$ 66,666
IPO [Member] \| Subsequent Event [Member]
Subsequent Events [Line Items]
Other related expenses								$ 5,900,000
Offering costs						$ 95,800		$ 1,081,000
Exercised option (in Shares)						221,250
Public offering price						$ 4
Total proceeds received																		$ 86,150
Notes payable principal					$ 187,900								$ 187,900					187,900
Reduction of principal amount																		$ 424
IPO [Member] \| Subsequent Event [Member] \| Common Stock [Member]
Subsequent Events [Line Items]
Issued shares of common stock (in Shares)								1,475,000
Public offering price per share								$ 4
IPO [Member] \| Subsequent Event [Member] \| Marketing Agreement [Member]
Subsequent Events [Line Items]
Additional common shares													$ 200,000
IPO price per share (in Dollars per share)					$ 4								$ 4					$ 4
Original Issue Discount Convertible Promissory Note - December 2024 [Member]
Subsequent Events [Line Items]
Principal amount paid																					$ 5,722,511
Accrued interest																					888,894
Original Issue Discount Convertible Promissory Note - December 2024 [Member] \| Forecast [Member]
Subsequent Events [Line Items]
Share payable				$ 7,500
Common stock shares issued (in Shares)				1,875
Maturity date				Feb. 15, 2025
Original Issue Discount Convertible Promissory Note - December 2024 [Member] \| Subsequent Event [Member]
Subsequent Events [Line Items]
Accrued interest					$ 7,500
Loan repaid					$ 150,000
Notes Payable [Member]
Subsequent Events [Line Items]
Principal amount paid				$ 80,000
Accrued interest																			29,223
Loan																					12,900									$ 12,198
Total repayment																			$ 29,223
Principal interest				80,000
IPO price per share (in Dollars per share)					$ 4								$ 4					$ 4
Notes Payable [Member] \| Forecast [Member]
Subsequent Events [Line Items]
Accrued interest				29,223
Loan repaid				$ 30,000
Promissory Note [Member] \| Subsequent Event [Member]
Subsequent Events [Line Items]
Loan																								$ 8,000,000
Interest rate																								5.00%
Original Issue Discount Convertible Promissory Note - December 2024 [Member]
Subsequent Events [Line Items]
Converted amount																					6,611,405
Discount on debt																					$ 90,000
Original Issue Discount Convertible Promissory Note - December 2024 [Member] \| Common Stock [Member]
Subsequent Events [Line Items]
Common stock shares issued (in Shares)																					11,250
Series A Convertible Preferred Stock [Member] \| Subsequent Event [Member]
Subsequent Events [Line Items]
Issuance of shares of common stock (in Shares)					82,096								82,096					82,096
Series A Convertible Preferred Stock [Member] \| Unanimous [Member] \| Subsequent Event [Member]
Subsequent Events [Line Items]
Common stock shares issued (in Shares)					1								1					1
Minimum [Member] \| Warrant [Member]
Subsequent Events [Line Items]
Exercise price per share (in Dollars per share)																$ 0.59			$ 0.59
Minimum [Member] \| Original Issue Discount Convertible Promissory Note - December 2024 [Member] \| Subsequent Event [Member]
Subsequent Events [Line Items]
Loan repaid					$ 25,000
Maximum [Member] \| Warrant [Member]
Subsequent Events [Line Items]
Exercise price per share (in Dollars per share)																$ 0.78			$ 0.78
Maximum [Member] \| Original Issue Discount Convertible Promissory Note - December 2024 [Member] \| Subsequent Event [Member]
Subsequent Events [Line Items]
Accrued interest					$ 7,500

Nature of the Organization and Business

9 Months Ended

12 Months Ended

Sep. 30, 2025

Dec. 31, 2024

Nature of the Organization and Business [Abstract]

NATURE OF THE ORGANIZATION AND BUSINESS

NOTE 1 — NATURE OF THE ORGANIZATION AND BUSINESS

Corporate History

Brag House Holdings, Inc. (“Brag House” or “BHHI” or the “Company”) was formed as a Delaware corporation on December 3, 2021. The Company’s principal executive offices are located at 45 Park Street, Montclair, NJ 07042.

Brag House Inc. (“BHI”), the Company’s wholly owned indirect subsidiary, was formed as a Delaware corporation in February 2018. Their principal offices are located at 45 Park Street, Montclair, NJ 07042.

On June 11, 2021, Brag House Ltd. (“BHL”) was registered in the United Kingdom. Their principal offices are located at 7 – 9 Swallow Street, London W1B 4DE, United Kingdom.

On August 16, 2021, BHL acquired all of the 10,000,000 issued and outstanding BHI shares held by BHI shareholders on a one for 14.07 basis (rounded to the nearest whole number) in exchange for 140,700,000 ordinary shares of £0.0001 in BHL, making BHI a wholly owned subsidiary of BHL (“UK Reorganization”).

Following the UK Reorganization, the board of directors of BHL determined that it was in the best interests of BHL and its shareholders that an initial public offering (“IPO”) in the United States and concurrent listing on Nasdaq be pursued. To effect that proposed IPO and listing on Nasdaq, in December 2021, the Company was formed. In connection with this IPO, prior to the effectiveness of the registration statement, on February 8, 2022, the Company approved a reorganization, in which the shareholders of BHL would exchange their ordinary shares and preference shares of BHL for a proportionate number of common and preferred shares in the Company on a 21 to 1 basis (“U.S. Reorganization”). Immediately following the U.S. Reorganization, BHL became the wholly-owned subsidiary of the Company, and BHI became the indirect wholly-owned subsidiary of the Company. Management anticipates that BHL will be wound down and dissolved as soon as reasonably practicable.

On June 11, 2024, the Company’s board of directors approved, and on June 13, 2024, the Company’s stockholders approved the original reverse stock split (“Original Reverse Stock Split”). On June 14, 2024, the Company filed the Second Certificate of Amendment to its Certificate of Incorporation to effect the Original Reverse Stock Split, such that every holder of Common Stock and Series A Preferred Stock of the Company received 1 share of Common Stock and 1 share of Series A Preferred Stock for every 5.1287 of a share held. On October 11, 2024, the Company canceled the Original Reverse Stock Split and effected a 1 for 2.43615 consolidation of its issued and outstanding Common Stock and Series A Preferred Stock (the “Reverse Stock Split”). On October 11, 2024, the Company filed the Third Certificate of Amendment to its Certificate of Incorporation to effect the Reverse Stock Split. The Conversion Price of Series A Convertible Preferred Stock, par value $0.0001 per share (the “Series A Preferred Stock”), will reflect the Reverse Stock Split. All fractional shares created by the 1 for 2.43615 exchange will be paid in cash. The resulting payment amount due for the fractional shares is not material. The Reverse Stock Split had no impact on the par value per share of the Company’s Common Stock and Series A Preferred Stock, all of which remain at $0.0001.

On February 14, 2025, the Company received its notice of effectiveness from the U.S. Securities and Exchange Commission (“SEC”) and became a public company. On March 5, 2025, the Company entered into a material definitive agreement in the form of an underwriting agreement with Kingswood Capital Partners, LLC (“Kingswood”) as representative of the underwriters named therein, for the offer and sale of 1,475,000 shares of the Company’s Common Stock at a public offering price of $4.00 per share for gross proceeds of $5.9 million, before deducting underwriting discounts and other related expenses totaling $1.1 million.

On March 6, 2025, the Company’s shares began trading on Nasdaq under the symbol “TBH” and on March 7, 2025, the Company filed its prospectus with the SEC and completed its IPO.

Pursuant to the underwriting agreement, as partial compensation for their services, the Company issued to the underwriters on the closing date of the IPO (the “Closing Date”), warrants (the “Underwriter Warrants”) to purchase an aggregate of 44,250 shares of the Company’s Common Stock, representing 3% of the shares issued on the Closing Date. The Underwriter Warrants became exercisable, in whole or in part, commencing on September 3, 2025 and expiring on September 9, 2029, at an initial exercise price per share of common stock of $4.00, which is equal to

100% of the offering price. The terms of the Underwriter Warrants are substantially the same as the terms set forth in the form of such warrants which is filed as Exhibit 4.1 to the report on Form 8-K filed by the Company on March 11, 2025.

On March 10, 2025, Kingswood, as representative of the underwriters, exercised in full its option to purchase an additional 221,250 shares of the Company’s Common Stock to cover over-allotments at a public offering price of $4.00 per share for gross proceeds from the over-allotment exercise of $885,000, before deducting underwriting discounts and other related expenses totaling $95,800. The over-allotment exercise closed on March 11, 2025 and, on that same date, the Company issued a press release announcing the closing of the over-allotment exercise.

Brag House Merger Sub, Inc. (“Merger Sub” or “BHMS”), a wholly owned subsidiary of the Company, was formed as a Delaware corporation on October 9, 2025. The Company’s principal executive offices are located at 45 Park Street, Montclair, NJ 07042. Please refer to Note 11.

The Company entered into a Merger Agreement dated as of October 12, 2025 (the “Merger Agreement”), by and among the Company, House of Doge Inc., a Texas Corporation (“House of Doge”), and the Merger Sub. The Merger Agreement and the transactions contemplated thereby were unanimously approved by the respective boards of directors of both Brag House and House of Doge. Pursuant to the Merger Agreement, upon the terms and subject to the conditions set forth therein, among other things, House of Doge will merge (the “Merger”) with and into Merger Sub, with the House of Doge continuing as the surviving entity and a wholly owned subsidiary of the Company.

The proposed merger is subject to customary closing conditions, including regulatory approvals, filing of required registration statements, shareholder consent, and completion of due diligence. As of the date these financial statements were issued, the merger had not yet closed. The Company expects the transaction to be finalized during the first quarter of 2026, pending satisfaction of all closing conditions. Please refer to Note 11.

Nature of the Business

Brag House is a vertically integrated social network for college gamers. The Company’s mission is to create a community which empowers gamers, streamers, and fans to interact with one another. The Company’s platform, which focuses on building a centralized gaming experience for non-professional college gamers and their fans, achieves this by allowing college students to compete against one another, support their favorite gamers and teams, and win prizes.

Liquidity and Going Concern

The accompanying condensed consolidated financial statements have been prepared on the basis that the Company will continue as a going concern, which contemplates realization of assets and the satisfaction of liabilities in the normal course of business. As of September 30, 2025, the Company had an accumulated deficit of $14,879,956. For the nine months ended September 30, 2025, the Company had a net loss of $232,254 and negative cash flows from operations of $4,215,961. The Company’s operating activities consume the majority of its cash resources. The Company will continue to promote its services to existing and potential customers, but it anticipates that it will continue to incur operating losses as it executes its development plans through 2025, in addition to pursuing other potential strategic and business development initiatives including the contemplated Merger Agreement. In addition, the Company has had, and expects to have, negative cash flows from operations, at least into the near future. The Company previously funded these losses primarily through the sale of equity and infusions of cash from advances by its Chief Executive Officer, and plans to continue funding operations through the sale of equity or issuance of debt instruments. The accompanying condensed consolidated financial statements do not include any adjustments that might be necessary should the Company be unable to continue as a going concern for the next twelve months from the issuance of these condensed consolidated financial statements.

The Company also secured a strategic partnership for tournament and promotional events in 2025 with Learfield Communications, LLC, formerly Learfield IMG College, a billion-dollar media company that holds the media rights to hundreds of colleges in the US, including collegiate properties such as the NCAA and its 89 championships and NCAA Football. In May 2025, the Company launched the first activation under its strategic partnership with Learfield.

This activation was for students and alumni at the University of Florida, one of Learfield’s media rights properties. In July 2025, the Company executed the second activation under its strategic partnership with Learfield, expanding on the success of the initial May 2025 event. This activation was conducted virtually and designed to engage students and alumni through a digital tournament centered around EA College Football 26, following the game’s national release. The event incorporated university-branded content and featured participation from student-athletes, further aligning with the Company’s Name, Image, and Likeness (“NIL”) engagement strategy. The Company believes these activations demonstrated its ability to scale digital experiences across collegiate communities and reinforced its commercial model for integrating sponsorship, branded content and messaging, and fan engagement at the intersection of gaming and college sports. The Company believes this partnership positions it to leverage Learfield’s college network and gain access to media rights and assets across nearly 200 universities, enabling physical and digital activations to generate sponsorship revenue and brand engagement opportunities, while giving the Company access to extensive datasets from diverse college campuses as the Company evolves into a scalable data insights revenue model, where the Company aims to enable brands to gain data insights to create enhanced, personalized and effective marketing campaigns. The Company further believes this partnership will contribute directly to its model through shared sponsorship earnings, while validating its marketing and data strategy for reaching college-aged Gen Z gamers. Through this, the Company plans to scale across Learfield’s properties, expanding brand partnerships in the gaming and esports spaces.

Management believes this strategic partnership is a strong indicator of growth in the coming years for tournament revenue. Until revenue from such tournaments provides sufficient and steady cash flow, management intends to raise funds through equity and debt offerings, and believes that the actions presently being taken to further implement its business plan will enable the Company to continue as a going concern. While the Company believes in its ability to raise additional funds, there can be no assurances to that effect. The ability of the Company to continue as a going concern is dependent upon the Company’s ability to further implement its business plan and raise additional funds as described.

Although no assurances can be given as to the Company’s ability to deliver on its revenue plans or that unforeseen expenses will not arise, management believes that the revenue to be generated from operations, together with equity and debt financing, will provide the necessary funding for the Company to continue as a going concern. However, the Company has earned no revenue through the nine months ended September 30, 2025, minimal revenue since inception, and management cannot guarantee that any potential debt or equity financing will be available or, if available, will be available on favorable terms. As such, these matters raise substantial doubt about the Company’s ability to continue as a going concern for the next twelve months from the issuance of the accompanying condensed consolidated financial statements. If adequate funds are not available on acceptable terms, or at all, the Company will need to curtail operations or cease operations completely.

On July 24, 2025, the Company entered into an agreement to sell an aggregate of 15,000 shares of its Series B Convertible Preferred Stock in a private placement offering for total gross proceeds of $15,000,000 (the “PIPE Offering”). Please refer to Note 5.

Additionally, on September 2, 2025, the Company invested $4,000,000 in Pre-Funded Common Stock Purchase Warrants (the “Pre-Funded Warrants”) of CleanCore Solutions, Inc., with a purchase price of $1 per warrant share. The exercise price of the warrants is $0.0001 per share and each warrant is for one share of Class B Common Stock of CleanCore Solutions, Inc., a publicly traded company. Please refer to Notes 9 and 10.

Emerging Growth Company

Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s condensed consolidated financial statements with another public company, which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period, difficult or impossible because of the potential differences in accounting standards used.

NOTE 1 — NATURE OF THE ORGANIZATION AND BUSINESS

Corporate History

Brag House, Inc. (“BHI”), the Company’s wholly owned indirect subsidiary, was formed as a Delaware corporation in February 2018. Their principal offices are located at 45 Park Street, Montclair, NJ 07042.

On June 11, 2021, Brag House, Ltd. (“BHL”) was registered in the United Kingdom. Their principal offices are located at 7 – 9 Swallow Street, London W1B 4DE, United Kingdom.

Following the UK Reorganization, the board of directors of BHL determined that it was in the best interests of BHL and its shareholders that an initial public offering in the United States and concurrent listing on Nasdaq be pursued. To effect that proposed initial public offering and listing on Nasdaq, in December 2021, the Company was formed. In connection with this offering, prior to the effectiveness of the registration statement, on February 8, 2022, the Company approved a reorganization, in which the shareholders of BHL would exchange their ordinary shares and preference shares of BHL for a proportionate number of common and preferred shares in the Company on a 21 to 1 basis (“U.S. Reorganization”). Immediately following the U.S. Reorganization, BHL became the wholly-owned subsidiary of the Company, and BHI became the indirect wholly-owned subsidiary of the Company. Management anticipates that BHL will be wound down and dissolved as soon as reasonably practicable following the consummation of this offering.

On June 11, 2024 the Company’s board of directors approved, and on June 13, 2024 the Company’s stockholders approved the original reverse stock split (“Original Reverse Stock Split”). On June 14, 2024 the Company filed the Second Certificate of Amendment to its Certificate of Incorporation to effect the Original Reverse Stock Split, such that every holder of Common Stock and Series A Preferred Stock of the Company received 1 share of Common Stock and 1 share of Series A Preferred Stock for every 5.1287 of a share held. On October 11, 2024 the Company canceled the Original Reverse Split and effected a 1 for 2.43615 consolidation of its issued and outstanding Common Stock and Series A Preferred Stock (the “Reverse Stock Split”). On October 11, 2024, the Company filed the Third Certificate of Amendment to its Certificate of Incorporation to effect the Reverse Stock Split. The Conversion Price of Series A convertible preferred stock, par value $0.0001 per share (the “Series A Preferred Stock”), will reflect the Reverse Stock Split. All fractional shares created by the 1 for 2.43615 exchange will be paid in cash. The resulting payment amount due for the fractional shares is not material. The Reverse Stock Split had no impact on the par value per share of the Company’s Common Stock and Series A Preferred Stock, all of which remain at $0.0001. All current and prior period amounts related to shares, share prices and loss per share, presented in the Company’s financial statements and the accompanying Notes have been restated for the Reverse Stock Split.

On February 14, 2025, the Company received its notice of effectiveness from the Securities Exchange Commission and became a public company. On March 5, 2025 the Company entered into a material definitive agreement in the form of an underwriting agreement with Kingswood Capital Partners, LLC (“Kingswood”) as representative of the underwriters named therein, for the offer and sale of 1,475,000 shares of the Company’s common stock at a public offering price of $4.00 per share for gross proceeds, before deducting underwriting discounts and other related expenses, of $5.9 million.

On March 6, 2025 the Company’s shares began trading on Nasdaq under the symbol “TBH” and on March 7, 2025, the Company filed its prospectus with the Securities Exchange Commission and completed its IPO.

Date. The Underwriter Warrants will be exercisable, in whole or in part, commencing on September 3, 2025 and expiring on March 6, 2030, at an initial exercise price per share of common stock of $4.00, which is equal to 100% of the Offering price. The terms of the Representative’s Warrant are substantially the same as the terms set forth in the form of such warrant which is filed as Exhibit 4.1 to the report on Form 8-K filed by the Company on March 11, 2025.

On March 10, 2025, Kingswood, as representative of the underwriters, exercised in full its option to purchase an additional 221,250 shares of the Company’s common stock to cover over-allotments at a public offering price of $4.00 per share for gross proceeds from the over-allotment exercise, before deducting underwriting discounts and other related expenses, of $885,000. The over-allotment exercise closed on March 11, 2025 and, on that same date, the Company issued a press release announcing the closing of the over-allotment exercise.

Nature of the Business

Brag House is a vertically integrated social network for college esports. The Company’s mission is to create a community which empowers gamers, streamers, and fans to interact with one another. The Company’s platform, which focuses on building a centralized esports experience for non-professional college gamers and their fans, achieves this by allowing college students to compete against one another, support their favorite gamers and teams, and win prizes.

Liquidity and Going Concern

The accompanying consolidated financial statements have been prepared on the basis that the Company will continue as a going concern, which contemplates realization of assets and the satisfaction of liabilities in the normal course of business. At December 31, 2024, the Company had an accumulated deficit of $14,647,702. For the year ended December 31, 2024, the Company had a net loss of $3,288,519 and negative cash flows from operations of $571,681. The Company’s operating activities consume the majority of its cash resources. The Company will continue to promote its services to existing and potential customers, but it anticipates that it will continue to incur operating losses as it executes its development plans through 2025, as well as other potential strategic and business development initiatives. In addition, the Company has had, and expects to have, negative cash flows from operations, at least into the near future. The Company previously funded these losses primarily through the sale of equity and infusions of cash from advances by its Chief Executive Officer, and plans to continue funding operations through the sale of equity or issuance of debt instruments. The accompanying consolidated financial statements do not include any adjustments that might be necessary should the Company be unable to continue as a going concern for the next twelve months from the issuance of these consolidated financial statements.

The Company also secured a strategic partnership for tournament and promotional events in 2025 with Learfield Communications, LLC, formerly Learfield IMG College, a billion dollar media company that holds the media rights to hundreds of colleges in the US, including collegiate properties as the NCAA and its 89 championships and NCAA Football. The partnership’s first activation is planned to be held online on May 17, 2025 (originally scheduled for March 5, 2025) for students and alumni of the University of Florida, one of Learfield’s media rights properties. The Company believes this partnership positions itself to leverage Learfield’s college network to generate sponsorship revenue and brand engagement opportunities while giving the Company access to extensive datasets from diverse college campuses as the Company evolves into a scalable data insight revenue model, where the Company aims to enable brands to gain data insights to create enhanced, personalized and effective marketing campaigns. The Company further believes this partnership will contribute directly to its model through shared sponsorship earnings, while validating its marketing and data strategy for reaching college-aged Gen Z gamers. Through this, the Company plans to scale across Learfield’s properties, expanding brand partnerships in the gaming and esports spaces.

Management believes this is a strong indicator of continued growth in the coming years for tournament revenue. Until revenue from such tournaments provides sufficient and steady cash flow, management intends to raise funds through this Initial Public Offering and believes that the actions presently being taken to further implement its business plan will enable the Company to continue as a going concern. While the Company believes in its viability to raise

additional funds, there can be no assurances to that effect. The ability of the Company to continue as a going concern is dependent upon the Company’s ability to further implement its business plan and raise additional funds through the Initial Public Offering or otherwise.

Although no assurances can be given as to the Company’s ability to deliver on its revenue plans or that unforeseen expenses may arise, management believes that the revenue to be generated from operations, together with equity and debt financing, will provide the necessary funding for the Company to continue as a going concern. However, the Company has earned minimal revenue through the year ended December 31, 2024, and there are currently no arrangements or agreements for such financing and management cannot guarantee any potential debt or equity financing will be available, or if available, on favorable terms. As such, these matters raise substantial doubt about the Company’s ability to continue as a going concern for the next twelve months from the issuance of the accompanying consolidated financial statements. If adequate funds are not available on acceptable terms, or at all, the Company will need to curtail operations or cease operations completely.

Emerging Growth Company

The Company is an “emerging growth company,” as defined in Section 2(a)(19) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (“JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404(b) of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a non binding advisory vote on executive compensation and approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s consolidated financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.

Commitments and Contingencies

9 Months Ended

12 Months Ended

Sep. 30, 2025

Dec. 31, 2024

Commitments and Contingencies [Abstract]

COMMITMENTS AND CONTINGENCIES

NOTE 4 — COMMITMENTS AND CONTINGENCIES

The Company evaluates its business transactions and agreements during the course of business to identify whether any contingencies or commitments exist which would give rise to the recognition of a loss or liability. The Company is currently not involved with or knows of any pending or threatening litigation against the Company or any of its officers. Further, the Company is currently complying with all relevant laws and regulations and does not have any long-term commitments or guarantees.

Marketing Agreement

In March of 2024, the Company entered into a marketing agreement with Outside the Box Capital, Inc. (“OTB Capital”) for marketing services to be provided for the six-month period from May 1, 2024 to October 31, 2024. Compensation for these services will be $100,000 in cash and due upon the earlier of the successful completion of the Company’s IPO or within six months from the effective date of the agreement. Additionally, the Company will issue shares of BHHI Common Stock, priced at the IPO, totaling $200,000 which equals 50,000 shares. These shares became due 10 days after the successful completion of the Company’s IPO on March 6, 2025, deemed the listing date (“Listing Date”), and were issued in April of 2025. This balance of $200,000, which is an increase to stockholders’ equity for the issuance of common stock for services for the nine months ended September 30, 2025, was separated into 6 months of service and the portion of the remaining period of approximately two months representing the days between July 1st through September 6th, $66,666, was added to the prepaid expense balance during the three months ended September 30, 2025. Lastly, if within the term of the Company’s agreement with OTB Capital, the Company’s shares achieve a 7-day moving average (calculated using daily VWAP) share price of $9 or more, the Company will issue an additional 50,000 shares to OTB Capital. This share price threshold was not achieved during the nine or three months ended September 30, 2025. Services under this contract were not provided during the expected service period of May through October of 2024. A modification of the agreement was negotiated and finalized in November of 2024. Services were amended to begin on December 15, 2024 through June 15, 2025. Services had not yet commenced as of December 31, 2024 and through March 5, 2025. As a result, another modification of the agreement was executed on March 28, 2025. This new agreement revised the dates of service to begin on March 6, 2025 through September 6, 2025. It also revised the terms of compensation and, as a result, the base compensation of $100,000 will be payable in two tranches, the first payment for $50,000 within 10 business days following the Company’s Listing Date as a publicly traded company and the second and final payment for the remaining amount will be due three months from the Listing Date. The first payment of $50,000 was made in April of 2025 and the final payment was made on June 5, 2025. No accrual for a liability was required or recorded as of December 31, 2024. The balance of $50,000 of the final payment was separated into 3 months of service starting with June 2025. A total of $100,000 and $33,333 was recorded as an advertising and marketing expense during the nine and three months ended September 30, 2025, respectively.

Broncos Sponsorship Agreement

During 2023, the Company entered into a sponsorship agreement with Stadium Management Company and the Denver Broncos. This resulted in marketing expenses totaling $305,000 accrued during the year ended December 31, 2023. In September of 2024, the parties terminated the sponsorship agreement and this resulted in a reduction of the payable amount from $305,000 to $61,000. The reduction of $244,000 was recorded as other income during the three and nine months ended September 30, 2024. The balance of $61,000 remains outstanding as of September 30, 2025 and December 31, 2024, and is recorded as accounts payable on the balance sheets.

Cloud Computing Arrangements — Technology Purchase Agreements

On November 13, 2024 (the “Artemis Effective Date”), the Company entered into a MSA with Artemis, a skilled technology company, whereby Artemis agreed to develop a proprietary machine learning solution for the Company’s platform (the “Software”) and provide certain services. In exchange, the Company agreed to issue 937,500 shares of its Common Stock to Artemis (the “Artemis Stock Consideration”) in December 2024. The Artemis Stock Consideration is subject to a lock-up provision, with shares of the Artemis Stock Consideration to be released in three (3) equal tranches of 312,500 shares each according to the terms outlined in the MSA and the respective Statements of Work (“SOWs”) attached thereto. In connection with the execution of the MSA, on November 13, 2024 (the “EVEMeta Effective Date”), the Company entered into a SaaS Agreement with EVEMeta, an innovative technology company, whereby EVEMeta agreed to license its solution to the Company. In exchange, the Company agreed to issue 312,500 shares of its Common Stock to EVEMeta (the “EVEMeta Stock Consideration” and, collectively, with the Artemis Stock Consideration, the “Stock Consideration”). The 1,250,000 shares granted to Artemis and EVEMeta in exchange for services had a fair market value of $4.00 per share at the date of grant for a total cost of $5,000,000. Further, once released from lock up, the Company will provide each vendor with a guarantee of a minimum value for the released shares for 18 months from the date of release. In the event that either vendor is not able to resell the shares at the IPO price of $4.00 per share, the Company will make additional payments under its minimum value guarantee to the vendor in cash to ensure a total compensation of $3,750,000 to Artemis and $1,250,000 to EVEMeta. Those payments will be made in cash and not in additional shares of Common Stock.

The issuances of the Stock Consideration are accounted for as a combination award in accordance with the accounting provisions under ASC 718, “Compensation — Stock Compensation” and ASC 350-40, “Intangibles — Goodwill and Other-Internal-Use Software” as noted in Note 2, regarding the technology purchase agreements.

The Stock Consideration is classified as a combination of equity awards (referred to herein as Issuance of Common Stock for Services) or liability awards (referred to herein as Stock-Based Compensation Liability) in accordance with GAAP. The fair value of an equity-classified award is determined at the grant date and is either recognized as an expense to software expense, an operating expense, on a straight-line basis over the service period, or is capitalized as an implementation cost and amortized to software expense over the useful life of the cloud computing arrangement once the software is placed in use. Whether the amount is expensed or capitalized is based on the respective statement of work in each agreement, the value attributed to each and the realization of those services. The fair value of a liability-classified award is determined on a quarterly basis beginning at the grant date until final vesting. Changes in the fair value of liability-classified awards are either recorded to software expense, an operating expense, on a straight-line basis over the service period, or capitalized as an implementation cost and amortized to software expense over the useful life of the cloud computing arrangement once the software is placed in use. Changes in the fair value of liability-classified awards do not result in an impact to the Company’s stockholders’ equity (deficit) balance.

As of December 31, 2024, the Company only recognized the par value of the shares that were issued and has recorded $125 as a non-current prepaid expense in other assets. The services in accordance with the agreements commenced on the Company’s IPO date, March 7, 2025, and as of September 30, 2025, services have been performed under the agreements and compensation costs for the services rendered has been recognized as a software expense or capitalized to capitalized implementation costs, based on the respective agreements.

The Company recognized the following amounts in total non-employee stock-based compensation costs in relation to the Stock Consideration issued for the technology purchase agreements for the nine and three months ended September 30, 2025 and 2024:

	Nine Months Ended September 30,				Three Months Ended September 30,
	2025		2024		2025		2024
Stock Consideration – Total Expensed	$	199,089	$	—	$	—	$	—
Stock Consideration – Total Capitalized	$	389,171	$	—	$	—	$	—

Equity-Classified Awards

The Company recognized the following amounts in non-employee equity-classified stock-based compensation costs for the nine and three months ended September 30, 2025 and 2024:

	Nine Months Ended September 30,				Three Months Ended September 30,
	2025		2024		2025		2024
Equity-Classified Awards – Expensed	$	159,091	$	—	$	—	$	—
Equity-Classified Awards – Capitalized	$	312,500	$	—	$	—	$	—

As of September 30, 2025, there was $4.5 million of total unrecognized compensation cost related to the Company’s equity-classified awards. This cost is expected to be recognized over a weighted-average period of 6.25 years, contingent upon the Company’s ongoing discussions with Artemis and EVEMeta to resolve the issues that caused the Company to send the notices of breach referenced above in Note 2 of this filing. During the nine and three months ended September 30, 2025, the Company recorded software expenses of $159,091 and $0, respectively, in connection with the services rendered with the support and maintenance services with Artemis and the use of the EVEMeta compression software, which included the expensing of the $62 previously recorded as a debit to non-current prepaid expense asset and a credit to Common Stock as of December 31, 2024, for a total increase to stockholders’ equity of $159,029 and $0 during the nine and three months ended September 30, 2025, respectively. Further, during the nine and three months ended September 30, 2025, the Company recorded an increase to capitalized implementation costs of $312,500 and $0, respectively, in connection with the development services rendered, which included the expensing of the $63 previously recorded as a debit to non-current prepaid expense asset and a credit to Common Stock as of December 31, 2024, for a total increase to stockholders’ equity of $312,437 during the nine months ended September 30, 2025. As a result, the total increase to stockholders’ equity for the issuance of common stock for services was $471,466 for the nine months ended September 30, 2025, which is the sum of the aforementioned $312,437 and $159,029 amounts. For the three months ended September 30, 2025, there was no increase to stockholders’ equity for the issuance of common stock for services in connection with the technology purchase agreements.

Liability-Classified Awards

The Company recognized the following amounts in non-employee liability-classified stock-based compensation costs for the nine and three months ended September 30, 2025 and 2024:

	Nine Months Ended September 30,				Three Months Ended September 30,
	2025		2024		2025		2024
Liability-Classified Awards – Expensed	$	39,998	$	—	$	—	$	—
Liability-Classified Awards – Capitalized	$	76,671	$	—	$	—	$	—

On May 12, 2025, the Company executed an amendment to the MSA with Artemis. The amendment eliminated the minimum share price guarantee, therefore no longer requiring the Company to guarantee a minimum return of $4 on the sale of each share received in compensation for the MSA. The amendment triggered a cash payment of $225,000 by the Company to Artemis. Further, the Company agreed to remove the lock-up provision and gradual release

obligations relating only to the stock consideration included in Exhibit A of the amended agreement, which releases 234,375 shares of Common Stock as of the amendment date. The cash payment, elimination of the $4 guarantee, and removal of the lock-up provision and gradual release obligations were made in contemplation of Artemis delivering to the Company the Services and Deliverable to be provided pursuant to the MSA.

On the same day, the Company executed an amendment to the SaaS Agreement with EVEMeta. The amendment eliminated the minimum share price guarantee, therefore no longer requiring the Company to guarantee a minimum return of $4 on the sale of each share received in compensation for the SaaS Agreement. The amendment triggered a cash payment of $25,000 by the Company to EVEMeta. No shares were released from lock-up provisions for EVEMeta. The cash payment and elimination of the $4 guarantee were made in contemplation of EVEMeta delivering to the Company the Compression Services to be provided pursuant to the SaaS.

On May 12, 2025, the Company completed a fair value measurement valuation for the cash settlement provision, the liability classified award, using a Monte Carlo simulation model and determined a total fair value of $2,942,136. The Company recognized a stock-based compensation liability from the total fair value only to the extent in which services were provided to the Company through the amendment date, which resulted in partial recognition and was an estimate by the Company as of the amendment date. This resulted in the recognition of an increase to the stock-based compensation liability of $44,392 as of March 31, 2025 for $72,277 from April 1, 2025 through the amendment date, of which $41,331 was capitalized to capitalized implementation costs and $30,946 was expensed as a software expense. During the three months ended September 30, 2025, these amounts did not have an impact on the balance of the Company’s stockholders’ equity.

As of May 12, 2025, the Company recognized a stock-based compensation liability of $116,669, of which $76,671 was capitalized to capitalized implementation costs and $39,998 was expensed as a software expense. The stock-based compensation liability was extinguished as a result of the amendment on May 12, 2025.

NOTE 4 — COMMITMENTS AND CONTINGENCIES

The Company evaluates its business transactions and agreements during the course of business to identify whether any contingencies or commitments exist which would give rise to the recognition of a loss or liability. The Company is currently not involved with or know of any pending or threatening litigation against the Company or any of its officers. Further, the Company is currently complying with all relevant laws and regulations and does not have any long-term commitments or guarantees.

Marketing Agreement

In March of 2024, the Company also entered into a marketing agreement with Outside the Box Capital, Inc. for marketing services to be provided for the six-months period from May 1, 2024 to October 31, 2024. Compensation for these services will be $100,000 in cash and due upon either the successful completion of the Company’s IPO or within six months from the effective date of the agreement, the earlier of the two dates. Additionally, the Company will issue shares of BHHI Common Stock, priced at the IPO, totaling $200,000. The shares became due 10 days after the successful completion of the Company’s IPO on March 6, 2025, deemed the listing date, and were issued in April of 2025. Lastly, if the Company achieves a $50 million market cap for a minimum of seven days during the period of services, the Company will issue an additional 50,000 shares. Services under this contract were not provided during the expected service period of May through October of 2024. A modification of the agreement was negotiated and finalized in November of 2024. Services were amended to begin on December 15, 2024 through June 15, 2025. Services had not yet commenced as of December 31, 2024. As a result, a modification of the agreement was executed on March 28, 2025. This new agreement revised the dates of service to begin on March 6, 2025 through September 6, 2025. It also revised the terms of compensation and, as a result, the base compensation of $100,000 will be payable in two tranches, the first payment for $50,000 within 10 business days following the Company’s listing date as a publicly traded company (“Listing Date”) and the second and final payment for the remaining amount will be due three months from the Listing Date. The first payment of $50,000 was made in April of 2025. As a result, no accrual for a liability was recorded as of December 31, 2024. Please see Note 10 for more detail on this amendment.

Broncos Sponsorship Agreement

During 2023, the Company entered into a sponsorship agreement with Stadium Management Company and the Denver Broncos. This resulted in marketing expenses totaling $305,000 during the year ended December 31, 2023. In September of 2024, the parties concluded the sponsorship agreement and this resulted in a reduction of the payable amount from $305,000 to $61,000. The reduction of $244,000 was recorded as other income during the year ended December 31, 2024.

Technology Purchase Agreements

On November 13, 2024 (the “Artemis Effective Date”), the Company entered into a MSA with Artemis, a skilled technology company, whereby Artemis agreed to develop a proprietary machine learning solution for the Company’s platform (the “Software”) and provide certain services. In exchange, the Company agreed to issue 937,500 shares of its Common Stock to Artemis (the “Artemis Stock Consideration”) in December 2024. The Artemis Stock Consideration is subject to a lock-up provision, with shares of the Artemis Stock Consideration to be released in three (3) equal tranches of 312,500 shares each according to the terms outlined in the MSA and the respective Statements of Work (“SOWs”) attached thereto. In connection with the execution of the MSA, on November 13, 2024 (the “EVEMeta” Effective Date”), the Company entered into a SaaS Agreement with EVEMeta, an innovative technology company, whereby EVEMeta agreed to license its solution to the Company. In exchange, the Company issued 312,500 shares of its Common Stock to EVEMeta (the “EVEMeta Stock Consideration” and, collectively, with the Artemis Stock Consideration, the “Stock Consideration”). The 1,250,000 shares granted to Artemis and EVEMeta in exchange for services had a fair market value of $4.00 per share at the date of grant for a total cost of $5,000,000. Further, once released from lock up, the Company will provide each vendor with a guarantee of a minimum value for the released shares for 18 months from the date of release. In the event that either vendor is not able to resell the shares at the IPO price of $4.00 per share, the Company will make additional payments under its minimum value guarantee to the vendor in cash to ensure a total compensation of $3,750,000 to Artemis and $1,250,000 to EVEMeta. Those payments will be made in cash and not in additional shares of Common Stock.

The issuances of the Stock Consideration are accounted for in accordance with the accounting provisions under ASC 718, “Compensation — Stock Compensation” and ASC 350-40, “Intangibles — Goodwill and Other-Internal-Use Software” as noted in Note 2, regarding the technology purchase agreements. As of December 31, 2024, the Company did not recognize a liability for the cash settlement provision since the IPO had not yet taken place. Further, the Company has only recognized the par value of the shares that were granted and has recorded $125 as an other assets. The remaining cost basis will be recognized as the milestones are achieved and shares are removed from the lock-up provisions, which is expected to commence in 2025. Please refer to Note 2 and 5 for further detail about the technology purchase agreements.

Segment Reporting

9 Months Ended

12 Months Ended

Sep. 30, 2025

Dec. 31, 2024

Segment Reporting [Abstract]

SEGMENT REPORTING

NOTE 8 — SEGMENT REPORTING

The Company and its subsidiaries manage its business activities on a consolidated basis and operate as a single operating segment (the “Gaming” segment). The Company is a vertically integrated social network for college gaming and its mission is to create a community which empowers gamers, streamers, and fans to interact with one another. The Company’s platform, which focuses on building a centralized gaming experience for non-professional college gamers and their fans, achieves this by allowing college students to compete against one another, support their favorite gamers and teams, and win prizes. The accounting policies of the Gaming segment are the same as those described in Note 2 — Summary of Significant Accounting Policies of our Annual Report on Form 10-K for the year ended December 31, 2024.

The Company’s CODM is our Chief Executive Officer, Lavell Juan Malloy, II. The CODM uses net income (loss), as reported on our condensed consolidated statements of operations and comprehensive income (loss), in evaluating performance of the Gaming segment and determining how to allocate resources of the Company as a whole. The CODM does not review assets in evaluating the results of the Gaming segment, and therefore, such information is not presented.

The following table provides the operating financial results of our Gaming segment:

	Nine Months Ended September 30,						Three Months Ended September 30,
	2025			2024			2025			2024
Total Revenue	$	—		$	55		$	—		$	—
Less: Significant and Other Segment Expenses
Cost of Sales		—			464			—			—
Advertising and Marketing		475,972			160,478			182,216			160,270
Legal and Professional		843,712			486,262			374,943			224,510
Selling, General and Administrative		1,595,027			457,362			713,415			113,566
Software Expense		240,215			—			14,880			—
Software Development		1,621			18,955			457			6,118
Stock-Based Compensation		700,140			137,006			344,569			44,974
Interest Expense and Amortization of Debt Discount		438,709			1,985,213			—			704,239
Other Income		(162,441	)		(245,269	)		(91,131	)		(244,235	)
Other Expenses		46,405			—			—			—
Other Expense – Stock-Based Compensation Liability		133,331			—			—			—
Foreign Currency Loss		(437	)		766			14			616
Net Unrealized Gain on Equity Securities		(4,080,000	)		—			(4,080,000	)		—
Provision for Income Taxes		—			—			—			—
Segment Net Income (Loss)	$	(232,254	)	$	(3,001,182	)	$	2,540,636		$	(1,010,058	)

NOTE 9 — SEGMENT REPORTING

The Company and its subsidiaries manage its business activities on a consolidated basis and operate as a single operating segment. The Company is a vertically integrated social network for college gaming and its mission is to create a community which empowers gamers, streamers, and fans to interact with one another. The Company’s platform, which focuses on building a centralized gaming experience for non-professional college gamers and their fans, achieves this by allowing college students to compete against one another, support their favorite gamers and teams, and win prizes. The accounting policies of the gaming segment are the same as those described in Note 2 — Summary of Significant Accounting Policies.

The Company’s CODM is our Chief Executive Officer, Lavell Juan Malloy, II. The CODM uses net loss, as reported on our consolidated statements of operations and comprehensive loss, in evaluating performance of the gaming segment and determining how to allocate resources of the Company as a whole. The CODM does not review assets in evaluating the results of the gaming segment, and therefore, such information is not presented.

The following table provides the operating financial results of our gaming segment:

	Year Ended December 31,
	2024			2023
Total Revenue	$	105		$	366,438
Less: Significant and Other Segment Expenses
Cost of Sales		464			34,835
Advertising and Marketing		172,989			311,464
Legal and Professional		490,528			321,506
Selling, General and Administrative		626,901			1,099,576
Software Development		21,034			24,074
Stock-Based Compensation		179,766			556,222
Rent Expense		92			1,114
Interest Expense and Amortization of Debt Discount		2,179,122			2,769,208
Other Income		(384,047	)		(79,113	)
Foreign Currency Loss		1,775			—
Segment Net Loss	$	(3,288,519	)	$	(4,672,348	)

- Definition

The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 21
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-21

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 21
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-21

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-32

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 31
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-31

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 15
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-15

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 42
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-42

Reference 7: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 48
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482785/280-10-55-48

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-32

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 270
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (i)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482964/270-10-50-1

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (ee)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-32

Reference 11: http://fasb.org/us-gaap/role/ref/otherTransitionRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-32

Reference 12: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 54
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482785/280-10-55-54

Reference 13: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 47
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482785/280-10-55-47

Reference 14: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 54
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482785/280-10-55-54

Reference 15: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 47
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482785/280-10-55-47

Reference 16: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 54
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482785/280-10-55-54

Reference 17: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 47
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482785/280-10-55-47

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 22
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-22

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 34
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-34

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 26C
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-26C

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 26B
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-26B

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 40
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-40

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org/280/tableOfContent

Reference 24: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 26
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-26

Reference 25: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 41
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-41

+ Details

Summary of Significant Accounting Policies

9 Months Ended

12 Months Ended

Sep. 30, 2025

Dec. 31, 2024

Summary of Significant Accounting Policies [Abstract]

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

NOTE 2 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (“GAAP”) and applicable rules and regulations of the SEC regarding interim financial reporting. In the opinion of management, the accompanying unaudited condensed consolidated financial statements contain all adjustments (consisting of normal recurring adjustments) and disclosures necessary for a fair statement of the Company’s financial position as of September 30, 2025 and the results of its operations for the nine months then ended. The results of operations for the nine months ended September 30, 2025 are not necessarily indicative of the results to be expected for the year ending December 31, 2025 or for any other interim period or for any other future year. These interim unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto contained in the Company’s Annual Report within its Form 10-K filing. Interim disclosures generally do not repeat those in the annual statements. The Company and its subsidiaries operate as a single operating segment.

Principles of Consolidation

The condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation.

Segment Reporting

The Company follows the guidance in ASC Topic 280, “Segment Reporting”, for the identification and disclosure of reportable segments. Operating segments are defined as components of an enterprise for which separate financial information is available and evaluated regularly by the Company’s chief operating decision maker (“CODM”) in deciding how to allocate resources and in assessing performance.

The Company’s CODM, who is its Chief Executive Officer, reviews financial information presented on a consolidated basis for purposes of making operating decisions and assessing performance. The Company manages its operations and evaluates financial performance as a single operating segment. Accordingly, the Company has determined that it operates in one reportable segment.

The Company’s operations are currently located in the United States, and substantially all revenues are derived from U.S. customers. Management will continue to evaluate the Company’s operations to determine if, in the future, changes in organizational structure or business activities require the identification of additional reportable segments.

Use of Estimates

The preparation of financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets, liabilities, equity-based transactions and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.

The Company bases its estimates and assumptions on an ongoing basis using historical experience and other factors, known or expected trends and various other assumptions that it believes to be reasonable. As future events and their effects cannot be determined with precision, actual results could differ from these estimates, which may cause the Company’s future results to be affected.

Cash and Cash Equivalents

The Company considers all highly liquid investments with maturities of three months or less at the time of purchase to be cash equivalents. As of September 30, 2025, the Company had $9,575,000 of cash in a sweep account, which is classified as cash. There were no cash equivalents as of September 30, 2025 and December 31, 2024.

Allowance for Credit Losses

Trade accounts receivable are stated net of an allowance for credit losses. The Company estimates the credit losses using historical information, current economic conditions and reasonable and supportable forecast information for a reasonable period of time. The Company starts by determining expected credit losses by using historical loss information based on the aging of receivables. An analysis of the current economic conditions along with forecast information is then used to determine any adjustment to the historical loss rates to determine the appropriate rates for future losses and the Company’s current expected credit losses for trade receivables. As of September 30, 2025 and December 31, 2024, there were no accounts receivable balances. As such, an allowance was not necessary.

Offering Costs

Further, during the nine months ended September 30, 2025, additional offering costs of $1,252,780 were incurred simultaneously with the closing of the IPO. Of this amount, $190,980 is recorded as offering costs and the remaining $1,061,800 is displayed as a net amount against the IPO and over-allotment option proceeds on the condensed consolidated statements of changes in stockholders’ equity (deficit). No costs were incurred from the closing of the IPO during the three months ended September 30, 2025.

Lastly, the Company incurred an additional $3,549,294 in offering costs in connection with the PIPE Offering during the nine and three months ended September 30, 2025. Please refer to Note 5 for details.

Subscription Receivable

The Company records share issuances at the effective date. If the subscription is not funded upon issuance, the Company records a subscription receivable as an asset on its balance sheet. When subscription receivables are not received prior to the issuance of financial statements at a reporting date in satisfaction of the requirements under Financial Accounting Standards Board (the “FASB”) Accounting Standards Codification (“ASC”) 505-10-45-2, “Equity” — Other Presentation Matters, the subscription receivable is reclassified as a contra account to stockholders’ equity (deficit) on the condensed consolidated balance sheet.

During the nine and three months ended September 30, 2025, the Company received $713 in cash from outstanding subscriptions receivable and wrote off the remaining balance of $2,987.

Employee Retention Tax Credit

The Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”) provided an employee retention credit which was a refundable tax credit against certain employment taxes. The Consolidated Appropriations Act (the “Appropriations Act”) extended and expanded the availability of the employee retention credit through December 31, 2021. The Appropriations Act amended the employee retention credit to be equal to 70% of qualified wages paid to employees during the 2021 fiscal year. The Company qualified for the employee retention credit beginning in October 2021 for qualified wages through December 2021 and filed a cash refund claim during the year ended December 31, 2023.

The Company has a tax credit receivable of $17,408 and $34,667 included as an other receivable in the current assets section of the Company’s condensed consolidated balance sheets as of September 30, 2025 and December 31, 2024, respectively.

Accounts Payable

Accounts payable consist of amounts due to vendors and service providers for goods and services received in the ordinary course of business. Accounts payable are recognized when the obligation to pay arises, typically upon receipt of goods or services and are recorded at their nominal amounts, which approximate fair value due to their short-term nature.

The Company’ standard payment terms with vendors generally range from net 15 to net 60 days. Discounts received from vendors for early payment are recognized when earned. Vendor discounts are recorded as a reduction of the related expense in the accompanying consolidated statements of operations. If such discounts are not clearly associated with a specific expense category, they are recorded as a reduction to cost of goods sold or, if immaterial, may be recognized as other income.

The Company reviews accounts payable regularly to ensure timely payment and to assess the need for accruals for goods or services received but not yet invoiced. At each reporting period, any unbilled amounts are accrued and reflected in accrued liabilities, and estimates are based on historical trends, vendor communication, and other relevant factors.

The Company does not maintain a formal policy for interest on past due payables and generally does not incur material penalties or interest expenses in the normal course of settling vendor obligations.

During the nine months ended September 30, 2025 and 2024, the Company recognized other income due to discounts granted by vendors in the amount of $73,450 and $0, respectively. During the three months ended September 30, 2025 and 2024, the Company recognized other income due to discounts granted by vendors in the amount of $30,800 and $0, respectively.

Concentration of Credit Risk

Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash and cash equivalents in financial institutions, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. As of September 30, 2025, the Company was exposed to significant risks in one of its bank accounts, which had balances that exceeded the insurance coverage amount by a total of $9,345,577. The Company has not experienced any losses in such accounts.

Advertising and Marketing

The Company expenses advertising and marketing costs as they are incurred. Advertising and marketing expenses were $475,972 and $160,478 for the nine months ended September 30, 2025 and 2024, respectively. The Company incurred $182,216 and $160,270 in advertising and marketing expenses for the three months ended September 30, 2025 and 2024, respectively.

Fair Value Measurements

As defined in ASC 820, “Fair Value Measurements and Disclosures”, fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (exit price). The Company utilizes market data or assumptions that market participants would use in pricing the asset or liability, including assumptions about risk and the risks inherent in the inputs to the valuation technique. These inputs can be readily observable, market corroborated, or generally unobservable. ASC 820 establishes a fair value hierarchy that prioritizes the inputs used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurement) and the lowest priority to unobservable inputs (Level 3 measurement). This fair value measurement framework applies at both initial and subsequent measurement.

		Level 1:		Quoted prices are available in active markets for identical assets or liabilities as of the reporting date.
		Level 2:		Pricing inputs are other than quoted prices in active markets included in Level 1, which are either directly or indirectly observable as of the reported date. Level 2 includes those financial instruments that are valued using models or other valuation methodologies.
		Level 3:		Pricing inputs include significant inputs that are generally less observable from objective sources. These inputs may be used with internally developed methodologies that result in management’s best estimate of fair value. The significant unobservable inputs used in the fair value measurement for nonrecurring fair value measurements of long-lived assets include pricing models, discounted cash flow methodologies and similar techniques.

The carrying value of the Company’s financial instruments: cash, other receivables, accounts payable and accrued liabilities, and borrowings, approximate their fair values because of the short-term nature of these financial instruments.

Equity Awards with a Guaranteed Minimum-Value Cash Settlement — Technology Purchase Agreements

The Company evaluates its stock-based compensation arrangements within the scope of ASC 718, “Compensation — Stock Compensation”. The Company has issued an equity award with a guaranteed minimum-value cash settlement in accordance with the terms that were agreed upon by the Company in the Master Services Agreement (“MSA”) with Artemis Ave LLC (“Artemis”) and the Software as a Service Agreement (the “SaaS” Agreement) with EVEMeta, LLC (“EVEMeta”). Subsection ASC 718-10-20 defines these equity awards as combination awards. Under this classification, the share grant is accounted for as an equity-classified award measured at grant-date fair value, and the cash-settled written put option is liability classified and marked to fair value at each reporting period. Compensation costs for the share grant are measured and fixed on the date of grant and recognized over the vesting period, which is consistent with the delivery of goods and services. Compensation costs associated with the cash-settled written put option should be recognized over the vesting period based on the remeasured fair value at each reporting period, which is consistent with the delivery of goods and services from the vendor, until settlement. To value the cash-settled written put option, the Company remeasures the fair market value of the written put option via an appropriate option pricing model in accordance with ASC 718, and records the appropriate liability as of each reporting period with a corresponding adjustment to software expense. The Company determines the fair value of the liability using a Monte Carlo simulation model at each reporting period. On May 12, 2025, the Company amended the Artemis MSA and EVEMeta SaaS agreements and removed the guaranteed minimum-value cash settlement in exchange for cash payments

totaling $250,000 in contemplation of Artemis delivering to the Company the Services and Deliverable to be provided pursuant to the MSA and EVEMeta delivering to the Company the Compression Services to be provided pursuant to the SaaS. This amendment effectively settled the stock-based compensation liability. A valuation was completed as of May 12, 2025, and the fair value measurement of the cash-settled written put option for services provided thus far resulted in an additional stock-based compensation liability of $72,277, for a total balance of $116,669. The settlement of the stock-based compensation liability in exchange for a cash payment of $250,000 resulted in the derecognition of the total liability balance of $116,669 and an other expense of $133,331 for the difference. As of May 12, 2025, a stock-based compensation liability no longer exists.

Please refer to Notes 4 and 5 for a detailed explanation of the terms of the technology purchase agreements.

Cloud Computing Arrangements — Technology Purchase Agreements

The Company applies the guidance under ASC 350-40, “Intangibles — Goodwill and Other-Internal-Use Software”, when evaluating the applicable accounting treatment for the purchase of technological products and services. The Company has determined that the MSA with Artemis and the SaaS agreement with EVEMeta constitute a cloud computing arrangement (“CCA”). The terms of the agreements provide for software development, which include CCA implementation costs, support and maintenance services, and the use of the EVEMeta compression software. The Company accounts for the CCA implementation costs in a different manner than the support and maintenance services from the Artemis agreement and the terms of the SaaS agreement with EVEMeta.

The Company capitalizes implementation costs associated with its CCA consistent with costs capitalized for internal-use software. The stock-based payments provided in advance for implementation costs are recorded as capitalized implementation costs as the services are rendered. Capitalized implementation costs related to the CCA are included on the condensed consolidated balance sheets. The CCA implementation costs are amortized over the term of the related hosting agreement, including renewal periods that are reasonably certain to be exercised. Amortization will begin only when the software is placed into use and the amortization expense will be recorded as an operating expense. As of December 31, 2024, $63 was recognized as a non-current prepaid expense asset related to the development services to be provided by Artemis. As of September 30, 2025 and December 31, 2024, $389,171 and $0 was recognized, respectively, as capitalized implementation costs related to the Company’s cloud computing arrangements and no amortization expense has been recognized for the three or nine months ended September 30, 2025 or 2024 as the software is in the process of being developed by Artemis. The amount of $389,171 is a recognition of $312,500 for services provided, which included the reclassification of the $63 recorded as a non-current prepaid expense asset as of December 31, 2024, and a portion of the change in fair value of the stock-based compensation liability which equaled $76,671 during the nine months ended September 30, 2025. During the three months ended September 30, 2025 and 2024, the stock-based compensation liability did not exist and no change was recognized.

The costs associated with the support and maintenance services and the use of the EVEMeta compression software are recorded as software expenses over the service period defined in the respective agreements. As of December 31, 2024, $62 was recognized as a non-current prepaid expense asset related to the services by Artemis and EVEMeta for support and maintenance. During the nine months ended September 30, 2025, the Company recorded software expenses of $159,091 in connection with the EVEMeta compression software, which included the expensing of the $62 recorded as a non-current prepaid expense asset as of December 31, 2024. During the three months ended September 30, 2025, the Company did not record any additional software expenses in connection with the services rendered with the support and maintenance services and the use of the EVEMeta compression software. The Company sent notices of material breach to both Artemis and EVEMeta regarding the MSA and SaaS Agreements during the three months ended September 30, 2025, and all services from Artemis and EVEMeta have remained halted. As such, no additional software expenses or capitalized assets were recognized in relation to the MSA and SaaS Agreements during the three months ended September 30, 2025.

Convertible Debt

The Company accounts for convertible debt instruments in accordance with the provisions of ASC 470-20, “Debt with Conversion and Other Options”. Under this guidance, convertible debt instruments that do not meet the criteria for separation of embedded conversion features from the host contract are accounted for as a single liability. If a convertible debt instrument contains embedded features (e.g., conversion options, redemption rights) that require separate accounting under ASC 815, the Company evaluates such features and bifurcates them as derivative liabilities when applicable. Issuance costs related to convertible debt are presented as a direct deduction from the carrying amount of the liability and are amortized to interest expense over the term of the debt using the effective interest method.

Shares Payable

The Company has incurred obligations that are payable in shares of the Company’s equity. If shares are not issued to satisfy those obligations, a short-term liability is recognized as a share payable. The Company has a share payable balance of $221,434 and $32,500 as of September 30, 2025 and December 31, 2024, respectively. Please refer to Notes 5, 6 and 10 for more detail.

Revenue Recognition

The Company recognizes revenue from the sale of products and services in accordance with ASC 606, “Revenue Recognition” following the five step procedure:

Step 1: Identify the contract(s) with customers

Step 2: Identify the performance obligations in the contract

Step 3: Determine the transaction price

Step 4: Allocate the transaction price to performance obligations

Step 5: Recognize revenue when or as performance obligations are satisfied

The Company generates revenues mainly from advertising, sponsorship and league tournaments. An insignificant amount of revenue is generated through the operation of its live streaming platform using a revenue model whereby gamers and creators can get free access to certain live streaming of amateur tournaments, and gamers and creators pay fees or subscriptions to compete in league competitions. Streaming revenue amounts are recognized as live-streaming services on the condensed consolidated statements of operations and comprehensive income (loss).

Foreign Currency Translation

For the Company’s non-U.S. operations where the functional currency is the local currency, the Company translates assets and liabilities at exchange rates in effect at the balance sheet date and record translation adjustments in stockholders’ equity. The Company translates income statement amounts at average rates for the period. Transaction gains and losses are recorded in other (income) expense, net in the condensed consolidated statement of operations and comprehensive income (loss).

The Company recognized a gain on foreign currency from the settlement of a note payable for $424 and the fluctuation of receivables and payables due in foreign currency totaling $13, for a total foreign currency gain of $437. Please refer to Note 6.

Comprehensive Income (Loss)

The Company reports comprehensive income (loss) and its components in its condensed consolidated financial statements. Comprehensive income (loss) consists of net income (loss) and foreign currency translation adjustments, affecting stockholders’ equity (deficit) that, under U.S. GAAP, is excluded from net income (loss).

Net Income (Loss) per Common Share

The computation of earnings per share (“EPS”) includes basic and diluted EPS in accordance with ASC 260, “Earnings per Share”. Basic EPS is measured as the income (loss) available to common stockholders divided by the weighted average common shares outstanding for the period. Diluted income (loss) per share reflects the potential dilution, using the if-converted and treasury stock methods, that could occur if securities or other contracts to issue common stock were exercised or converted into common stock or resulted in the issuance of common stock that then shared in the income (loss) of the Company as if they had been converted at the beginning of the periods presented, or issuance date, if later. In computing diluted income (loss) per share, the treasury stock method assumes that outstanding options and warrants have been exercised, and the proceeds have been used to purchase common stock at the average market price during the period. Options and warrants may have a dilutive effect under the treasury stock method only when the average market price of the common stock during the period exceeds the exercise price of the options and warrants. Potential common shares that have an anti-dilutive effect (i.e., those that increase income per share or decrease loss per share) are excluded from the calculation of diluted EPS. All outstanding convertible promissory notes and convertible preferred stock are considered common stock at the beginning of the period or at the time of issuance, if later, pursuant to the if-converted method. Since the effect of common stock equivalents is anti-dilutive with respect to losses, the shares issuable upon conversion have been excluded from the Company’s computation of net loss per common share for all periods except the three months ended September 30, 2025, since the Company recognized income in that period.

The following table summarizes the securities that are excluded from the diluted per share calculation because the effect of including these potential shares is anti-dilutive. This exclusion applies to all periods except the three months ended September 30, 2025, since the Company recorded income during the three months ended September 30, 2025 and therefore the effect of these shares was no longer anti-dilutive.

	As of September 30,
	2025	2024
Convertible Debt	—	1,813,923
Unvested Restricted Stock	17,446	87,514
Shares Payable	300,355	—
Convertible Preferred Stock	15,923,567	82,096
Warrants	7,581,490	—
Stock Options	885,588	—
Total	24,708,446	1,983,533

As of September 30, 2025, no dividends have been declared since inception and all classes of BHHI’s stock do not have cumulative dividend features. As such, the Company did not include any adjustment to the net income (loss) for dividends.

The table below represents the calculation for both basic and diluted net income (loss) per share:

	Nine Months Ended September 30,						Three Months Ended September 30,
	2025			2024			2025		2024
Net Income (Loss)	$	(232,254	)	$	(3,001,182	)	$	2,540,636	$	(1,010,058	)
Weighted-average Shares Outstanding – Basic		9,786,460			5,664,529			10,829,664		5,688,797
Income (Loss) per share – Basic	$	(0.02	)	$	(0.53	)	$	0.23	$	(0.18	)
Net Income (Loss)	$	(232,254	)	$	(3,001,182	)	$	2,540,636	$	(1,010,058	)
Increase to Net Income attributable to dilutive instruments		—			—			—		—
Net Income available to Common Shareholders – Diluted	$	(232,254	)	$	(3,001,185	)	$	2,540,636	$	(1,010,058	)
Weighted-average Shares Outstanding – Basic		9,786,460			5,664,529			10,829,664		5,688,797
Effect of Unvested Restricted Stock		—			—			17,446		—
Effect of Shares Payable		—			—			241,659		—
Effect of Convertible Preferred Stock		—			—			10,731,100		—
Effect of Warrants		—			—			3,657,119		—
Effect of Stock Options		—			—			610,858		—
Weighted-average Shares Outstanding – Diluted*		9,786,460			5,664,529			26,087,846		5,688,797
Income (Loss) per share – Diluted	$	(0.02	)	$	(0.53	)	$	0.10	$	(0.18	)

____________

* Only noted for the periods in which the result is not anti-dilutive.

Income Taxes

The Company follows the asset and liability method of accounting for income taxes under ASC 740, Income Taxes. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The Company’s temporary differences result primarily from capitalization of certain qualifying research and development expenses, stock-based compensation, and net operating loss carryovers. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. A valuation allowance is recorded for deferred tax assets if it is more likely than not that some portion or all of the deferred tax assets will not be realized.

The Company recognizes the effect of income tax positions only if those positions are more likely than not to be sustained. Recognized income tax positions are measured at the largest amount that is greater than 50% of likely being realized. Changes in recognition or measurement are reflected in the period in which the change in judgment occurs.

The Company records interest related to unrecognized tax benefits in interest expense and penalties in selling, general and administrative expenses.

The Company, with stockholder’s consent, elected to be taxed as an “S Corporation” during the years prior to 2021 under the provisions of the Internal Revenue Code under Section 1362(a) and comparable state income tax law. As an S Corporation, the Company is generally not subject to corporate income taxes and the Company’s net income or loss is reported on the individual tax return of the stockholders of the Company. As a result of the UK Reorganization, the Company was no longer eligible to elect an S Corporation status for tax purposes and was subject to tax filings as a C-Corporation for the years ending 2021 through 2024. The Company filed all necessary Federal and State tax returns as a C-Corporation for the years ending 2021 through 2024, and has accrued $95,000 as of September 30,

2025 and December 31, 2024 for any potential non-compliance penalties that may be incurred as a selling, general and administrative expense. This amount was reclassified from a provision for income taxes during the second quarter of 2024 to a selling, general and administrative expense during the third quarter of 2024.

The Company identified its federal, New York state, and the United Kingdom tax returns as its “major” tax jurisdictions. The period for income tax returns that are subject to examination for the United Kingdom jurisdiction are 2021 through 2024. The periods 2022 through 2024 for income tax returns are subject to examination for the federal and New York state jurisdictions. The Company believes its income tax filing positions and deductions will be sustained on audit, and management does not anticipate any adjustments that would result in a material change to its financial position. Therefore, no liabilities for uncertain tax positions have been recorded.

As of September 30, 2025, the Company had approximately $14,854,359 in gross federal net operating loss carry-forwards. The Company also had approximately $16,514,918 in gross state net operating loss carry-forwards. As a result of the Tax Cuts Job Act 2017 (the “Act”), certain future federal carry-forwards do not expire. Beginning in 2018, under the TCJ Act, federal loss carryforwards have an unlimited carryforward period, however such losses can only offset 80% of taxable income in any one year. The Company has not performed a formal analysis, but believes its ability to use such net operating losses and tax credit carry-forwards in the future is subject to annual limitations due to change of control provisions under Sections 382 and 383 of the Internal Revenue Code, which will significantly impact its ability to realize these deferred tax assets. For net loss carryforwards in the State of New York, the Company is able to carry it back three tax years preceding the tax year of the loss (the loss year). However, a loss cannot be carried back to a tax year beginning before January 1, 2015. The loss is first carried to the earliest of the three tax years. If it is not entirely used in that year, the remainder is carried to the second tax year preceding the loss year, and any remaining amount is carried to the tax year immediately preceding the loss year. Any unused amount of loss then remaining may be carried forward for as many as 20 tax years following the loss year. Losses carried forward are carried forward first to the tax year immediately following the loss year, then to the second tax year following the loss year, and then to the next immediately subsequent tax year or years until the loss is used up or the 20th tax year following the loss year, whichever comes first.

The Company recorded a valuation allowance in the full amount of its net deferred tax assets since realization of such tax benefits has been determined by the Company’s management to be less likely than not. The valuation allowance decreased $1,044,912 during the quarter ended September 30, 2025.

The Company’s effective tax rate is 0% for the three and nine months ended September 30, 2025 and 2024.

Stock-Based Compensation

The Company evaluates its stock-based compensation arrangements within the scope of ASC 718, “Compensation — Stock Compensation”. The Company measures and records the expense related to stock-based payment awards based on the fair value of those awards as determined on the date of grant. The Company recognizes stock-based compensation expense over the requisite service period of the grant, generally equal to the vesting period, and uses the straight-line method to recognize stock-based compensation. For stock options with performance conditions, the Company records compensation expense when it is deemed probable that the performance condition will be met. The Company measures the fair value of stock options and warrants granted to employees, directors, and non-employees using option pricing models, including the Black-Scholes-Merton (“Black-Scholes”) option-pricing model and Binomial Lattice models. The determination of the fair value of these instruments requires management to make certain estimates and assumptions that have a material impact on the amount of stock-based compensation expense recognized.

Key assumptions used in these models include expected volatility, expected term, risk-free interest rate, and expected dividend yield. Because the Company has a limited operating history and insufficient historical trading data to estimate expected volatility, the Company bases its volatility assumption on the historical volatilities of a group of comparable publicly traded companies within its industry. The risk-free interest rate is based on the yield

of U.S. Treasury securities with maturities consistent with the expected term of the related option or warrant. The expected dividend yield is assumed to be zero, as the Company has not historically declared or paid dividends and does not anticipate doing so in the foreseeable future.

The Company uses the “simplified method” to estimate the expected term for stock options that have exercise prices issued at the money and are considered plain vanilla options, consistent with SEC Staff Accounting Bulletin Topic 14. For stock options with exercise prices that are out of the money, the Company uses a Binomial Lattice model, which incorporates assumptions about future exercise behavior and potential changes in stock price over the life of the award.

The Company issued stock options exercisable into 1,950,000 shares of its Common Stock during the nine months ended September 30, 2025. The Company has issued warrants convertible into 44,250 shares of its Common Stock to the underwriter in connection with its IPO, and warrants convertible into an additional 17,517,203 shares of its Common Stock in connection with the PIPE Offering as of September 30, 2025. Please refer to Notes 1 and 5 for more information. Stock-based payment awards, such as stock options or restricted stock awards, are valued based on the fair value on the date of grant and amortized ratably over the estimated life of the award. Stock-based payment awards may vest based on the passage of time, or upon occurrence of a specific event or achievement of goals as defined in the grant agreements. In such cases, the Company records compensation expenses related to grants of stock-based payment awards on management’s estimates of the probable dates of the vesting events. The Company recognizes forfeitures of stock-based payment awards as they occur.

Investment in Equity Securities

Investments in equity securities are accounted for under ASC 321 and reported at their readily determinable fair values as quoted by market exchanges, with changes in fair value recorded in other (income) expense in the condensed consolidated statements of operations and comprehensive income (loss). All changes in an equity security’s fair value are reported in earnings as they occur. As such, the sale of an equity security does not necessarily give rise to a significant gain or loss. Unrealized gains (losses) due to fluctuations in fair value are recorded in the condensed consolidated statements of operations and comprehensive income (loss).

Recently Issued but not yet Adopted Accounting Pronouncements

On December 14, 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740). This ASU requires the use of consistent categories and greater disaggregation in tax rate reconciliations and income taxes paid disclosures. These amendments are effective for fiscal years beginning after December 15, 2024 and for interim periods in fiscal years beginning after December 31, 2025. These income tax disclosure requirements can be applied either prospectively or retrospectively to all periods presented in the financial statements. Management is currently evaluating the impact of adopting this standard, and does not expect it to have a material impact on the financial statements.

In November 2024, the FASB issued ASU 2024-03, “Income Statement-Reporting Comprehensive Income-Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses.” The standard requires that public business entities disclose additional information about specific expense categories in the notes to financial statements for interim and annual reporting periods. The standard will become effective for the Company for its fiscal year 2027 annual financial statements and interim financial statements thereafter and may be applied prospectively to periods after the adoption date or retrospectively for all prior periods presented in the financial statements, with early adoption permitted. The Company plans to adopt the standard beginning with the fiscal year 2027 annual financial statements, and management is currently evaluating the impact this standard will have on the disclosures included in the notes to the financial statements.

In July 2025, the FASB issued Accounting Standards Update (ASU) 2025-05, Financial Instruments — Credit Losses (Topic 326): Measurement of Credit Losses for Accounts Receivable and Contract Assets. This ASU introduces a practical expedient, applicable to all entities, permitting the assumption that current conditions as of the balance sheet date remain unchanged over the remaining life of current accounts receivable and current contract assets arising

from transactions under ASC 606. These amendments are effective for annual periods beginning after December 15, 2025, including interim periods within those fiscal years, with early adoption permitted. The guidance is to be applied prospectively. The Company is currently evaluating the impact of ASU 2025-05 on its accounting estimates and allowance methodology. At this time, the Company has not yet determined the effect, if any, that adoption of this ASU will have on its consolidated financial position, results of operations, disclosures, or processes.

NOTE 2 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation

The accompanying audited consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (“U.S. GAAP”) and include the balances and results of operations of the Company and our consolidated subsidiaries. The summary of significant accounting policies presented below are designed to assist in understanding the Company’s consolidated financial statements. Such consolidated financial statements and accompanying notes are the representations of the Company’s management, who is responsible for their integrity and objectivity. The Company and its subsidiaries operate as a single operating segment.

Use of Estimates

The preparation of financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets, liabilities, equity-based transactions and disclosure of contingent assets and liabilities at the date of the financial statement and the reported amounts of revenues and expenses during the reporting period.

Cash and cash equivalents

The Company considers all highly liquid investments with maturities of three months or less at the time of purchase to be cash equivalents. There were no cash equivalents as of December 31, 2024 and 2023.

Allowance for Credit Losses

Trade accounts receivable are stated net of an allowance for credit losses. The Company estimates the credit losses using historical information, current economic conditions and reasonable and supportable forecast information for a reasonable period of time. The Company starts by determining expected credit losses by using historical loss information based on the aging of receivables. An analysis of the current economic conditions along with forecast information is then used to determine any adjustment to the historical loss rates to determine the appropriate rates for future losses and the Company’s current expected credit losses for trade receivables. As of December 31, 2024 and 2023, there were no accounts receivable balances.

Deferred Offering Costs

Deferred offering costs represent legal, accounting and other direct costs related to the IPO, which had not closed as of 12/31/2024. These direct offering costs will remain classed as a non-current asset and will be reclassified to additional paid-in capital once the IPO has closed. These amounts will then be shown, along with underwriters’ fees paid, net against IPO proceeds received. During the years ended December 31, 2024 and 2023, the Company incurred a total of $608,341 and $610,835, respectively, in additional deferred costs in connection with the offering of equity securities. The Company recorded $1,219,176 and $610,835 of deferred offering costs as a non-current asset in the accompanying consolidated balance sheets as of December 31, 2024 and 2023, respectively.

Subscription Receivable

The Company records share issuances at the effective date. If the subscription is not funded upon issuance, the Company records a subscription receivable as an asset on a balance sheet. When subscription receivables are not received prior to the issuance of financial statements at a reporting date in satisfaction of the requirements under Financial Accounting Standards Board (the “FASB”) Accounting Standards Codification (“ASC”) 505-10-45-2, “Equity” — Other Presentation Matters, the subscription receivable is reclassified as a contra account to stockholders’ deficit on the consolidated balance sheet.

Employee Retention Tax Credit

beginning in October 2021 for qualified wages through December 2021 and filed a cash refund claim during year ended December 31, 2023. The employee retention credit totaling $50,000 was recognized as other income on the consolidated statements of operations during the year ended December 31, 2023 and the cash that is receivable is net of the $5,000 fee that the Company paid for the processing service.

As of December 31, 2023, $15,333 of the tax credit receivable has been received and the $5,000 fee was paid for the processing service. The remaining receivable of $34,667 is included as an other receivable in the current assets section of the Company’s consolidated balance sheet as of December 31, 2024 and 2023.

Software Development Costs

The Company incurs cost to develop computer software to be sold, leased, or otherwise marketed. Their research and development expenses consist principally of salaries and benefits, costs of computer equipment, and facility expenses. Per ASC 985, “Software — Costs of Software to Be Sold, Leased, or Marketed,” all costs incurred to establish the technological feasibility of a computer software product to be sold, leased, or otherwise marketed are research and development costs. Those costs shall be charged to expense as incurred. The technological feasibility of a computer software product is established when the entity has completed all planning, designing, coding, and testing activities that are necessary to establish that the product can be produced to meet its design specifications including functions, features, and technical performance requirements. Development costs for software incurred subsequent to the establishment of technological feasibility, but prior to the general release of the product, are capitalized and, upon general release, are amortized using the greater of either the straight-line method over the expected life of the related products or based upon the pattern in which economic benefits related to such assets are realized. No development costs for software were capitalized in 2024 or in prior years.

Concentration of Credit Risk

Financial Instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. As of December 31, 2024 and 2023, management believes the Company was not exposed to significant risks on such accounts.

Advertising and Marketing

The Company expenses advertising and marketing costs as they are incurred. Advertising and marketing expenses were $172,989 and $311,364 for the years ended December 31, 2024 and 2023, respectively.

Fair Value Measurements

As defined in Accounting Standards Codification (“ASC”) 820, “Fair Value Measurements and Disclosures”, fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (exit price). The Company utilizes market data or assumptions that market participants would use in pricing the asset or liability, including assumptions about risk and the risks inherent in the inputs to the valuation technique. These inputs can be readily observable, market corroborated, or generally unobservable. ASC 820 establishes a fair value hierarchy that prioritizes the inputs used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurement) and the lowest priority to unobservable inputs (level 3 measurement). This fair value measurement framework applies at both initial and subsequent measurement.

Level 1:		Quoted prices are available in active markets for identical assets or liabilities as of the reporting date.
Level 2:		Pricing inputs are other than quoted prices in active markets included in Level 1, which are either directly or indirectly observable as of the reported date. Level 2 includes those financial instruments that are valued using models or other valuation methodologies.

Level 3:

Pricing inputs include significant inputs that are generally less observable from objective sources. These inputs may be used with internally developed methodologies that result in management’s best estimate of fair value. The significant unobservable inputs used in the fair value measurement for nonrecurring fair value measurements of long-lived assets include pricing models, discounted cash flow methodologies and similar techniques.

The Company did not have any financial liabilities that were subject to fair value measurement.

Derivatives

The Company evaluates its convertible instruments to determine if those contracts or embedded components of those contracts qualify as derivative financial instruments, in accordance with ASC 815, “Derivatives and Hedging”. The standard requires that the Company record embedded conversion options (“ECOs”) and any related freestanding instruments at their fair values as of the inception date of the agreement and at fair value as of each subsequent balance sheet date. Any change in fair value is recorded as non-operating, non-cash income or expense for each reporting period at each balance sheet date. Conversion options are recorded as a discount to the host instrument and are amortized as amortization of debt discount on the financial statements over the life of the underlying instrument. The Company reassesses the classification of its derivative instruments at each balance sheet date. If the classification changes as a result of events during the period, the contract is reclassified as of the date of the event that caused the reclassification.

Equity Awards with a Guaranteed Minimum-Value Cash Settlement — Technology Purchase Agreements

The Company evaluates its stock-based compensation arrangements within the scope of ASC 718, “Compensation — Stock Compensation”. The Company has issued an equity award with a guaranteed minimum-value cash settlement in accordance with the terms that were agreed upon by the Company in the Master Services Agreement (“MSA”) with Artemis Ave LLC (“Artemis”) and the Software as a Service Agreement (the “SaaS” Agreement) with EVEMeta, LLC (“EVEMeta”). Subsection ASC 718-10-20 defines these equity awards as combination awards. Under this classification, the share grant is to be accounted for as an equity-classified award measured at grant-date fair value, and the cash-settled written put option should be liability classified and marked to fair value at each reporting period. Compensation costs for the share grant is measured and fixed on the date of grant and recognized over the vesting period, which is consistent with the delivery of goods and services. Compensation costs associated with the cash-settled written put option should be recognized over the vesting period based on the remeasured fair value at each reporting period, which is consistent with the delivery of goods and services from the vendor, until settlement. To value the cash-settled written put option, the Company remeasures the fair market value of the written put option via an appropriate option pricing model in accordance with ASC 718 and records the appropriate liability as of each reporting period with a corresponding adjustment to compensation costs. Please refer to Notes 4 and 5 for a detailed explanation of the terms of the technology purchase agreements.

Cloud Computing Arrangements — Technology Purchase Agreements

The Company applies the guidance under ASC 350-40, “Intangibles — Goodwill and Other-Internal-Use Software”, when evaluating the applicable accounting treatment for the purchase of technological products and services. The Company has determined that the MSA with Artemis and the SaaS Agreement with EVEMeta constitute a cloud computing arrangement (“CCA”). Accordingly, the Company capitalizes implementation costs associated with its CCA consistent with costs capitalized for internal-use software. Capitalized CCA implementation costs are included in “other assets.” The CCA implementation costs are amortized over the term of the related hosting agreement, including renewal periods that are reasonably certain to be exercised. . As of December 31, 2024, $125 was recognized as an other asset related to the Company’s cloud computing arrangements and no amortization costs have been recognized for the year ended December 31, 2024.

Convertible Debt

The Company accounts for convertible debt instruments in accordance with the provisions of ASC 470-20, “Debt with Conversion and Other Options”. Under this guidance, convertible debt instruments that do not meet the criteria for separation of embedded conversion features from the host contract are accounted for as a single liability. If a convertible debt instrument contains embedded features (e.g., conversion options, redemption rights) that require separate accounting under ASC 815, “Derivatives and Hedging”, the Company evaluates such features and bifurcates them as derivative liabilities when applicable. Issuance costs related to convertible debt are presented as a direct deduction from the carrying amount of the liability and are amortized to interest expense over the term of the debt using the effective interest method.

Shares Payable

The Company has incurred obligations that are payable in shares of the Company’s equity. If shares are not issued to satisfy those obligations, a short-term liability is recognized as a share payable and the corresponding expense is recorded in the appropriate account.

During 2023, the Company entered into several agreements with contractors to pay them for services with shares of the Company’s Common Stock. These shares of stock are valued at fair market value as of the date the services were provided. All shares payable to contractors were either valued at the fair market value of the stock as of the grant date or at the fair market value of the services provided and a total of 31,956 shares were due as of December 31, 2023 (as adjusted for the Reverse Stock Split), for a total share balance of $71,100. A total of 27,790 shares (as adjusted for the Reverse Stock Split) were due for services provided during the year ended December 31, 2024 for a total additional expense of $93,530. Further, in March of 2024, the Company sold 29,093 shares (as adjusted for the Reverse Stock Split) of BHHI Common Stock for total proceeds of $100,000. All shares payable were issued in May of 2024 and are included in the Common Stock and additional paid in capital, net of offering cost balances as of each period end.

Additionally, upon issuing convertible debt, the Company is required to concurrently issue equity kicker shares to investors in accordance with the terms of the convertible debt agreement. These shares were not yet issued as of December 31, 2023 and were subsequently issued in May of 2024. As such, the corresponding balances for shares payable in connection with the issuance of convertible debt are $0 and $179,956 as of December 31, 2024 and December 31, 2023, respectively. Refer to Note 7, Debt, for more detail. A total of 2,304 shares (as adjusted for the Reverse Stock Split) were added for additional convertible debt added during the year ended December 31, 2024 for a total additional expense of $6,819.

In December of 2024, the Company raised $25,000 from a short-term loan which has a 30% original issue discount that constitutes the interest due on the loan, a payment in equity kicker shares of the Company’s Common Stock having a combined value equaling 30% of the principal amount and a maturity date of February 15, 2025. The number of the shares subject to the equity kicker were calculated based on the Company’s anticipated price per share at the IPO of $4. This resulted in an additional 1,875 shares of Common Stock becoming due and these were not issued as of December 31, 2024. As such, it resulted in an increase of $7,500 to the shares payable balance during the year ended December 31, 2024. The 1,875 shares were issued in April of 2025, subsequent to the maturity date of February 15, 2025. Please refer to Note 7 for more detail.

Lastly, in December of 2024, the Company sold 6,250 shares of Common Stock for total cash proceeds of $25,000. These shares of Common Stock are pending issuance subsequent to the consummation of the IPO. These were not issued as of December 31, 2024 and are included in the shares payable balance as of year-end. These shares were issued in April of 2025.

The Company had a shares payable balance of $32,500 and $251,056 as of December 31, 2024 and 2023, respectively.

Revenue Recognition

The Company recognizes revenue from the sale of products and services in accordance with ASC 606, “Revenue Recognition” following the five steps procedure:

Step 1: Identify the contract(s) with customers

Step 2: Identify the performance obligations in the contract

Step 3: Determine the transaction price

Step 4: Allocate the transaction price to performance obligations

Step 5: Recognize revenue when or as performance obligations are satisfied

The Company generates revenues mainly from advertising, sponsorship and league tournaments. An insignificant amount of revenue is generated through the operation of its live streaming platform using a revenue model whereby gamers and creators can get free access to certain live streaming of amateur tournaments, and gamers and creators pay fees or subscriptions to compete in league competitions. Streaming revenue amounts are recognized as live-streaming services on the consolidated statements of operations and comprehensive loss.

Leases

In February 2016, the FASB issued ASU No. 2016-02, “Leases” (“ASC 842”). The standard requires all leases that have a term of over 12 months to be recognized on the balance sheet with the liability for lease payments and the corresponding right-of-use asset initially measured at the present value of amounts expected to be paid over the term. Recognition of the costs of these leases on the income statement will be dependent upon their classification as either an operating or a financing lease. Costs of an operating lease will continue to be recognized as a single operating expense on a straight-line basis over the lease term. Costs for a financing lease will be disaggregated and recognized as both an operating expense (for the amortization of the right-of-use asset) and interest expense (for interest on the lease liability).

Right of use (“ROU”) assets include any prepaid lease payments and exclude any lease incentive and initial direct costs incurred; a corresponding lease liability will be recorded for future lease payments using an incremental borrowing rate. Lease expense for minimum lease payments is recognized on a straight-line basis over a lease term. The lease terms may include options to extend or terminate the lease if it is reasonably certain that the Company will exercise that option.

Foreign Currency Translation

For the Company’s non-U.S. operations where the functional currency is the local currency, the Company translates assets and liabilities at exchange rates in effect at the balance sheet date and record translation adjustments in stockholders’ equity. The Company translates income statement amounts at average rates for the period. Transaction gains and losses are recorded in other (income) expense, net in the Consolidated Statement of Operations and Comprehensive Loss.

Net Loss per Common Share

Net loss per common share is computed by dividing the net loss by the weighted average number of common shares outstanding during the period. All outstanding convertible promissory notes are considered Common Stock at the beginning of the period or at the time of issuance, if later, pursuant to the if-converted method. Since the effect of Common Stock equivalents is anti-dilutive with respect to losses, the shares issuable upon conversion have been excluded from the Company’s computation of net loss per common share for the years ended December 31, 2024 and 2023.

The following table summarizes the securities that would be excluded from the diluted per share calculation because the effect of including these potential shares was antidilutive due to the Company’s net loss. In accordance with the Reverse Stock Split on October 11, 2024 (see Note 2 — Summary of Significant Accounting Policies), the number of shares of Common Stock underlying the Original Issue Discount Convertible Promissory Notes, the Convertible Series A Preferred Stock, Shares Payable, and Unvested Restricted Stock are now 1 for 2.43615, and the below information gives effect to the Reverse Split:

	Years Ended December 31,
	2024	2023
Original Issue Discount Convertible Promissory Notes	1,903,675	1,436,208
Unvested Restricted Stock	69,782	150,308
Shares Payable	8,125	29,185
Convertible Preferred Stock	82,096	82,096
Total	2,063,678	1,697,797

As of the date of these financial statements, no dividends have been declared in any year since inception and all classes of BHHI’s stock do not have cumulative dividend features. As such, we did not include any adjustment to the net loss for dividends. Ultimately, there was no adjustment needed to determine dilutive loss per share and only basic loss per share was calculated.

The table below represents the calculation for both basic and diluted net loss per share (as adjusted for the Reverse Stock Split):

	Years Ended December 31,
	2024			2023
Net loss	$	(3,288,519	)	$	(4,672,348	)
Weighted-average shares outstanding – Basic		5,697,212			5,594,621
Loss per share – Basic and Diluted	$	(0.58	)	$	(0.84	)

Income Taxes

The Company follows the asset and liability method of accounting for income taxes under ASC 740, Income Taxes. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The Company’s temporary differences result primarily from capitalization of certain qualifying research and development expenses, stock based compensation, and net operating loss carryovers. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. A valuation allowance is recorded for deferred tax assets if it is more likely than not that some portion or all of the deferred tax assets will not be realized.

The Company records interest related to unrecognized tax benefits in interest expense and penalties in selling, general and administrative expenses.

Stock-Based Compensation

The Company measures and records the expense related to stock-based payment awards based on the fair value of those awards as determined on the date of grant. The Company recognizes stock-based compensation expense over the requisite service period of the grant, generally equal to the vesting period, and uses the straight-line method to recognize stock-based compensation. For stock options with performance conditions, the Company records compensation expense when it is deemed probable that the performance condition will be met. Companies typically use the Black-Scholes-Merton (“Black-Scholes”) option-pricing model to determine the fair value of stock awards. The Black-Scholes option-pricing model requires the use of highly subjective and complex assumptions, which determine the fair value of share-based awards, including the option’s expected term and the price volatility of the underlying stock. No stock options have been issued by the Company through December 31, 2024. Restricted stock awards are valued based on the fair value on the date of grant and amortized ratably over the estimated life of the award. Restricted stock may vest based on the passage of time, or upon occurrence of a specific event or achievement of goals as defined in the grant agreements. In such cases, the Company records compensation expenses related to grants of restricted stock based on management’s estimates of the probable dates of the vesting events. The Company recognizes forfeitures of stock-based awards as they occur.

Recent Accounting Pronouncements

The FASB issues ASUs to amend the authoritative literature in ASC. There have been a number of ASUs to date that amend the original text of ASC.

In November 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2023-07, “Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures.” The standard expands reportable segment disclosure requirements for public business entities primarily through enhanced disclosures about significant segment expenses that are regularly provided to the chief operating decision maker (“CODM”) and included within each reported measure of segment profit (referred to as the “significant expense principle”). The ASU also requires that an entity that has a single reportable segment provide all the disclosures required by this ASU and all existing segment disclosures in Topic 280. The ASU does not change how operating segments are identified or, when applicable, aggregated. The Company adopted this standard for fiscal year 2024. Refer to Note 9 Segment Reporting.

On December 14, 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740). This ASU requires the use of consistent categories and greater disaggregation in tax rate reconciliations and income taxes paid disclosures. These amendments are effective for fiscal years beginning after December 15, 2024. These income tax disclosure requirements can be applied either prospectively or retrospectively to all periods presented in the financial statements. Management is currently evaluating the impact of adopting this standard; and do not expect it to have a material impact on the consolidated financial statements.

In November 2024, the FASB issued ASU 2024-03, “Income Statement-Reporting Comprehensive Income-Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses.” The standard requires that public business entities disclose additional information about specific expense categories in the notes to financial statements for interim and annual reporting periods. The standard will become effective for us for our fiscal year 2027 annual financial statements and interim financial statements thereafter and may be applied prospectively to periods after the adoption date or retrospectively for all prior periods presented in the financial statements, with early adoption permitted. The Company plans to adopt the standard beginning with the fiscal year 2027 annual financial statements, and management is currently evaluating the impact this guidance will have on the disclosures included in the Notes to the Consolidated Financial Statements.

Condensed Consolidated Statements of Changes in Stockholders’ Equity (Deficit) (Unaudited) - USD ($)	Preferred Stock Series B Preferred Stock	Preferred Stock	Common Stock	Subscription Receivable	Additional Paid-in Capital – Net of Offering Costs	Accumulated Deficit	Accumulated Other Comprehensive Loss	Total
Beginning Balance at Dec. 31, 2022		$ 420	$ 14,794	$ (4,276)	$ 4,730,140	$ (6,686,835)	$ (15,179)	$ (1,960,936)
Beginning Balance (in Shares) at Dec. 31, 2022		82,096	5,744,929
Stock-Based Compensation					556,222			556,222
Stock-Based Compensation – Restricted Stock Agreements					556,222			556,222
Offering Costs					(2,000)			(2,000)
Net Income (Loss)						(4,672,348)		(4,672,348)
Ending Balance at Dec. 31, 2023		$ 420	$ 14,794	(4,276)	5,284,362	(11,359,183)	(15,179)	(6,079,062)
Ending Balance (in Shares) at Dec. 31, 2023		82,096	5,744,929
Stock-Based Compensation					46,016			46,016
Stock-Based Compensation – Restricted Stock Agreements					46,016			46,016
Net Income (Loss)						(1,034,161)		(1,034,161)
Ending Balance at Mar. 31, 2024		$ 420	$ 14,794	(4,276)	5,330,378	(12,393,344)	(15,179)	(7,067,207)
Ending Balance (in Shares) at Mar. 31, 2024		82,096	5,744,929
Beginning Balance at Dec. 31, 2023		$ 420	$ 14,794	(4,276)	5,284,362	(11,359,183)	(15,179)	(6,079,062)
Beginning Balance (in Shares) at Dec. 31, 2023		82,096	5,744,929
Net Income (Loss)								(3,001,182)
Ending Balance at Sep. 30, 2024		$ 420	$ 14,429	(3,700)	6,147,562	(14,360,365)	(15,179)	(8,216,833)
Ending Balance (in Shares) at Sep. 30, 2024		82,096	5,783,386
Beginning Balance at Dec. 31, 2023		$ 420	$ 14,794	(4,276)	5,284,362	(11,359,183)	(15,179)	(6,079,062)
Beginning Balance (in Shares) at Dec. 31, 2023		82,096	5,744,929
Issuance of Shares Payable			$ 33		351,372			351,405
Issuance of Shares Payable (in Shares)			135,856
Sale of Common Stock			$ 7		99,993			100,000
Sale of Common Stock (in Shares)			29,093
Retirement of Shares			$ (425)	576	(151)
Retirement of Shares (in Shares)			(208,010)
Issuance of common stock for services			$ 125					125
Issuance of common stock for services (in Shares)			1,250,000
Interest Payment in Shares			$ 20		279,980			280,000
Interest Payment in Shares (in Shares)			81,462
Stock-Based Compensation					179,766			179,766
Stock-Based Compensation – Restricted Stock Agreements					179,766			179,766
Issuance of Common Stock								(351,405)
Net Income (Loss)						(3,288,519)		(3,288,519)
Ending Balance at Dec. 31, 2024		$ 420	$ 14,554	(3,700)	6,195,322	(14,647,702)	(15,179)	(8,456,285)
Ending Balance (in Shares) at Dec. 31, 2024		82,096	7,033,330
Beginning Balance at Mar. 31, 2024		$ 420	$ 14,794	(4,276)	5,330,378	(12,393,344)	(15,179)	(7,067,207)
Beginning Balance (in Shares) at Mar. 31, 2024		82,096	5,744,929
Issuance of Shares Payable			$ 40		451,365			451,405
Issuance of Shares Payable (in Shares)			165,005
Retirement of Shares			$ (425)	576	(151)
Retirement of Shares (in Shares)			(208,010)
Stock-Based Compensation					46,016			46,016
Stock-Based Compensation – Restricted Stock Agreements					46,016			46,016
Offering Costs					(5,000)			(5,000)
Net Income (Loss)						(956,963)		(956,963)
Ending Balance at Jun. 30, 2024		$ 420	$ 14,409	(3,700)	5,822,608	(13,350,307)	(15,179)	(7,531,749)
Ending Balance (in Shares) at Jun. 30, 2024		82,096	5,701,924
Interest Payment in Shares			$ 20		279,980			280,000
Interest Payment in Shares (in Shares)			81,462
Stock-Based Compensation					44,974			44,974
Stock-Based Compensation – Restricted Stock Agreements					44,974			44,974
Net Income (Loss)						(1,010,058)		(1,010,058)
Ending Balance at Sep. 30, 2024		$ 420	$ 14,429	(3,700)	6,147,562	(14,360,365)	(15,179)	(8,216,833)
Ending Balance (in Shares) at Sep. 30, 2024		82,096	5,783,386
Beginning Balance at Dec. 31, 2024		$ 420	$ 14,554	(3,700)	6,195,322	(14,647,702)	(15,179)	(8,456,285)
Beginning Balance (in Shares) at Dec. 31, 2024		82,096	7,033,330
Issuance of common stock for services					164,647			164,647
Stock-Based Compensation					42,500			42,500
Stock-Based Compensation – Restricted Stock Agreements					42,500			42,500
Issuance of Common Stock
Issuance of Common Stock (in Shares)			56
Offering Costs					(1,427,079)			(1,427,079)
Conversion of Preferred Stock to Common Stock		$ (420)	$ 420
Conversion of Preferred Stock to Common Stock (in Shares)		(82,096)	82,096
Conversion of Convertible Debt and Accrued Interest			$ 191		6,611,214			6,611,405
Conversion of Convertible Debt and Accrued Interest (in Shares)			1,912,176
Issuance of Common Stock in Connection with IPO and Over-allotment, Net of $1,176,800 of Offering Costs			$ 169		5,608,031			5,608,200
Issuance of Common Stock in Connection with IPO and Over-allotment, Net of $1,176,800 of Offering Costs (in Shares)			1,696,250
Underwriter Warrants					130,980			130,980
Net Income (Loss)						(1,067,673)		(1,067,673)
Ending Balance at Mar. 31, 2025			$ 15,334	(3,700)	17,325,615	(15,715,375)	(15,179)	1,606,695
Ending Balance (in Shares) at Mar. 31, 2025			10,723,908
Beginning Balance at Dec. 31, 2024		$ 420	$ 14,554	(3,700)	6,195,322	(14,647,702)	(15,179)	(8,456,285)
Beginning Balance (in Shares) at Dec. 31, 2024		82,096	7,033,330
Net Income (Loss)								(232,254)
Ending Balance at Sep. 30, 2025	$ 1		$ 1,097		31,495,785	(14,879,956)	(15,179)	16,601,748
Ending Balance (in Shares) at Sep. 30, 2025	15,000		10,972,588
Beginning Balance at Mar. 31, 2025			$ 15,334	(3,700)	17,325,615	(15,715,375)	(15,179)	1,606,695
Beginning Balance (in Shares) at Mar. 31, 2025			10,723,908
Issuance of common stock for services			$ 5		506,814			506,819
Issuance of common stock for services (in Shares)			50,000
Stock-Based Compensation					313,071			313,071
Issuance of Shares Payable – Subscription			$ 1		24,999			25,000
Issuance of Shares Payable – Subscription (in Shares)			6,250
Stock-Based Compensation – Restricted Stock Agreements					313,071			313,071
Issuance of Shares Payable – Subscription			$ 1		24,999			25,000
Issuance of Shares Payable – Subscription (in Shares)			6,250
Conversion of Convertible Debt and Accrued Interest			$ 4		154,363			154,367
Conversion of Convertible Debt and Accrued Interest (in Shares)			42,430
Net Income (Loss)						(1,705,217)		(1,705,217)
Ending Balance at Jun. 30, 2025			$ 15,344	(3,700)	18,324,862	(17,420,592)	(15,179)	900,735
Ending Balance (in Shares) at Jun. 30, 2025			10,822,588
Stock-Based Compensation					344,569			344,569
Common Stock Granted but not yet Issued for Services in Connection with the PIPE Offering					(220,200)			(220,200)
Issuance of Common Stock for Services in Connection with the PIPE Offering			$ 15		(15)
Issuance of Common Stock for Services in Connection with the PIPE Offering (in Shares)			150,000
Settlement of Subscription Receivable				3,700	(2,987)			713
Adjustment of Par Value of Common Stock			(14,262)		14,262
Stock-Based Compensation – Restricted Stock Agreements					344,569			344,569
Common Stock Granted but not yet Issued for Services in Connection with the PIPE Offering					(220,200)			(220,200)
Issuance of Common Stock for Services in Connection with the PIPE Offering			$ 15		(15)
Issuance of Common Stock for Services in Connection with the PIPE Offering (in Shares)			150,000
Settlement of Subscription Receivable				3,700	(2,987)			713
Adjustment of Par Value of Common Stock			(14,262)		14,262
Issuance of Common Stock in Connection with IPO and Over-allotment, Net of $1,176,800 of Offering Costs	$ 1				13,035,294			13,035,295
Issuance of Common Stock in Connection with IPO and Over-allotment, Net of $1,176,800 of Offering Costs (in Shares)	15,000
Net Income (Loss)						2,540,636		2,540,636
Ending Balance at Sep. 30, 2025	$ 1		$ 1,097		$ 31,495,785	$ (14,879,956)	$ (15,179)	$ 16,601,748
Ending Balance (in Shares) at Sep. 30, 2025	15,000		10,972,588

Stockholders’ Equity

9 Months Ended

12 Months Ended

Sep. 30, 2025

Dec. 31, 2024

Stockholders’ Deficit [Abstract]

STOCKHOLDERS’ EQUITY

NOTE 5 — STOCKHOLDERS’ EQUITY

Capital Structure

On December 3, 2021, BHHI was incorporated and the Company authorized 50,000,000 shares of Common Stock with a par value of $0.0001 per share and 5,000,000 shares of preferred stock with a par value of $0.0001 per share. On February 22, 2022, the certificate of incorporation was amended and the Company authorized 250,000,000 shares of Common Stock with a par value of $0.0001 per share and 25,000,000 shares of preferred stock with a par value of $0.0001 per share. Further, the Company designated 200,000 shares of preferred stock as Series A Preferred Stock with a par value of $0.0001 per share. Shares of Convertible Series A Preferred Stock and Common Stock (the “Junior Securities”) are entitled to one vote for each share. In order of liquidation rights, distributions will be made to the Series A Preferred holders then to the holders of the other remaining Junior Securities, which are currently Common Stock. The Series A Preferred Stock has a liquidation preference of $0.50 per share in the event of a liquidation and distribution. Further, each share of Convertible Series A Preferred Stock shall automatically convert into one share of Common Stock upon consummation of an underwritten public offering of Common Stock. The Company completed an initial public offering during March of 2025. Please refer to Note 1 and the following section for the details of the IPO. There were no shares of Series A Preferred Stock issued and outstanding during any period since inception, and 0 shares and 82,096 shares of Preferred Stock issued and outstanding as of September 30, 2025 and December 31, 2024, respectively. Further, a total of 10,972,588 and 7,033,330 shares of Common Stock were issued and outstanding as of September 30, 2025 and December 31, 2024, respectively.

In July of 2025, the Company filed a certificate of designation and a subsequent amendment to the certificate of designation with the Secretary of State of the State of Delaware to designate 15,000 shares of the available 24,800,000 shares of Preferred Stock as Series B Convertible Preferred Stock (“Series B Preferred Stock”). Each share is convertible at the option of the holder into shares of Common Stock at a conversion price of $0.942. The Series B Preferred Stock is not redeemable into cash or other assets and is classified as permanent equity. On July 30, 2025, an

amendment was filed to establish that each share of Series B Preferred Stock is non-voting. All 15,000 shares were issued and outstanding as of September 30, 2025. Please refer to the Private Investment into Public Entity (PIPE) section below.

Initial Public Offering

On February 14, 2025, the Company received its notice of effectiveness from the SEC and became a public company. On March 5, 2025, the Company entered into a material definitive agreement in the form of an underwriting agreement with Kingswood as representative of the underwriters named therein, for the offer and sale of 1,475,000 shares of the Company’s Common Stock at a public offering price of $4.00 per share for gross proceeds, before deducting underwriting discounts and other related expenses, of $5.9 million. Underwriting discounts and other related expenses totaled $1.1 million and were recorded as offering costs during the nine months ended September 30, 2025, for total net proceeds of $4.8 million. Payment of those offering costs was made directly from the proceeds of the offering. No such amounts were recorded during the three months ended September 30, 2025.

On March 6, 2025, the Company’s shares began trading on Nasdaq under the symbol “TBH” and on March 7, 2025, the Company filed its prospectus with the SEC and completed its IPO.

On March 10, 2025, Kingswood, as representative of the underwriters, exercised in full its option to purchase an additional 221,250 shares of the Company’s common stock to cover over-allotments at a public offering price of $4.00 per share for gross proceeds from the over-allotment exercise of $885,000. Underwriting discounts and other related expenses totaled $95,800, and are recorded as offering costs during the nine months ended September 30, 2025 for total net proceeds of $789,200. Payment of those offering costs was made directly from the proceeds of the offering. No such amounts were recorded during the three months ended September 30, 2025. Please refer to Note 1 for further detail.

Offering costs represent legal, accounting and other direct costs related to the IPO, which closed on March 7, 2025. Prior to the close of the IPO, these costs were recognized as deferred offering costs. These direct offering costs were reclassified to additional paid-in capital from deferred offering costs. The Company recorded $0 and $1,219,176 of deferred offering costs in the accompanying condensed consolidated balance sheets as of September 30, 2025 and December 31, 2024, respectively. During the nine months ended September 30, 2025 and 2024, the Company incurred a total of $131,922 and $295,019, respectively, in additional deferred offering costs in connection with the offering of equity securities in the IPO. During the three months ended September 30, 2025 and 2024, the Company incurred a total of $0 and $24,906, respectively, in additional deferred offering costs in connection with the offering of equity securities. As of September 30, 2025, a total of $1,351,098 was reclassified from deferred offering costs to offering costs. Of this amount, $1,236,098 is recorded as offering costs and the remaining $115,000 was paid directly from the IPO proceeds and included in the offering costs which are netted against the IPO proceeds on the condensed consolidated statements of changes in stockholders’ equity (deficit).

Incentive Award Plan

On June 11, 2024, the Company’s Board of Directors adopted the 2024 Omnibus Incentive Plan (“Stock Incentive Plan”), which was approved by its stockholders on June 13, 2024. On December 31, 2024 the Company’s Board of Directors adopted the Stock Incentive Plan, which was approved by the Company’s stockholders on January 30, 2025. The Stock Incentive Plan became effective on February 13, 2025. The Stock Incentive Plan will provide for the grant of incentive stock options, within the meaning of Section 422 of the Internal Revenue Code (“Code”) to the Company’s employees, and for the grant of stock options (including incentive stock options (“ISOs”) and non-qualified stock options (“NSOs”), SARs, restricted stock, restricted stock units (“RSUs”), and other stock-based and cash-based incentive awards, and other stock-based performance awards to the Company’s employees, directors, and consultants (collectively, “Awards”).

A total of 2,250,000 shares of common stock will be reserved for issuance pursuant to the Stock Incentive Plan (“Plan Share Reserve”). The Plan Share Reserve shall be increased on the first day of each fiscal year beginning with the 2025 fiscal year, in an amount equal to the lesser of (i) ten percent (10.0%) of the outstanding shares of common stock on the last day of the immediately preceding fiscal year and (ii) an amount determined by the Board of Directors.

Shares with respect to which options or SARs are not exercised prior to termination of the option or SAR, shares that are subject to restricted stock units which expire without converting to Common Stock, and shares of restricted stock which are forfeited before the restrictions lapse, shall be available for grants of new Awards under the Stock Incentive Plan. Notwithstanding the foregoing, neither (i) shares accepted by the Company in payment of the exercise price of any option, if permitted under the terms of such option, nor (ii) any shares withheld from a participant, or delivered to the Company in satisfaction of required withholding taxes arising from Awards, nor (iii) the difference between the total number of shares with respect to SAR, shall be available for reissuance under the Stock Incentive Plan.

Awards granted under the Stock Incentive Plan upon the assumption of, or in substitution for, awards authorized or outstanding under a qualifying equity plan maintained by an entity directly or indirectly acquired by the Company will not reduce the shares available for grant under the Stock Incentive Plan. However, any such shares issued in connection with the assumption of, or in substitution for, outstanding options intended to qualify as incentive stock options shall be counted against the aggregate number of shares of Common Stock available for Awards of incentive stock options under the Plan. Subject to applicable stock exchange requirements, available shares under a stockholder-approved plan of an entity directly or indirectly acquired by the Company may be used for Awards under the Stock Incentive Plan and shall not reduce the number of shares of Common Stock available for issuance under the Stock Incentive Plan.

The Compensation Committee of the Company’s Board of Directors will administer the Stock Incentive Plan (the “Administrator”). Each Award will be set forth in a separate agreement and will indicate the type and terms and conditions of the Award. Compensation for grants of awards will be determined in accordance with the Company’s stock-based compensation policy.

As of September 30, 2025, the Company has issued stock options to Executives, an employee, Directors and a contractor of the Company with options reserved in the Stock Incentive Plan to purchase a total of 1,950,000 shares of Common Stock. Please refer to the Stock Options section below.

Underwriter Warrants

Pursuant to the underwriting agreement, the Company issued to the underwriters on the closing date of the IPO (the “Closing Date”), warrants (the “Underwriter Warrants”) to purchase an aggregate of 44,250 shares of the Company’s common stock, representing 3% of the shares issued on the Closing Date. The Underwriter Warrants will be exercisable, in whole or in part, commencing on September 3, 2025, and expiring on September 9, 2029, at an initial exercise price per share of common stock of $4.00, which is equal to 100% of the offering price. No warrants have been exercised as of September 30, 2025.

The Underwriter Warrants are classified as equity instruments in accordance with ASC 815-40, “Derivatives and Hedging — Contracts in Entity’s Own Equity”. The warrants are considered indexed to the Company’s own stock and meet the equity classification criteria under GAAP.

The fair value of the underwriter warrants was estimated using the Black-Scholes option pricing model, a Level 3 measurement, with the following assumptions:

•	Stock Price:	$4.30
•	Risk-free interest rate:	4.00%
•	Expected term:	4.5 years
•	Expected volatility:	87.00%
•	Dividend yield:	0%

The estimated fair value of the Underwriter Warrants on the grant date was approximately $2.96 per share for a total value of $130,980 which was accounted for as a cost of issuing equity, in offering costs. Accordingly, it has been recorded as a reduction to the additional paid-in capital in the statement of stockholders’ equity (deficit), in accordance with SEC Staff Accounting Bulletin Topic 5.A.

The Company does not have liability classified warrants.

Stock Options

During the nine months ended September 30, 2025, the Company issued stock options (“Options”) to Executives, an employee, Directors and a contractor of the Company to purchase a total of 1,950,000 shares of Common Stock. Vesting terms extend from three to four years, with some of the Options vesting immediately. As of September 30, 2025, 968,504 Options had vested. The Options carry strike prices ranging from $0.576 to $1.00. Stock options issued to purchase 1,052,888 shares of Common Stock were issued with a strike price that was at the money (“at-the-money options”) and the remaining stock options to purchase 897,112 shares of Common Stock were issued with a strike price that was out of the money (“out-of-the-money options”). The Company uses the “simplified method” to estimate the expected term for stock options that have exercise prices issued at-the-money, consistent with SEC Staff Accounting Bulletin Topic 14, and uses the Black-Scholes option pricing model to determine the fair value of these stock options. For stock options with exercise prices at issuance that are out-of-the-money, the Company uses a Binomial Lattice model, which incorporates assumptions about future exercise behavior and potential changes in stock price over the life of the award.

The Options are classified as equity instruments and accounted for in accordance with ASC 718, “Compensation — Stock Compensation”.

The fair value of the at-the-money options was estimated using the Black-Scholes option pricing model, a Level 3 measurement, with the following assumptions:

•	Stock Price:	$0.57 – $0.84
•	Risk-free interest rate:	3.84% – 4%
•	Expected term:	5.13 – 5.75 years
•	Expected volatility:	83.6% – 84.5%
•	Dividend yield:	0%

The fair value of the out-of-the-money options was estimated using the Binomial Lattice option pricing model, a Level 3 measurement, with the following assumptions:

•	Stock Price:	$0.73
•	Risk-free interest rate:	4.39%
•	Expected term:	10 years
•	Expected volatility:	82.4%
•	Dividend yield:	0%
•	Exercise Multiple to Strike Price:	2.2x
•	Derived Service Period:	7.35 years

The estimated fair values of the Options on the grant dates were within a range of $0.38 and $0.60 per share for a total value of $830,477. The Company recognized stock-based compensation of $426,173 and $161,845 for the vested Options for employees, which was classified as stock-based compensation for the nine and three months ended September 30, 2025, respectively. The Company recognized stock-based compensation of $146,467 and $140,224 for the vested Options for non-employees in connection with legal and professional expenses for the nine and three months ended September 30, 2025, respectively.

The following is an analysis of BHHI stock options issued as compensation:

	Nonvested Shares		Weighted Average Exercise Price
Nonvested shares, December 31, 2024	—		$	—
Granted	—		$	—
Vested	—		$	—
Forfeited	—		$	—
Nonvested shares, March 31, 2025	—		$	—
Granted	1,052,888		$	0.65
Vested	(436,833	)	$	0.62
Forfeited	—		$	—
Nonvested shares, June 30, 2025	616,055		$	0.68
Granted	897,112		$	1.00
Vested	(975,954	)	$	0.98
Forfeited	—		$	—
Nonvested shares, September 30, 2025	537,213		$	0.68

Stock Issuances

In March of 2024, the Company sold 29,094 shares of BHHI Common Stock for total proceeds of $100,000. These were issued during May of 2024 and, therefore, issued and outstanding as of September 30, 2024.

During the nine months ended September 30, 2024, the Company incurred an additional $5,000 in costs connected with the offering of equity securities. During the three months ended September 30, 2024, no additional offering costs were incurred. The balance of offering costs was $312,296 at September 30, 2024. These amounts were netted against the additional paid in capital balances in each year presented on the consolidated balance sheets.

During the nine months ended September 30, 2024, the Company issued shares payable to vendors and contractors and shares in connection with the issuance of convertible debt securities, which were designated as equity kicker shares, and made up the balance of shares payable in prior periods. A total of 135,911 shares of common stock were issued and outstanding with a total value of $351,405. During the three months ended September 30, 2024, no additional shares payable to vendors and contractors and shares in connection with the issuance of convertible debt securities, which were designated as equity kicker shares, were issued. Further, the Company received and retired 208,010 shares of common stock from previous shareholders with a total value of $576.

On November 13, 2024, the Company entered into a MSA with Artemis to develop software for the Company and provide certain services. Please refer to Note 4. As of September 30, 2025, 312,500 of the shares have been released from the lock-up provisions. The Company has recognized the par value of the shares, equaling $125, as an increase to Common Stock and other assets as of December 31, 2024. On March 7, 2025, the services per the SaaS Agreement and MSA began and the Company began recognizing compensation expenses as services were provided.

During the nine and three months ended September 30, 2025, $312,500 and $0, respectively, was recognized as capitalized implementation costs, in connection with the software development services in the MSA with Artemis, as the value for the services that were completed as of period end. Amortization of the capitalized implementation costs to software expense has not commenced as of September 30, 2025. A total of $159,091 and $0 was also recognized as software expense, in connection with the services and maintenance services in the MSA with Artemis and the SaaS with EVEMeta, as the value for the services that were completed during the nine and three months ended September 30, 2025, respectively. Please refer to Note 2 and Note 4 for further detail on these technology purchase agreements.

In December of 2024, the Company sold 6,250 shares of common stock for total cash proceeds of $25,000 to the Company’s current CFO, Chetan Jindal. The shares of common stock are to be issued immediately after the consummation of the IPO, in accordance with the subscription agreement. These shares were issued in April.

In March of 2025, the Company’s Board of Directors issued their unanimous consent to issue shares in connection with several transactions and the Company issued those shares. The Company authorized and issued 56 shares of common stock owed in January of 2025. The issuance of these shares did not have an impact on the balance in equity.

In March of 2025, the Company authorized and issued 82,096 shares of Common Stock due to the conversion of each share of preferred stock to one share of Common Stock as a result of the IPO.

In accordance with the Marketing agreement detailed in Note 4, $200,000 worth of the Company’s Common Stock, priced at the Company’s IPO price of $4.00 per share became due within ten business days of the Listing Date. The Company issued the shares, totaling 50,000 shares, in April of 2025, subsequent to the due date of March 20, 2025.

In April of 2025, the Company also issued 1,875 shares of Common Stock in repayment of accrued interest of $7,500, subsequent to the maturity date of February 15, 2025.

Restricted Stock Agreements

BHI, and therefore the Company, entered into Restricted Stock Purchase Agreements (“RSPA”) with various employees and advisors. The share exchanges that occurred during 2021 and 2022 have an effect on the number of restricted shares that are vested and unvested as of the end of each respective reporting period.

During the year ended December 31, 2020, BHI also entered into various RSPAs with an employee and two advisers, pursuant to which BHI sold 225,000 shares of restricted common stock in BHI at par value of $0.0001 per share for cash proceeds of $22. The restricted stock vests at varying rates. As of September 30, 2025, the Company wrote off the $22 recorded as contra equity on the December 31, 2024 condensed consolidated balance sheets as this amount was deemed uncollectable. As of September 30, 2025 and 2024, 61,880 and 61,594 shares of common stock were considered vested, respectively, and the Company recognized stock-based compensation expense of $0 and $9,505 for the restricted shares that vested during the nine months ended September 30, 2025 and 2024, respectively. The Company recognized stock-based compensation expense of $0 and $2,474 for the restricted shares that vested during the three months ended September 30, 2025 and 2024, respectively. All shares were fully vested as of December 31, 2024, and no unamortized stock compensation remained.

On February 10, 2022, the Company issued a restricted stock award to its outside legal counsel for 279,129 shares of common stock. The restricted stock vests 25% immediately and 25% over the next three years at each anniversary. As of September 30, 2025 and 2024, 261,684 and 191,901 shares of common stock were considered vested, and the Company recognized stock-based compensation expense of $127,500 for the restricted shares that vested during each nine-month period ended September 30, 2025 and 2024, respectively. The Company recognized stock-based compensation expense of $42,500 for the restricted shares that vested during each three-month period ended September 30, 2025 and 2024, respectively. As of September 30, 2025, unamortized stock compensation of $42,500 remained.

The following is an analysis of BHI and BHHI shares of Common Stock issued as compensation subsequent to the US Reorganization and presented entirely as BHHI Common Stock:

	Nonvested Shares		Weighted Average Fair Value
Nonvested shares, December 31, 2024	69,782		$	2.44
Granted	—		$	—
Vested	(17,446	)	$	2.44
Forfeited	—		$	—
Nonvested shares, March 31, 2025	52,336		$	2.44
Granted	—		$	—
Vested	(17,446	)	$	2.44
Forfeited	—		$	—
Nonvested shares, June 30, 2025	34,890		$	2.44
Granted	450,000		$	1.06
Vested	(467,446	)	$	1.04
Forfeited	—		$	—
Nonvested shares, September 30, 2025	17,444		$	2.44

Private Investment into Public Entity (PIPE)

On July 24, 2025, the Company entered into a Securities Purchase Agreement (the “Securities Purchase Agreement”) with twelve accredited investors (the “Investors”) for a private investment in public equity (the “PIPE Offering”) of 15,000 shares of its Series B Preferred Stock, par value $0.0001 per share convertible into 15,923,567 shares of Common Stock, par value $0.0001 per share, at a conversion price of $0.942 per share of Series B Preferred Stock, and an aggregate of 15,923,567 warrants (the “PIPE Warrants”) to acquire up to 15,923,567 shares of Common Stock. The purchase price of the securities was $1,000 per share of Series B Preferred Stock and accompanying 1,061.5711 PIPE Warrants to acquire up to 1,061.5711 shares of Common Stock, subject to beneficial ownership limitations. The PIPE Warrants issued in the PIPE Offering are exercisable immediately upon issuance at an exercise price of $0.817 per share and will expire five years from the date of issuance. No PIPE Warrants were exercised as of September 30, 2025.

The PIPE Offering closed on July 30, 2025, with aggregate gross proceeds totaling $15 million, before placement agent fees and other expenses which were directly deducted from the proceeds totaling $1,321,205. In addition to the fees directly deducted from the proceeds, the Company incurred an additional fee of $635,000, discussed further below, and other fees totaling $8,500 for total offering costs of $1,964,705. The Company intends to use the proceeds from the PIPE Offering for general corporate and working capital purposes.

The exercise price and number of shares of Common Stock issuable upon exercise of the PIPE Warrants is subject to appropriate adjustment in the event of stock dividends, stock splits, reorganizations or similar events affecting the Common Stock and the exercise price. Subject to limited exceptions, the Investors may not exercise any portion of the PIPE Warrants to the extent that the Investors would beneficially own more than 4.99% (or, at the election of the holder prior to the date of issuance, 9.99%) of the outstanding Common Stock after exercise. In the event of certain fundamental transactions, the holder of the PIPE Warrants will have the right to receive the Black Scholes Value (as defined in the PIPE Warrants) of its PIPE Warrants calculated pursuant to a formula set forth in the PIPE Warrants, payable in cash. There is no trading market available for the PIPE Warrants on any securities exchange or nationally recognized trading system. The Company does not intend to list the PIPE Warrants on any securities exchange or nationally recognized trading system.

Revere Securities, LLC acted as placement agent (the “Placement Agent”) in connection with the PIPE Offering, pursuant to that certain Placement Agent Agreement, dated as of July 24, 2025, between the Company and the Placement Agent, pursuant to which the Company paid the Placement Agent a total of $1,171,205 in fees, which were recognized as offering costs and included in the above $1,964,705 amount. Additionally, a total of 1,057,543 warrants were issued to the Placement Agent (the “Placement Agent Warrants”) to acquire up to 1,057,543 shares of Common Stock at an exercise price of $0.942 per share and will expire five years from the date of issuance. These warrants were valued using a Black-Scholes model calculation and were determined to have a fair value of $791,194, all of which were recognized as offering costs. No Placement Agent Warrants were exercised as of September 30, 2025.

In connection with the PIPE Offering and as a pre-condition to effecting the PIPE Offering through Revere Securities, LLC, the Company entered into an agreement to terminate its exclusive engagement with H.C. Wainwright & Co., LLC for professional services allowing the Company to proceed with the PIPE Offering. As consideration for the termination, the Company issued 536,093 warrants (the “H.C. Wainwright Warrants”) to acquire up to 536,093 shares of Common Stock at an exercise price of $1.884 per share, which will expire five years from the date of issuance. These warrants were valued using a Black-Scholes model calculation and were determined to have a fair value of $315,195, which was recognized as offering costs. Additionally, a cash payment of $635,000 was made, which was recognized as offering costs and included in the above $1,964,705 amount. No H.C. Wainwright Warrants were exercised as of September 30, 2025.

The fair value of the PIPE Warrants, Placement Agent Warrants and H.C. Wainwright Warrants was estimated using the Black-Scholes option pricing model, a Level 3 measurement, with the following assumptions:

•	Stock Price:	$1.130
•	Risk-free interest rate:	3.92%
•	Expected term:	5 years
•	Expected volatility:	73.2%
•	Dividend yield:	0%

The estimated fair values of the warrants on the grant dates were within a range of $0.59 and $ 0.78 per share for a total value of $13,498,967. The Company recognized the fair value of the Placement Agent Warrants and the H.C. Wainwright Warrants as offering costs in connection with the PIPE Offering, totaling $1,106,389 for the nine and three months ended September 30, 2025. The fair values attributed to the PIPE Warrants of $12,392,578 and the Series B Preferred Stock of $19,108,280 were used to bifurcate the PIPE Offering proceeds using the relative fair value method and resulted in an allocation of the proceeds of the PIPE Offering as $9,098,933 and $5,901,067 to the Series B Preferred Stock and PIPE Warrants, respectively, before deducting offering costs.

During the period from October 1, 2025 to November 12, 2025, holders of the Series B Preferred Stock converted a total of 6,902 shares into 7,327,378 shares of Common Stock. Further, during this period, a total of 1,598,843 PIPE Warrants were exercised at $0.817 per warrant for total proceeds of $1,306,255.

Common Stock Awards — PIPE

During the nine and three months ended September 30, 2025, the Company made two grants for 300,000 and 150,000 totaling 450,000 shares of fully vested Common Stock awards in exchange for legal and professional services, which are incremental costs in connection with the PIPE Offering and recognized as offering costs. The fair value of these shares at the date of grant was $0.73 and $1.72, respectively, and this resulted in fair values of $220,200 and $258,000, respectively, for a total cost of $478,200. The grant for 300,000 shares were not yet issued as of September 30, 2025. As a result, the fair value of those shares, $220,200, is recorded as shares payable.

Par Value Adjustment — Common Stock

During the three months ended September 30, 2025, the Company recorded a reclassification within stockholders’ equity (deficit) to correct the allocation between Common Stock and Additional Paid-In Capital. This adjustment ensured that the Common Stock account reflects the number of shares issued and outstanding multiplied by the par value. Following this reclassification, the ending balance of Common Stock was $1,097 as of September 30, 2025.

NOTE 5 — STOCKHOLDERS’ DEFICIT

Capital Structure

On December 3, 2021, BHHI was incorporated and the Company authorized 50,000,000 shares of Common Stock with a par value of $0.0001 per share and 5,000,000 shares of preferred stock with a par value of $0.0001 per share. On February 22, 2022, the certificate of incorporation was amended and the Company authorized 250,000,000 shares of Common Stock with a par value of $0.0001 per share and 25,000,000 shares of preferred stock with a par value of $0.0001 per share. Further, the Company designated 200,000 shares of preferred stock as Series A preferred stock with a par value of $0.0001 per share. Shares of Convertible Series A preferred stock and Common Stock (the “Junior Securities”) are entitled to one vote for each share. In order of liquidation rights, distributions will be made to the Series A preferred holders then to the holders of the Junior Securities. The Series A preferred stock has a liquidation preference of $0.50 per share in the event of a liquidation and distribution. Further, each share of Convertible Series A preferred stock shall automatically convert into one share of Common Stock upon consummation of an underwritten public offering of Common Stock. The Company completed an initial public offering during March of 2025. Please

refer to Note 1 for the details of the IPO. There were no shares of Series A preferred stock issued and outstanding during any period since inception and, 82,096 shares of preferred stock and a total of 6,296,434 and 5,744,929 shares of Common Stock, respectively, issued and outstanding as of December 31, 2024 and 2023 (as adjusted for the Reverse Stock Split), respectively.

In October of 2024, the Company authorized and filed an amendment to the Articles of Incorporation to authorize a 1 for 2.43615 Reverse Stock Split for all Common and Preferred Stock.

Incentive Award Plan

On June 11, 2024, the Company’s Board of Directors adopted the Original Stock Incentive Plan, which was approved by its stockholders on June 13, 2024. On December 31, 2024 our Board of Directors adopted the Stock Incentive Plan, which was approved by the Company’s stockholders on January 30, 2025. The Stock Incentive Plan became effective on February 13, 2025. The Stock Incentive Plan will provide for the grant of incentive stock options, within the meaning of Section 422 of the Code to the Company’s employees, and for the grant of nonstatutory stock options, restricted stock, restricted stock units, stock appreciation rights (“SARs”), and other stock-based performance awards to the Company’s employees, directors, and consultants (collectively, “Awards”).

Shares with respect to which options or SARs are not exercised prior to termination of the option or SAR, shares that are subject to restricted stock units which expire without converting to Common Stock, and shares of restricted stock which are forfeited before the restrictions lapse, shall be available for grants of new Awards under the Stock Incentive Plan. Notwithstanding the foregoing, neither (i) shares accepted by the Company in payment of the exercise price of any option, if permitted under the terms of such option, (ii) any shares withheld from a participant, or delivered to the Company in satisfaction of required withholding taxes arising from Awards, nor (iii) the difference between the total number of shares with respect to SAR, shall be available for reissuance under the Stock Incentive Plan.

The Compensation Committee of the Company’s Board of Directors will administer the Stock Incentive Plan (the “Administrator”) and the plan provides for the grant of stock options (including incentive stock options (“ISOs”) and non-qualified stock options (“NSOs”)), SARs, restricted stock, restricted stock units (“RSUs”), and other stock-based and cash-based incentive Awards. No determination has been made as to the types or amounts of Awards that will be granted to specific individuals pursuant to the Stock Incentive Plan. Each Award will be set forth in a separate agreement and will indicate the type and terms and conditions of the Award.

As of December 31, 2024, no awards have been granted and, thus, no compensation has been incurred in connection with the Stock Incentive Plan. Compensation for grants of awards will be determined in accordance with the Company’s stock-based compensation policy.

Stock Issuances

From April to June of 2022, the Company sold 132,243 shares of BHHI Common Stock for total cash proceeds of $322,164 (as adjusted for the Reverse Stock Split).

In March of 2024, the Company sold 29,093 shares (as adjusted for the Reverse Stock Split) of BHHI Common Stock for total proceeds of $100,000. These were issued during May of 2024 and, therefore, issued and outstanding as of December 31, 2024.

During the year ended December 31, 2024, the Company issued shares payable to vendors and contractors and shares in connection with the issuance of convertible debt securities, which were designated as equity kicker shares, and made up the balance of shares payable in prior periods. A total of 135,856 shares of Common Stock (as adjusted for the Reverse Stock Split) were issued and outstanding with a total value of $351,405. Further, the Company received and retired 208,010 shares of Common Stock (as adjusted for the Reverse Stock Split) from previous shareholders with a total value of $576.

During the year ended December 31, 2024, the Company also issued 81,462 shares of Common Stock (as adjusted for the Reverse Stock Split) in full payment of the $280,000 amount that was payable in shares of the Company in connection with the issuance of bridge loans. Please refer to Note 7. All 81,462 shares of Common Stock were issued during the year ended December 31, 2024.

On November 13, 2024, the Company entered into a MSA with Artemis to develop the Software and provide certain services. In exchange, the Company agreed to issue 937,500 shares of its Common Stock to Artemis. The Artemis Stock Consideration was issued to Artemis on December 26, 2024. In connection with the execution of the MSA, on November 13, 2024, the Company entered into a SaaS Agreement with EVEMeta to license its solution to the Company. In exchange, the Company issued 312,500 shares of its Common Stock to EVEMeta. The EVEMeta Stock Consideration was issued to EVEMeta on December 26, 2024. The 1,250,000 shares granted to Artemis and EVEMeta in exchange for services had a fair market value of $4.00 per share at the date of grant for a total cost of $5,000,000. The value of the shares will vest over the milestones in the agreement and the Company will recognize those costs as services are rendered. As of December 31, 2024, none of the shares have been released from the lock-up provisions. The Company has recognized the par value of the shares, equaling $125, as an increase to common stock and other assets as of December 31, 2024 and the remaining unrecognized compensation expense of $4,999,875 of the fair market value of the shares issued as consideration remains unrecognized. Please refer to Note 2 and Note 4 for further detail on these technology purchase agreements.

In December of 2024, the Company raised $25,000 from a short-term loan which has a 30% original issue discount that constitutes the interest due on the loan, a payment in equity kicker shares of the Company’s Common Stock having a combined value equaling 30% of the principal amount and a maturity date of February 15, 2025. The number of the shares subject to the equity kicker were calculated based on the Company’s anticipated price per share at the IPO of $4. This resulted in an additional 1,875 shares of Common Stock becoming due and were not issued as of December 31, 2024. As such, it resulted in an increase of $7,500 to the shares payable balance during the year ended December 31, 2024. The 1,875 shares were issued in April of 2025, subsequent to the maturity date of February 15, 2025. Please refer to Notes 7 and 10.

In December of 2024, the Company sold 6,250 shares of Common Stock for total cash proceeds of $25,000. The shares of Common Stock are to be issued immediately after the consummation of the IPO, in accordance with the subscription agreement. These were not issued as of December 31, 2024 and are included in the shares payable balance as of year-end. These shares were issued in April of 2025. Please refer to Note 10.

During 2023, the Company incurred a total of $2,000, respectively, in costs connected with the offering of equity securities and recorded this amount in the respective contra-equity account for additional paid-in capital offering costs. The total ending balance of offering costs as of December 31, 2024 and 2023 was $307,296 in each year. This amount was netted against the additional paid in capital balances in each year presented on the consolidated balance sheets. During 2023, the $2,000 in offering costs is in connection with professional fees in connection with equity offerings.

Restricted Stock Agreements

BHI, and therefore the Company, has entered into restricted stock purchase agreements with various employees and advisors. The share exchanges that occurred during 2021 and 2022 have an effect on the number of restricted shares that are vested and unvested as of the end of each respective year end.

On February 24, 2018, BHI entered into a Founder Restricted Stock Purchase Agreement (“Malloy FRSPA”) with Lavell Juan Malloy, II, the Company’s co-founder and Chief Executive Officer, pursuant to which BHI sold 4,008,417 shares of restricted common stock in BHI, par value of $0.0001 per share, for cash proceeds of $401. The restricted stock vests at 25% on the one-year anniversary of the date of the Malloy FRSA and then monthly during the subsequent thirty-six months. As of December 31, 2024, the Company has not received the proceeds from Mr. Malloy and the $401 is recorded as contra equity on the December 31, 2024 and 2023 consolidated balance sheets. During the year ended December 31, 2022, after the effect of the share exchanges, all 1,102,411 shares of Common Stock (as adjusted for the Reverse Stock Split) were considered vested, and the Company did not recognize any stock-based compensation for the years ended December 31, 2024 or 2023.

On December 21, 2019, BHI entered into a Founder Restricted Stock Purchase Agreement (“Leibovich FRSPA”) with Daniel Leibovich, the Company’s co-founder, Chief Operating Officer, pursuant to which BHI sold 3,120,917 shares of restricted Common Stock in BHI, par value of $0.0001 per share, for cash proceeds of $312. The restricted stock vests at 25% on the one-year anniversary of the date of the Leibovich FRSA and then monthly during the subsequent thirty-six months. As of December 31, 2024, the Company has yet to receive the proceeds from Mr. Leibovich and the $312 is recorded as contra equity on the December 31, 2024 and 2023 consolidated balance sheets. During the year ended December 31, 2023, after the effect of the share exchanges, 858,327 shares of Common Stock were considered vested, respectively, and the Company recognized stock-based compensation expense of $195,057 for the year, for the restricted shares that vested during each of those years with no unamortized stock compensation remaining at December 31, 2023 (as adjusted for the Reverse Stock Split). There was no stock based compensation expense recognized during the year ended December 31, 2024.

On July 7, 2020, BHI entered into a Founder Restricted Stock Purchase Agreement (“Simpson FRSPA”) with William Simpson, the Company’s co-founder and Former Chief Technology Officer, pursuant to which BHI sold 1,789,666 shares of restricted Common Stock in BHI, par value of $0.0001 per share, for cash proceeds of $179. The restricted stock vests at 25% on the one-year anniversary of the date of the Simpson FRSA and then monthly during the subsequent thirty-six months. As of December 31, 2024, the Company has yet to receive the proceeds from Mr. Simpson and the $179 is recorded as contra equity on the December 31, 2024 and 2023 consolidated balance sheets. During the years ended December 31, 2024 and 2023, after the effect of the share exchanges, 492,201 shares of Common Stock were considered vested at each period end, and the Company recognized stock-based compensation expense of $0 and $177,102 for the restricted shares that vested during 2024 and 2023, respectively with no unamortized stock compensation remaining at December 31, 2024 (as adjusted for the Reverse Stock Split).

During the year ended December 31, 2020, BHI also entered into various Restricted Stock Purchase Agreements (“RSPAs”) with an employee and two advisers, pursuant to which BHI sold 225,000 shares of restricted Common Stock in BHI at par value of $0.0001 per share for cash proceeds of $22. The restricted stock vests at varying rates. As of December 31, 2024, the Company has yet to receive proceeds for the restricted Common Stock issuances, and the $22 is recorded as contra equity on the December 31, 2024 and 2023 consolidated balance sheets. During the years ended December 31, 2024 and 2023, after the effect of the share exchanges, 61,880 and 51,137 shares of common stock were considered vested, respectively, and the Company recognized stock-based compensation expense of $9,766 and $14,063 for the restricted shares that vested during 2024 and 2023, respectively (as adjusted for the Reverse Stock Split). As of December 31, 2024, no unamortized stock compensation remained.

During the year ended December 31, 2021, BHI also entered into various Restricted Stock Purchase Agreements (“RSPAs”) with an employee and two advisers, pursuant to which BHI sold 756,000 shares of restricted Common Stock in BHI at par value of $0.0001 per share for cash proceeds of $76. The restricted stock vests at varying rates and as of December 31, 2022 no shares remained unvested. As of December 31, 2024, the Company has yet to receive

proceeds for the restricted Common Stock issuances, and the $76 is recorded as contra equity on the December 31, 2024 and 2023 consolidated balance sheets. After the effect of the share exchanges and the Reverse Stock Split, a total of 207,918 shares were deemed to have been granted. In May of 2022, the Company terminated the employment of the employee, and, therefore, the employee forfeited 119,176 unvested shares of Common Stock. During the year ended December 31, 2022, all remaining 88,741 shares of Common Stock were considered vested.

On February 10, 2022, the Company issued a Restricted Stock Award to its outside legal counsel for 279,129 shares of Common Stock. The restricted stock vests 25% immediately and 25% over the next three years at each anniversary. During the years ended December 31, 2024 and 2023, 209,347 and 139,565 shares of Common Stock were considered vested, and the Company recognized stock-based compensation expense of $170,000 per year for the restricted shares that vested during 2024 and 2023 (as adjusted for the Reverse Stock Split). At December 31, 2024 and 2023, unamortized stock compensation of $170,001 and $340,001 remained.

The following is an analysis of BHI and BHHI shares of Common Stock issued as compensation subsequent to the US Reorganization (21:1 exchange rate) and presented entirely as BHHI Common Stock (as adjusted for the Reverse Stock Split):

	Nonvested Shares		Weighted Average Fair Value
Nonvested shares, December 31, 2022	644,972		$	1.41
Granted	—		$	—
Vested	(494,664	)	$	1.22
Forfeited	—		$	—
Nonvested shares, December 31, 2023	150,308		$	2.34
Granted	—		$	—
Vested	(80,525	)	$	1.50
Forfeited	—		$	—
Nonvested shares, December 31, 2024	69,782		$	2.44

Summary of Significant Accounting Policies (Details)						3 Months Ended		9 Months Ended		12 Months Ended
Summary of Significant Accounting Policies (Details)	Apr. 30, 2025 USD ($) shares	Mar. 10, 2025 USD ($) $ / shares	Mar. 05, 2025 USD ($) $ / shares	Dec. 31, 2021	Dec. 31, 2020 USD ($)	Sep. 30, 2025 USD ($) shares	Sep. 30, 2024 USD ($)	Sep. 30, 2025 USD ($) Segment shares	Sep. 30, 2024 USD ($)	Dec. 31, 2024 USD ($) $ / shares shares	Dec. 31, 2023 USD ($) shares	May 12, 2025 USD ($)	Mar. 31, 2025 USD ($)	Nov. 30, 2024 shares	Nov. 13, 2024 shares	Mar. 31, 2024 USD ($)
Summary of Significant Accounting Policies [Line Items]
Deferred costs										$ 608,341	$ 610,835
Deferred offering costs										1,219,176	610,835
Employee retention credit				70.00%
Company paid processing fee											5,000
Tax credit receivable											15,333
Processing service fee											5,000
Other receivable						17,408		17,408		34,667	34,667
Federal depository insurance coverage										250,000
Advertising and marketing expenses						182,216	$ 160,270	475,972	$ 160,478	172,989	311,364
Other asset										$ 125	8,639
Fair market value											31,956
Reverse stock split stock balance											71,100
Reverse stock split (in Shares) \| shares										27,790
Additional expense value										$ 93,530
Company sold reverse stock split																$ 29,093
Common Stock total proceeds value																$ 100,000
Issuance of convertible debt										5,722,511	4,527,228
Other expense								133,331
Short-term loan								399,126	25,000	$ 25,000
Anticipated price per share (in Dollars per share) \| $ / shares										$ 125
Additional shares issued of common stock (in Shares) \| shares										1,875
Note payable						$ 424		$ 424		$ 32,500	$ 251,056
Common stock shares issued (in Shares) \| shares						10,972,588		10,972,588		7,033,330	5,744,929
Cash proceeds			$ 5,900,000		$ 22				100,000	$ 100,000
Percentage of recognized income tax								50.00%		50.00%
Reportable segment (in Segment) \| Segment								1
Cash						$ 9,575,000		$ 9,575,000		$ 50,649
Proceeds from initial public offering								6,785,000
Additional offering costs						1,252,780		1,252,780
Paid amount to IPO proceeds								115,000
Subscriptions receivable						713		713
Subscription write off						2,987		2,987
Other income						30,800	0	73,450	0
FDIC insurance amount						250,000		250,000
Exceeded the insurance coverage						9,345,577		9,345,577
Additional stock-based compensation liability												$ 116,669	$ 44,392
Cash paid for the settlement of the stock-based compensation liability								(250,000)
Total liability						1,609,053		1,609,053		9,757,813	6,797,652
Prepaid expense non-current										125
Capitalized implementation costs						389,171	$ 0	389,171	$ 0
Prepaid expense non current										62
Shares payable						221,434		221,434		32,500
Foreign currency totaling								13
Foreign currency gain								437
Selling, general and administrative expenses								95,000
Gross federal net operating loss carry-forwards						14,854,359		14,854,359
Gross state net operating loss carry-forwards						16,514,918		$ 16,514,918		11,337,446	8,133,984
Taxable income percent								80.00%
Valuation allowance						$ 1,044,912		$ 1,044,912
Effective tax rate						0.00%	0.00%	0.00%	0.00%
Convertible into additional shares (in Shares) \| shares										1,912,176
Forecast [Member]
Summary of Significant Accounting Policies [Line Items]
Short-term loan	$ 29,223
Cash proceeds	$ 25,000
Share Based Liability [Member]
Summary of Significant Accounting Policies [Line Items]
Gain (Loss) on Sale of Derivatives								$ 76,671
Common Stock [Member]
Summary of Significant Accounting Policies [Line Items]
Common stock shares issued (in Shares) \| shares										6,296,434	5,744,929			937,500	937,500
Cash proceeds										$ 25,000
Total liability						$ 116,669		$ 116,669
Common Stock [Member] \| Warrants [Member]
Summary of Significant Accounting Policies [Line Items]
Convertible into additional shares (in Shares) \| shares								17,517,203
Technology Purchase Agreements [Member]
Summary of Significant Accounting Policies [Line Items]
Prepaid expense non-current										63
Technology Purchase Agreements [Member] \| Common Stock [Member]
Summary of Significant Accounting Policies [Line Items]
Common stock shares issued (in Shares) \| shares														312,500	312,500
Stock Options [Member]
Summary of Significant Accounting Policies [Line Items]
Issued shares of stock options (in Shares) \| shares								1,950,000
IPO [Member]
Summary of Significant Accounting Policies [Line Items]
Deferred offering costs						0		$ 0		$ 1,219,176
Other expense								1,100,000
Maturity date										Feb. 15, 2025
Anticipated price per share (in Dollars per share) \| $ / shares			$ 4							$ 4
Note payable										$ 7,500
Common stock shares issued (in Shares) \| shares	29,305
Proceeds from initial public offering								1,351,098
Additional costs						3,549,294		$ 3,549,294
Convertible into additional shares (in Shares) \| shares								44,250
IPO [Member] \| Common Stock [Member]
Summary of Significant Accounting Policies [Line Items]
Adjusted for the reverse stock split (in Shares) \| shares										6,250
Over-Allotment Option [Member]
Summary of Significant Accounting Policies [Line Items]
Other expense								$ 95,800
Anticipated price per share (in Dollars per share) \| $ / shares		$ 4
Cash proceeds		$ 885,000
Offering costs								190,980
Paid amount to IPO proceeds								1,061,800
Advertising and Marketing Expenses [Member]
Summary of Significant Accounting Policies [Line Items]
Advertising and marketing expenses										$ 172,989	$ 311,364
Meta [Member]
Summary of Significant Accounting Policies [Line Items]
Stock-based compensation liability						250,000		250,000				$ 72,277
Prepaid expense non-current										62
Software expense						$ 159,091		$ 159,091
Convertible Debt [Member]
Summary of Significant Accounting Policies [Line Items]
Issuance of convertible debt										$ 0	179,956
Adjusted for the reverse stock split (in Shares) \| shares										2,304
Other expense										$ 6,819
Original issue discount interest due										30.00%
Convertible Debt [Member] \| Common Stock [Member]
Summary of Significant Accounting Policies [Line Items]
Short-term loan										$ 25,000
Percentage of common stock combined value										30.00%
Original Issue Discount [Member] \| Forecast [Member]
Summary of Significant Accounting Policies [Line Items]
Maturity date	Feb. 15, 2025
Common stock shares issued (in Shares) \| shares	1,875
Employee Retention Tax Credit [Member]
Summary of Significant Accounting Policies [Line Items]
Employee retention income											$ 50,000
Maximum [Member]
Summary of Significant Accounting Policies [Line Items]
Reclassification of non current prepaid expenses										$ 389,171
Minimum [Member]
Summary of Significant Accounting Policies [Line Items]
Reclassification of non current prepaid expenses										$ 312,500
Convertible Series A Preferred Stock [Member]
Summary of Significant Accounting Policies [Line Items]
Reverse stock Split										1 for 2.43615

Accounting Policies, by Policy (Policies)

9 Months Ended

12 Months Ended

Sep. 30, 2025

Dec. 31, 2024

Summary of Significant Accounting Policies [Abstract]

Basis of Presentation

Use of Estimates

The preparation of financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets, liabilities, equity-based transactions and disclosure of contingent assets and liabilities at the date of the financial statement and the reported amounts of revenues and expenses during the reporting period.

Cash and cash equivalents

Cash and Cash Equivalents

Cash and cash equivalents

Allowance for Credit Losses

Trade accounts receivable are stated net of an allowance for credit losses. The Company estimates the credit losses using historical information, current economic conditions and reasonable and supportable forecast information for a reasonable period of time. The Company starts by determining expected credit losses by using historical loss information based on the aging of receivables. An analysis of the current economic conditions along with forecast information is then used to determine any adjustment to the historical loss rates to determine the appropriate rates for future losses and the Company’s current expected credit losses for trade receivables. As of December 31, 2024 and 2023, there were no accounts receivable balances.

Offering Costs

Deferred Offering Costs

Subscription Receivable

During the nine and three months ended September 30, 2025, the Company received $713 in cash from outstanding subscriptions receivable and wrote off the remaining balance of $2,987.

Subscription Receivable

Employee Retention Tax Credit

Software Development Costs

Concentration of Credit Risk

Advertising and Marketing

The Company expenses advertising and marketing costs as they are incurred. Advertising and marketing expenses were $172,989 and $311,364 for the years ended December 31, 2024 and 2023, respectively.

Fair Value Measurements

		Level 1:		Quoted prices are available in active markets for identical assets or liabilities as of the reporting date.
		Level 2:		Pricing inputs are other than quoted prices in active markets included in Level 1, which are either directly or indirectly observable as of the reported date. Level 2 includes those financial instruments that are valued using models or other valuation methodologies.
		Level 3:		Pricing inputs include significant inputs that are generally less observable from objective sources. These inputs may be used with internally developed methodologies that result in management’s best estimate of fair value. The significant unobservable inputs used in the fair value measurement for nonrecurring fair value measurements of long-lived assets include pricing models, discounted cash flow methodologies and similar techniques.

Fair Value Measurements

Level 1:		Quoted prices are available in active markets for identical assets or liabilities as of the reporting date.
Level 2:		Pricing inputs are other than quoted prices in active markets included in Level 1, which are either directly or indirectly observable as of the reported date. Level 2 includes those financial instruments that are valued using models or other valuation methodologies.

Level 3:

The Company did not have any financial liabilities that were subject to fair value measurement.

Derivatives

Equity Awards with a Guaranteed Minimum-Value Cash Settlement — Technology Purchase Agreements

Please refer to Notes 4 and 5 for a detailed explanation of the terms of the technology purchase agreements.

Equity Awards with a Guaranteed Minimum-Value Cash Settlement — Technology Purchase Agreements

The Company evaluates its stock-based compensation arrangements within the scope of ASC 718, “Compensation — Stock Compensation”. The Company has issued an equity award with a guaranteed minimum-value cash settlement in accordance with the terms that were agreed upon by the Company in the Master Services Agreement (“MSA”) with Artemis Ave LLC (“Artemis”) and the Software as a Service Agreement (the “SaaS” Agreement) with EVEMeta, LLC (“EVEMeta”). Subsection ASC 718-10-20 defines these equity awards as combination awards. Under this classification, the share grant is to be accounted for as an equity-classified award measured at grant-date fair value, and the cash-settled written put option should be liability classified and marked to fair value at each reporting period. Compensation costs for the share grant is measured and fixed on the date of grant and recognized over the vesting period, which is consistent with the delivery of goods and services. Compensation costs associated with the cash-settled written put option should be recognized over the vesting period based on the remeasured fair value at each reporting period, which is consistent with the delivery of goods and services from the vendor, until settlement. To value the cash-settled written put option, the Company remeasures the fair market value of the written put option via an appropriate option pricing model in accordance with ASC 718 and records the appropriate liability as of each reporting period with a corresponding adjustment to compensation costs. Please refer to Notes 4 and 5 for a detailed explanation of the terms of the technology purchase agreements.

Cloud Computing Arrangements — Technology Purchase Agreements

The Company applies the guidance under ASC 350-40, “Intangibles — Goodwill and Other-Internal-Use Software”, when evaluating the applicable accounting treatment for the purchase of technological products and services. The Company has determined that the MSA with Artemis and the SaaS Agreement with EVEMeta constitute a cloud computing arrangement (“CCA”). Accordingly, the Company capitalizes implementation costs associated with its CCA consistent with costs capitalized for internal-use software. Capitalized CCA implementation costs are included in “other assets.” The CCA implementation costs are amortized over the term of the related hosting agreement, including renewal periods that are reasonably certain to be exercised. . As of December 31, 2024, $125 was recognized as an other asset related to the Company’s cloud computing arrangements and no amortization costs have been recognized for the year ended December 31, 2024.

Convertible Debt

The Company accounts for convertible debt instruments in accordance with the provisions of ASC 470-20, “Debt with Conversion and Other Options”. Under this guidance, convertible debt instruments that do not meet the criteria for separation of embedded conversion features from the host contract are accounted for as a single liability. If a convertible debt instrument contains embedded features (e.g., conversion options, redemption rights) that require separate accounting under ASC 815, “Derivatives and Hedging”, the Company evaluates such features and bifurcates them as derivative liabilities when applicable. Issuance costs related to convertible debt are presented as a direct deduction from the carrying amount of the liability and are amortized to interest expense over the term of the debt using the effective interest method.

Shares Payable

The Company has incurred obligations that are payable in shares of the Company’s equity. If shares are not issued to satisfy those obligations, a short-term liability is recognized as a share payable and the corresponding expense is recorded in the appropriate account.

The Company had a shares payable balance of $32,500 and $251,056 as of December 31, 2024 and 2023, respectively.

Revenue Recognition

The Company recognizes revenue from the sale of products and services in accordance with ASC 606, “Revenue Recognition” following the five step procedure:

Step 1: Identify the contract(s) with customers

Step 2: Identify the performance obligations in the contract

Step 3: Determine the transaction price

Step 4: Allocate the transaction price to performance obligations

Step 5: Recognize revenue when or as performance obligations are satisfied

Revenue Recognition

The Company recognizes revenue from the sale of products and services in accordance with ASC 606, “Revenue Recognition” following the five steps procedure:

Step 1: Identify the contract(s) with customers

Step 2: Identify the performance obligations in the contract

Step 3: Determine the transaction price

Step 4: Allocate the transaction price to performance obligations

Step 5: Recognize revenue when or as performance obligations are satisfied

The Company generates revenues mainly from advertising, sponsorship and league tournaments. An insignificant amount of revenue is generated through the operation of its live streaming platform using a revenue model whereby gamers and creators can get free access to certain live streaming of amateur tournaments, and gamers and creators pay fees or subscriptions to compete in league competitions. Streaming revenue amounts are recognized as live-streaming services on the consolidated statements of operations and comprehensive loss.

Leases

Foreign Currency Translation

For the Company’s non-U.S. operations where the functional currency is the local currency, the Company translates assets and liabilities at exchange rates in effect at the balance sheet date and record translation adjustments in stockholders’ equity. The Company translates income statement amounts at average rates for the period. Transaction gains and losses are recorded in other (income) expense, net in the Consolidated Statement of Operations and Comprehensive Loss.

Net Income (Loss) per Common Share

	As of September 30,
	2025	2024
Convertible Debt	—	1,813,923
Unvested Restricted Stock	17,446	87,514
Shares Payable	300,355	—
Convertible Preferred Stock	15,923,567	82,096
Warrants	7,581,490	—
Stock Options	885,588	—
Total	24,708,446	1,983,533

The table below represents the calculation for both basic and diluted net income (loss) per share:

	Nine Months Ended September 30,						Three Months Ended September 30,
	2025			2024			2025		2024
Net Income (Loss)	$	(232,254	)	$	(3,001,182	)	$	2,540,636	$	(1,010,058	)
Weighted-average Shares Outstanding – Basic		9,786,460			5,664,529			10,829,664		5,688,797
Income (Loss) per share – Basic	$	(0.02	)	$	(0.53	)	$	0.23	$	(0.18	)
Net Income (Loss)	$	(232,254	)	$	(3,001,182	)	$	2,540,636	$	(1,010,058	)
Increase to Net Income attributable to dilutive instruments		—			—			—		—
Net Income available to Common Shareholders – Diluted	$	(232,254	)	$	(3,001,185	)	$	2,540,636	$	(1,010,058	)
Weighted-average Shares Outstanding – Basic		9,786,460			5,664,529			10,829,664		5,688,797
Effect of Unvested Restricted Stock		—			—			17,446		—
Effect of Shares Payable		—			—			241,659		—
Effect of Convertible Preferred Stock		—			—			10,731,100		—
Effect of Warrants		—			—			3,657,119		—
Effect of Stock Options		—			—			610,858		—
Weighted-average Shares Outstanding – Diluted*		9,786,460			5,664,529			26,087,846		5,688,797
Income (Loss) per share – Diluted	$	(0.02	)	$	(0.53	)	$	0.10	$	(0.18	)

____________

* Only noted for the periods in which the result is not anti-dilutive.

Net Loss per Common Share

	Years Ended December 31,
	2024	2023
Original Issue Discount Convertible Promissory Notes	1,903,675	1,436,208
Unvested Restricted Stock	69,782	150,308
Shares Payable	8,125	29,185
Convertible Preferred Stock	82,096	82,096
Total	2,063,678	1,697,797

The table below represents the calculation for both basic and diluted net loss per share (as adjusted for the Reverse Stock Split):

	Years Ended December 31,
	2024			2023
Net loss	$	(3,288,519	)	$	(4,672,348	)
Weighted-average shares outstanding – Basic		5,697,212			5,594,621
Loss per share – Basic and Diluted	$	(0.58	)	$	(0.84	)

Income Taxes

The Company records interest related to unrecognized tax benefits in interest expense and penalties in selling, general and administrative expenses.

The Company’s effective tax rate is 0% for the three and nine months ended September 30, 2025 and 2024.

Income Taxes

The Company follows the asset and liability method of accounting for income taxes under ASC 740, Income Taxes. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The Company’s temporary differences result primarily from capitalization of certain qualifying research and development expenses, stock based compensation, and net operating loss carryovers. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. A valuation allowance is recorded for deferred tax assets if it is more likely than not that some portion or all of the deferred tax assets will not be realized.

The Company records interest related to unrecognized tax benefits in interest expense and penalties in selling, general and administrative expenses.

Stock-Based Compensation

Recently Issued but not yet Adopted Accounting Pronouncements

Recent Accounting Pronouncements

The FASB issues ASUs to amend the authoritative literature in ASC. There have been a number of ASUs to date that amend the original text of ASC.

On December 14, 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740). This ASU requires the use of consistent categories and greater disaggregation in tax rate reconciliations and income taxes paid disclosures. These amendments are effective for fiscal years beginning after December 15, 2024. These income tax disclosure requirements can be applied either prospectively or retrospectively to all periods presented in the financial statements. Management is currently evaluating the impact of adopting this standard; and do not expect it to have a material impact on the consolidated financial statements.

In November 2024, the FASB issued ASU 2024-03, “Income Statement-Reporting Comprehensive Income-Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses.” The standard requires that public business entities disclose additional information about specific expense categories in the notes to financial statements for interim and annual reporting periods. The standard will become effective for us for our fiscal year 2027 annual financial statements and interim financial statements thereafter and may be applied prospectively to periods after the adoption date or retrospectively for all prior periods presented in the financial statements, with early adoption permitted. The Company plans to adopt the standard beginning with the fiscal year 2027 annual financial statements, and management is currently evaluating the impact this guidance will have on the disclosures included in the Notes to the Consolidated Financial Statements.

Principles of Consolidation

Segment Reporting

Accounts Payable

Comprehensive Income (Loss)

Investment in Equity Securities

Debt

9 Months Ended

12 Months Ended

Sep. 30, 2025

Dec. 31, 2024

Debt [Abstract]

DEBT

NOTE 6 — DEBT

Convertible Debt

The Company issued convertible debt during 2022 through May of 2024 under its initial round of convertible debt. The balance of convertible debt as of December 31, 2024 was $5,722,511 in outstanding principal and no remaining unamortized debt issuance costs and debt discount. As of December 31, 2024, accrued interest for the notes totaled $888,894.

During 2024, the Company issued convertible debt in the form of original issue discount convertible promissory notes. These notes provide investors with a 20% discount on their investment amount. To determine the principal amount of the notes, the investment amount is divided by 0.80, reflecting that 20% original issue discount. Concurrent with the issue and sale of the notes, each holder was entitled to receive a number of shares of the Company’s Common Stock, par value $0.0001 per share equal to: (i) in the case of a holder that is a Lead Investor, the quotient resulting when 20% of the Holder’s purchase price is divided by a price per share equal to the Valuation Cap divided by the Company Capitalization, (ii) In the case of all other holders, the quotient resulting when 5% of the Holder’s purchase price is divided by a price per share equal to the Valuation Cap divided by the Company Capitalization. The purchase price means the product of the principal amount of the note multiplied by 0.80. The Valuation Cap is set at $20,000,000 and the Company Capitalization means the sum of all equity securities (on an as-converted basis) issued and outstanding, assuming exercise or conversion of all outstanding vested and unvested options, warrants and other convertible securities, but excluding the notes and all equity securities reserved and available for future grant under any equity incentive or similar plan of the Company.

During the nine and three months ended September 30, 2024, the Company extended the maturity date of the debt and incurred an additional $997,253 and $0 in principal due to extension fees. During the nine and three months ended September 30, 2024, the Company also raised a total of $158,424 and $0, respectively, in additional operating capital through the issuance of additional original issue discount convertible promissory notes, all of which carry the same terms as all other issued convertible debt. The issuance of these notes resulted in an additional debt discount totaling $39,606 for a total principal amount of $198,030 during the nine months ended September 30, 2024. In addition, note holders were entitled to 2,302 shares of common stock and with a share fair market value between $2.42 and $3.46 for a total additional debt discount and share payable of $6,819 and $0 during the nine and three months ended September 30, 2024, respectively. The Company recorded $46,410 and $0 in amortization of debt discount to interest expense on the condensed consolidated statements of operations and comprehensive income (loss) for the nine and three months ended September 30, 2024. The Company also incurred an additional $381,535 and $144,239 in accrued interest during the nine and three months ended September 30, 2024, respectively.

In connection with the completion of the IPO on March 7, 2025, which was deemed a qualifying financing event, the Company converted the total balance due to all holders of the original issue discount convertible promissory notes. The actual date of conversion of the notes was completed on March 6, 2025. The total amount that was converted was $6,611,405, which was the total principal of $5,722,511 and accrued interest of $888,894 as of December 31, 2024. These were converted into a total of 1,912,176 shares of the Company’s common stock. An additional accrual of interest through the date of the IPO, March 7, 2025, was recorded as of March 7, 2025 for $103,101 and this balance is included as a share payable since it was convertible to shares of common stock totaling 29,660 as of the date of IPO. In April of 2025, 29,305 of these shares were issued, representing an increase of $101,867 for an updated total converted

amount of $6,713,272 for the nine months ended September 30, 2025. The remaining 355 shares are pending to be issued and the balance of the accrued interest for the shares that were not yet issued, $1,234, is recorded as a share payable balance until issued.

Notes Payable

In June of 2024, the Company received a loan in the amount of $12,198 which was payable in the foreign currency of Great British Pounds. This loan had no maturity date or interest rate assigned to the loan. It was also unsecured and there were no assets pledged on the loan. This loan was revalued at December 31, 2024 and had a principal balance of $12,900. During the nine months ended September 30, 2025, a gain on foreign currency exchange was recognized for $424 on the revaluation of the loan. This loan was repaid in March of 2025 as part of a confidential release and final agreement, detailed below.

During August and September of 2024, the Company raised $280,000 in short-term loans that are expected to be repaid within a year, although a maturity date is not specified. These loans have a 100% interest fee that is due at the date of repayment and an additional 100% fee in shares of the Company’s Common Stock issued at the current fair market value, which was $1.41 at the dates of the loans. In September of 2024, the Company issued 198,454 shares of Common Stock in full payment of the $280,000 amount that was payable in shares of the Company. In the same period, the Company repaid $25,000 of the short-term loans along with the corresponding $25,000 interest fee. These loans resulted in a total interest expense of $560,000 that was recognized during the nine and three months ended September 30, 2024. A total principal balance of $255,000 and accrued interest of $255,000 remained outstanding as of December 31, 2024. The Company repaid $175,000 of the principal amount along with $175,000 of the accrued interest amount as part of a confidential release and final agreement, detailed below. The remaining $80,000 in principal and $80,000 in interest, was repaid in April of 2025, as detailed below, in connection with a loan repayment agreement that was entered into with a shareholder of the Company on April 2, 2025.

In November of 2024, the Company raised $30,000 from a short-term loan which carried a 100% interest fee. In addition, the Company requested from the underwriter that they unlock 24,500 shares of common stock currently owned by the lender to be available as freely floating, publicly tradable shares. A total principal balance of $30,000 and accrued interest of $30,000 remained outstanding as of December 31, 2024. The noteholder agreed to be repaid a total of $29,223 for the principal amount and $29,223 for the accrued interest on the loan. This resulted in a gain on debt extinguishment of $1,554. The final payment was made on April 1, 2025.

The Company entered into a loan agreement with one of its shareholders on February 5, 2025 for an amount totaling $9,314 and agreed to pay an interest fee of 200% of the principal loan and an additional 100% in common stock once the Company became a public company. In addition, this shareholder made an additional loan of $6,186 to the Company on February 10, 2025. The additional loan was not subject to a loan agreement and did not carry any written terms. The Company became a public company on March 6, 2025. On April 2, 2025, the shareholder and the Company agreed on repayment terms for those two loans and a pre-existing loan from August of 2024 (see above) that was owed to this shareholder together with all accrued interest. The total repayment was $206,617 and it included $95,500 in principal and $111,117 in interest. The total principal amount includes the $15,500 loans from February 2025 and the remaining $80,000 in principal and $80,000 in interest from a loan which was made to the Company during August of 2024. The final payment was made in April of 2025.

Confidential Release and Final Agreement

From January through March of 2025, the Company borrowed money from shareholders of the Company to pay for expenses in connection with the IPO. Total proceeds of $86,150 were received by the Company and these borrowed funds did not have a loan agreement or loan terms. These shareholders also had notes payable made to the Company during 2024, which are part of the notes payable disclosed in Note 6 totaling $187,900 in principal as of December 31, 2024.

In March of 2025, the Company entered into a confidential release and final agreement to settle all loan amounts and interest payable to these shareholders with a total payment of $650,000. The agreement also supersedes all prior loan agreements and settles any future claims for any reason and no longer requires the payment of any shares of equity. The total loans that were paid had a principal amount of $273,626 and accrued interest of $175,000. The Company recognized an additional $201,374 in interest expense. Payment of the settlement amount was made on March 31, 2025.

Convertible Debt — December 2024

In December of 2024, the Company raised $25,000 from a short-term convertible promissory note which is unrelated to the previously issued convertible debt through May of 2024 and carries different terms. This note has a 30% original issue discount that constitutes the interest due on the loan and was added to the principal balance, a payment in equity kicker shares of the Company’s common stock having a combined value equaling 30% of the principal amount and a maturity date of February 15, 2025. The number of the shares subject to the equity kicker were calculated based on the Company’s anticipated price per share at the IPO, which was at $4. The original issue discount and the equity kicker shares had values of $7,500 each for a total discount on debt of $15,000. During 2024, the Company recognized $4,219 in amortization of debt discount on the condensed consolidated statements of operations and comprehensive income (loss). The issuance of this loan resulted in an additional 1,875 shares of common stock becoming due and were not issued as of December 31, 2024. As such, it resulted in an increase of $7,500 to the shares payable balance during the year ended December 31, 2024. A total principal balance of $32,500 and unamortized debt discount of $10,781 was outstanding as of December 31, 2024. The Company amortized the remaining debt discount amount of $10,781 to interest expense during the nine months ended September 30, 2025. No amortization was recorded during the three months ended September 30, 2025.

Loan repayment options included the proceeds of the Company’s IPO, which occurred on March 6, 2025 and was the earliest of all other options. The lender had the option to convert the debt into shares of the Company’s common stock but, instead, the repayment of the loan principal of $25,000 and accrued interest of $7,500 was completed in March of 2025. The 1,875 shares were issued in April of 2025, subsequent to the maturity date of February 15, 2025, and were no longer included in the shares payable balance as of September 30, 2025.

In March of 2025, the Company raised an additional $150,000 from two short-term promissory notes which have a 30% original issue discount that constitutes the interest due on the loan and was added to the principal balance, a payment in equity kicker shares of the Company’s common stock having a combined value equaling 30% of the principal amount and a maturity date of April 10, 2025. The number of the shares subject to the equity kicker were calculated based on the Company’s anticipated price per share at the IPO, which was at $4. The original issue discount and the equity kicker shares had values of $45,000 each for a total discount on debt of $90,000. The issuance of this loan resulted in an additional 11,250 shares of common stock becoming due. As such, it resulted in an increase of $45,000 to the shares payable balance during 2025. The Company repaid the total loan principal of $150,000 and accrued interest of $45,000 in March of 2025. The shares in connection with the share payable amount of $45,000 were issued in April of 2025 and were no longer included in the shares payable balance as of September 30, 2025. The Company amortized the $90,000 debt discount amount to interest expense during the nine months ended September 30, 2025.

NOTE 7 — DEBT

Original Issue Discount Convertible Promissory Notes

The Company issued convertible debt during 2022 through May of 2024. The balances of convertible debt as of December 31, 2022 were $2,300,575 in outstanding principal and $469,082 in unamortized debt issuance costs and debt discount.

During 2023 and through May of 2024, the Company issued additional convertible debt in the form of original issue discount convertible promissory notes. These notes provide investors with a 20% discount on their investment amount. To determine the principal amount of the notes, the investment amount is divided by 0.80, reflecting that 20% original issue discount. A total addition to debt discount in the amount of $39,606 and $72,500 was recognized during the years ended December 31, 2024 and 2023, respectively, for notes issued during those periods.

Concurrent with the issue and sale of the notes, each holder was entitled to receive a number of shares of the Company’s Common Stock, par value $0.0001 per share equal to: (i) in the case of a holder that is a Lead Investor, the quotient resulting when 20% of the Holder’s purchase price is divided by a price per share equal to the Valuation Cap divided by the Company Capitalization, (ii) In the case of all other holders, the quotient resulting when 5% of the Holder’s purchase price is divided by a price per share equal to the Valuation Cap divided by the Company Capitalization. The purchase price means the product of the principal amount of the note multiplied by 0.80. The Valuation Cap is set at $20,000,000 and the Company Capitalization means the sum of all equity securities (on an as-converted basis) issued and outstanding, assuming exercise or conversion of all outstanding vested and unvested options, warrants and other convertible securities, but excluding the notes and all equity securities reserved and available for future grant under any equity incentive or similar plan of the Company. Company capitalization was determined to be 5,819,896 as of the date of issuance of the notes and increased with each instance of shares payable to each new investor. As of December 31, 2023, the total number of shares payable to investors was determined to be 73,869 shares of Common Stock at calculated prices per share between $3.43 and $3.48 per share (as adjusted for the Reverse Stock Split). As of December 31, 2023, those shares were not yet issued to investors and, therefore, recognized as a share payable liability with a share fair market value of $2.44 for a total liability and debt discount addition of $179,956 (as adjusted for the Reverse Stock Split). The Company recorded incremental debt discount in the amount of $6,819 for 2,304 shares (as adjusted for the Reverse Stock Split) which were issued in connection with the issuance of convertible debt during the year ended December 31, 2024.

The Company recorded $46,410 and $462,170 in amortization of debt discount on the consolidated statements of operations and comprehensive loss for the years ended December 31, 2024 and 2023, respectively.

During the years ended December 31, 2024 and 2023, the Company had no unamortized balances of debt issuance costs and $143,905 was recognized in amortization on the consolidated statements of operations and comprehensive loss for the year ended December 31, 2023 as a result of the amortization of those costs.

These notes had an original maturity date of June 5, 2023 and carried the option to extend the maturity date on two occasions for 45-day periods. If the option to extend the maturity is exercised, a 10% increase in the outstanding principal amount will be applied at the start of each extension period. These notes pay simple interest at a rate of 10% per annum on the original outstanding principal amount and all accrued interest and unpaid principal amounts are due at maturity. The notes matured on June 5, 2023 and were extended on two occasions in accordance with the applicable terms of the notes, for an additional 45 days on each extension, and a revised maturity date of September 3, 2023. This resulted in an additional principal amount of $532,615 added to the original outstanding principal amount at the date of maturity, which was $2,663,075.

During September 2023 and November 2023, the Company obtained the written consent of required noteholders on both occasions to amend the terms of the notes and add four additional 45-day extension periods to the loan’s maturity date, for a total of six extension periods from the original maturity date. The terms for each extension remain the same and a 10% increase in the original outstanding principal amount was applied at the start of each extension period. In addition to this fee, and as consideration for amending the note accordingly as of September 2023, on the maturity date, in addition to the unpaid interest and principal amount due and payable, the Company was required to pay to each holder of notes an amount equal to 15% of the original principal amount of such holder’s note. The 15% fee was amended and increased to 20% as consideration for amending the note in November 2023. As of December 31, 2023, the Company extended the maturity on three additional occasions from the revised maturity date of September 3, 2023. This resulted in an additional principal amount of $266,308 added to the original outstanding principal amount at the start of each extension period, which resulted in an additional $798,923 in principal amount. In addition to this fee, the 20% due at maturity resulted in an additional $532,615 in principal amount.

During January 2024, the Company obtained the written consent of required noteholders to amend the terms of the notes and add two additional 45-day extension periods to the loan’s maturity date, for a total of eight extension periods from the original maturity date. The terms for each extension remain the same and a 10% increase in the outstanding principal amount, based on the original outstanding principal amount, will be applied at the start of each extension period. This resulted in an additional principal amount of $266,308 as of January 16, 2024 added to the outstanding principal amount at the start of the extension period. In addition to this fee, and as consideration for amending the note accordingly, on the maturity date, in addition to the unpaid interest and principal amount due and payable, the Company shall pay to each holder of notes an amount equal to 25% of the original principal amount of such holder’s note, which replaces the 20% that was due as a result of the second amendment in November 2023. This resulted in an additional principal amount of $156,749 added to the outstanding principal amount. The notes matured on March 1, 2024 and were extended an additional time in accordance with the applicable terms of the notes, for an additional 45 days on each extension, and a revised maturity date of May 30, 2024. This resulted in an additional principal amount of $266,307 as of March 1, 2024 added to the outstanding principal amount at the start of the extension period.

During April and May of 2024, the Company raised a total of $82,920 in additional operating capital through the issuance of additional original issue discount convertible promissory notes, all of which carry the same terms as all other issued convertible debt. The issuance of these notes resulted in an additional debt discount totaling $20,730 for a total principal amount of $103,650. In addition, note holders were entitled to an issuance of Common Stock. The beginning Company capitalization was determined to be 5,819,896 as of the date of issuance of the notes and increased with each instance of shares payable to each new investor. The total number of shares payable to investors was determined to be 1,204 shares of Common Stock (as adjusted for the Reverse Stock Split) at a calculated price range per share of $3.43 through $3.46. These shares were issued to investors with a share fair market value of $3.43 for a total additional debt discount of $4,159. These costs were amortized through the maturity date of the notes, which was May 30, 2024.

The notes were extended an additional time on April 15, 2024 in accordance with the applicable terms of the notes, for an additional 45 days. This resulted in an additional principal amount of $281,977. In addition to this fee, and as consideration for amending the note accordingly, on the maturity date, in addition to the unpaid interest and principal amount the due and payable, the Company shall pay to each holder of notes an amount equal to 25% of the original principal amount of such holder’s note. This resulted in an additional principal amount of $25,912 added to the outstanding principal amount of loans which were added during the year ended December 31, 2024 and were not already previously increased due to the loan extension in March of 2024.

On May 30, 2024, the convertible debt balance plus accrued interest became due. Holders of a majority of the outstanding principal, or required holders, prior to May 30, 2024, elected to sign a conversion notice agreement (“Conversion Notice”) that will convert all of the notes to shares of Common Stock of the Company subject to the completion of the IPO. This election triggers a conversion for all investors of the notes, including those who did not sign the Conversion Notice. For those investors that agreed, the conversion price will be set at the lower of the IPO price or based on a pre-IPO valuation of $20 million divided by the outstanding Company capitalization. For those which did not sign the Conversion Notice, the conversion price will be based on a pre-IPO valuation of $20 million divided by the outstanding Company capitalization.

On July 13, 2024, the Conversion Notice was amended and the date extended to August 9, 2024. This date was subsequently amended on August 9, 2024 to extend the date to October 31, 2024. On October 31, 2024, the date was extended to February 15, 2025. Finally, on February 15, 2025, the date was extended to March 31, 2025.

The terms of the note establish a conversion either upon a qualified financing, change of control, or voluntary conversion on the maturity date. Qualified financing means a transaction or series of transactions completed after the date of the note pursuant to which the Company issues and sells equity securities with the principal purpose of raising capital. Upon a qualified financing, then at the option of the holder in its sole discretion, the entire outstanding principal amount of the note and all accrued and unpaid interest shall automatically and simultaneously with the closing thereof convert (which such conversion shall be mandatory as to all notes outstanding at the time of such

qualified financing) into the equity securities issued in such qualified financing at the conversion price. The issuance of such equity securities pursuant to the conversion of these notes shall be upon and subject to the same terms and conditions applicable to the Equity Securities sold in the Qualified Financing. The conversion price means, with respect to a qualified financing, a price per share equal to the cash price per share paid by the other purchasers of the equity securities sold in the qualified financing.

A change of control means (i) a consolidation or merger of the Company with or into any other corporation or other entity or person; (ii) any transaction or series of related transactions to which the Company is a party in which in excess of 50% of the Company’s voting power is transferred; (iii) the sale or transfer of all or substantially all of the Company’s assets, or the exclusive license of all or substantially all of the Company’s material intellectual property; provided that a Change of Control shall not include any transaction or series of transactions principally for bona fide equity financing purposes in which cash is received by the Company or any successor, indebtedness of the Company is canceled, converted or a combination thereof.

If the outstanding principal amount of the note and all accrued and unpaid interest is not converted or repaid on or prior to the maturity date pursuant to a Qualified Financing or a Change of Control or otherwise, then, on the maturity date, at the option of the required holders in their sole discretion, all, but not less than all, of the outstanding principal amount of the note and all accrued and unpaid interest shall either be (x) repaid, or (y) converted into Equity Securities of the Company at a price per Equity Security equal to the Valuation Cap divided by Company’s Capitalization.

As of December 31, 2024 and 2023, the convertible debt had the following balances:

	12/31/2024		12/31/2023
Outstanding Principal	$	5,722,511	$	4,527,228
Unamortized Debt Issuance Costs	$	—	$	—
Unamortized Debt Discount – Shares Payable	$	—	$	—
Unamortized Debt Discount – Original Issue Discount	$	—	$	—
Convertible Debt, Net	$	5,722,511	$	4,527,228

The outstanding balance remained unpaid as of December 31, 2024 and was converted to equity concurrent with the Company’s initial public offering (“IPO”) in March of 2025. Please refer to Note 10 for subsequent events.

As of December 31, 2024 and 2023, total accrued interest on the notes equaled $888,894 and $363,120, respectively.

Notes Payable

In June of 2024, the Company received a loan in the amount of $12,198 in United States Dollar which will be payable in the foreign currency of Great Britain Pounds. This loan had no maturity date or interest rate assigned to the loan. It was also unsecured and there were no assets pledged on the loan. This loan was revalued at December 31, 2024 and had a principal balance of $12,900 in United States Dollar. This loan was repaid in March of 2025 as part of a confidential release and final agreement. Please refer to Note 10 for subsequent events.

In November of 2024, the Company raised $30,000 from a short-term loan which carried a 100% interest fee. In addition, the Company requested from the underwriter that they unlock 24,500 shares of common stock currently owned by the lender to be available as freely floating, publicly tradable shares. A total principal balance of $30,000 and accrued interest of $30,000 remained outstanding as of December 31, 2024. This loan was repaid in April of 2025. Please refer to Note 10 for subsequent events.

Original Issue Discount Convertible Promissory Note — December 2024

In December of 2024, the Company raised $25,000 from a short-term convertible promissory note which is unrelated to the previously issued convertible debt through May of 2024 and carries different terms. This note has a 30% original issue discount that constitutes the interest due on the loan and was added to the principal balance, a payment in equity kicker shares of the Company’s common stock having a combined value equaling 30% of the principal amount and a maturity date of February 15, 2025. The number of the shares subject to the equity kicker were calculated based on the Company’s anticipated price per share at the IPO, which was at $4. The original issue discount and the equity kicker shares had values of $7,500 each for a total discount on debt of $15,000. During 2024, the Company recognized $4,219 in amortization of debt discount on the consolidated statements of operations and comprehensive loss. The issuance of this loan resulted in an additional 1,875 shares of common stock becoming due and were not issued as of December 31, 2024. As such, it resulted in an increase of $7,500 to the shares payable balance during the year ended December 31, 2024. Please refer to Note 7. A total principal balance of $32,500 and unamortized debt discount of $10,781 remained outstanding as of December 31, 2024.

- Definition

The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 8A
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480434/815-10-50-8A

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(c))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481544/470-10-50-6

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481544/470-10-50-6

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 405
-SubTopic 40
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477092/405-40-50-1

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 405
-SubTopic 40
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)(3)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477092/405-40-50-1

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 405
-SubTopic 40
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477092/405-40-50-1

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 405
-SubTopic 40
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477092/405-40-50-1

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 405
-SubTopic 40
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477092/405-40-50-1

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Subparagraph (h)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B

Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 470
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org/470/tableOfContent

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 835
-SubTopic 30
-Name Accounting Standards Codification
-Section 45
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482925/835-30-45-2

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Subparagraph (g)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Subparagraph (i)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1C
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1C

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1C
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1C

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1C
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1C

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1E
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1I
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1I
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1I
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I

+ Details

Summary of Significant Accounting Policies - Schedule of Calculation for Both Basic and Diluted Net Income (Loss) Per Share (Details) - USD ($)

3 Months Ended

9 Months Ended

12 Months Ended

Sep. 30, 2025

Jun. 30, 2025

Mar. 31, 2025

Sep. 30, 2024

Jun. 30, 2024

Mar. 31, 2024

Sep. 30, 2025

Sep. 30, 2024

Dec. 31, 2024

Dec. 31, 2023

Summary of Significant Accounting Policies - Schedule of Calculation for Both Basic and Diluted Net Income (Loss) Per Share (Details) [Line Items]

Net Income (Loss) (in Dollars)

$ 2,540,636

$ (1,705,217)

$ (1,067,673)

$ (1,010,058)

$ (956,963)

$ (1,034,161)

$ (232,254)

$ (3,001,182)

$ (3,288,519)

$ (4,672,348)

Weighted-average Shares Outstanding – Basic

10,829,664

5,688,797

9,786,460

5,664,529

5,697,212

5,594,621

Income (Loss) per share – Basic (in Dollars per share)

$ 0.23

$ (0.18)

$ (0.02)

$ (0.53)

$ (0.58)

$ (0.84)

Increase to Net Income attributable to dilutive instruments (in Dollars)

Net Income available to Common Shareholders – Diluted (in Dollars)

$ 2,540,636

$ (1,010,058)

$ (232,254)

$ (3,001,185)

Effect of anti-dilutive

24,708,446

1,983,533

2,063,678

1,697,797

Weighted-average Shares Outstanding – Diluted

26,087,846

^[1]

5,688,797

^[1]

9,786,460

^[1]

5,664,529

^[1]

5,697,212

5,594,621

Income (Loss) per share – Diluted (in Dollars per share)

$ 0.1

$ (0.18)

$ (0.02)

$ (0.53)

$ (0.58)

$ (0.84)

Effect of Unvested Restricted Stock [Member]

Summary of Significant Accounting Policies - Schedule of Calculation for Both Basic and Diluted Net Income (Loss) Per Share (Details) [Line Items]

Effect of anti-dilutive

17,446

Effect of Shares Payable [Member]

Summary of Significant Accounting Policies - Schedule of Calculation for Both Basic and Diluted Net Income (Loss) Per Share (Details) [Line Items]

Effect of anti-dilutive

241,659

Effect of Convertible Preferred Stock [Member]

Summary of Significant Accounting Policies - Schedule of Calculation for Both Basic and Diluted Net Income (Loss) Per Share (Details) [Line Items]

Effect of anti-dilutive

10,731,100

Effect of Warrants [Member]

Summary of Significant Accounting Policies - Schedule of Calculation for Both Basic and Diluted Net Income (Loss) Per Share (Details) [Line Items]

Effect of anti-dilutive

3,657,119

Effect of Stock Options [Member]

Summary of Significant Accounting Policies - Schedule of Calculation for Both Basic and Diluted Net Income (Loss) Per Share (Details) [Line Items]

Effect of anti-dilutive

610,858

[1]	Only noted for the periods in which the result is not anti-dilutive.

Segment Reporting - Schedule of Operating Financial (Details) - Operating Segments [Member] - USD ($)	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2025	Sep. 30, 2024	Sep. 30, 2025	Sep. 30, 2024	Dec. 31, 2024	Dec. 31, 2023
Schedule of Operating Financial [Line Items]
Total Revenue				$ 55	$ 105	$ 366,438
Less: Significant and Other Segment Expenses
Cost of Sales				464	464	34,835
Advertising and Marketing	182,216	160,270	475,972	160,478	172,989	311,464
Legal and Professional	374,943	224,510	843,712	486,262	490,528	321,506
Selling, General and Administrative	713,415	113,566	1,595,027	457,362	626,901	1,099,576
Software Expense	14,880		240,215		92	1,114
Software Development	457	6,118	1,621	18,955	21,034	24,074
Stock-Based Compensation	344,569	44,974	700,140	137,006	179,766	556,222
Interest Expense and Amortization of Debt Discount		704,239	438,709	1,985,213	(2,179,122)	(2,769,208)
Other Income	(91,131)	(244,235)	(162,441)	(245,269)
Other Expenses			46,405
Other Expense - Stock-Based Compensation Liability			133,331
Foreign Currency Loss	14	616	(437)	766	1,775
Net Unrealized Gain on Equity Securities	(4,080,000)		(4,080,000)
Provision for Income Taxes
Segment Net Income (Loss)	$ 2,540,636	$ (1,010,058)	$ (232,254)	$ (3,001,182)	$ (3,288,519)	$ (4,672,348)

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended		12 Months Ended
	Sep. 30, 2025	Sep. 30, 2024	Dec. 31, 2024	Dec. 31, 2023
OPERATING ACTIVITIES
Net Loss	$ (232,254)	$ (3,001,182)	$ (3,288,519)	$ (4,672,348)
Adjustments to reconcile net loss to net cash used in operating activities:
Accrued Interest	(146,084)	636,535	826,225	298,979
Share Payable	(6,266)	100,349	132,849	81,694
Stock-Based Compensation	700,140	137,006	179,766	556,222
Amortization of Debt Discount	100,781	46,410	50,629	462,170
Amortization of Debt Issue Costs				143,906
Loan Extension Fees		997,253	997,253	1,864,153
Deferred Offering Costs			(6,647)
Interest Payment in Shares		280,000	280,000
Change in Fair Value of Stock-Based Compensation Liability – Software Expense	39,998
Other Expense – Stock-Based Compensation Liability	133,331
Issuance of Common Stock for Services – Marketing Expenses	133,334
Issuance of Common Stock for Services – Software Expenses	159,091
Foreign Currency Gain (Loss)	(437)
Net Unrealized Gain on Equity Securities	(4,080,000)
Changes in operating assets and liabilities:
Prepaid Expenses and Other Current Assets	(28,647)
Accounts Receivable				100,000
Other Receivable	17,398			(34,667)
Other Current Assets	(15,000)	12,459	12,228	(28,659)
Other Assets			8,639
Accounts Payable	(752,266)	553,234	489,577	451,339
Related Party Payable	(24,303)	14,067	14,692	(33,952)
Accrued Payroll	(251,043)	154,698	203,733	(3,339)
Accrued Liabilities	28,893	(529,382)	(567,106)	37,506
Other Current Liabilities	7,373	70,049	95,000
Net Cash Flows Used In Operating Activities	(4,215,961)	(528,504)	(571,681)	(776,996)
INVESTING ACTIVITIES
Investment in Equity Securities	(4,000,000)
Net Cash Flows Used In Investing Activities	(4,000,000)
FINANCING ACTIVITIES
Proceeds from Notes Payable	101,650	292,900	322,900
Repayment of Notes Payable	(399,126)	(25,000)	(25,000)
Cash paid for the settlement of the Stock-Based Compensation Liability	(250,000)
Repayment of Convertible Debt – December 2024, net	(227,500)
Proceeds from Convertible Debt	105,000	151,620	169,120	252,506
Proceeds from the sale of Common Stock in IPO	6,785,000
Proceeds from the sale of Common Stock		100,000	100,000
Offering Costs Paid, Netted against IPO Proceeds	(1,250,800)
Offering Costs Paid	(761,422)	(5,000)		(2,000)
Offering Costs Paid, Netted against PIPE Offering Proceeds	(1,321,205)
Proceeds from the sale of Series B Convertible Preferred Stock and Warrants	15,000,000
Proceeds from the Collection of Subscription Receivable	713
Net Cash Flows from Financing Activities	17,782,310	514,520	567,020	250,506
Net change in cash	9,566,349	(13,984)	(4,661)	(526,490)
Cash and Equivalents at the beginning of the year	29,228	33,889	33,889	560,379
Cash and Equivalents at the end of the year	9,595,577	19,905	29,228	33,889
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION
Cash paid during the year for interest	532,943	25,000	25,000
NONCASH INVESTING AND FINANCING ACTIVITIES
Deferred Offering Costs			608,341	610,835
Conversion of Convertible Debt and Accrued Interest into Common Stock	6,765,772
Issuance of Underwriter Warrants included as Offering Costs	130,980
Change in Stock-Based Compensation Liability Capitalized to Implementation Costs	76,671
Prepaid Expenses Reclassified to Issuance of Common Stock for Services – Software Expense	62
Prepaid Expenses Reclassified to Capitalized Implementation Costs	63
Issuance of Common Stock for Capitalized Implementation Costs	312,437
Deferred Offering Costs In Connection with IPO		295,019
Deferred Offering Costs at December 31, 2024 Reclassified to Offering Costs	1,219,176
Other Current Assets Reclassified to Other Receivables	18,081
Other Current Assets Reclassified to Prepaid Expenses	250
Write Off of Deferred Offering Costs Accrued at December 31, 2024	115,000
Conversion of Series A Preferred Stock to Common Stock	420
Prepaid Expenses Recognized by Issuance of Common Stock	66,666
Issuance of Shares Payable – Subscription	25,000		351,405
Issuance of Placement Agent and H.C. Wainwright Warrants included as Offering Costs – PIPE Offering	1,106,389
Issuance of Common Stock for Services Included in Offering Costs – PIPE Offering	258,000
Shares Payable and Offering Costs – PIPE Offering	$ 220,200
Other Assets paid for with Shares			$ 125

Condensed Consolidated Balance Sheets - USD ($)	Sep. 30, 2025	Dec. 31, 2024	Dec. 31, 2023
Current Assets:
Cash and Cash Equivalents	$ 9,595,577	$ 29,228	$ 33,889
Other Receivable	35,490	34,667	34,667
Other Current Assets	15,000	18,332	30,560
Total Current Assets	9,741,630	82,227	99,116
Other Assets:
Deferred Offering Costs		1,219,176	610,835
Other Assets		125	8,639
Total Other Assets	8,469,171	1,219,301	619,474
Total Assets	18,210,801	1,301,528	718,590
Current Liabilities:
Accounts Payable	1,177,330	1,929,469	953,198
Accrued Interest		1,189,345	363,120
Accrued Payroll		251,043	47,310
Accrued Liabilities	107,678	193,785	645,891
Share Payable	221,434	32,500	251,056
Other Current Liabilities	102,611	95,238	238
Notes Payable		297,900
Convertible Debt		21,719
Convertible Debt, net of discount and issuance costs		5,722,511	4,527,228
Total Current Liabilities	1,609,053	9,757,813	6,797,652
Total Liabilities	1,609,053	9,757,813	6,797,652
Commitments and Contingencies
Stockholders’ Equity (Deficit)
Preferred Stock, value		420	420
Common Stock, value	1,097	14,554	14,794
Stock Subscription Receivable		(3,700)	(4,276)
Additional Paid In Capital	31,495,785	6,195,322	5,284,362
Accumulated Deficit	(14,879,956)	(14,647,702)	(11,359,183)
Accumulated Other Comprehensive Loss	(15,179)	(15,179)	(15,179)
Total Stockholders’ Equity (Deficit)	16,601,748	(8,456,285)	(6,079,062)
Total Liabilities and Stockholders’ Equity (Deficit)	18,210,801	1,301,528	718,590
Prepaid Expenses	95,563
Prepaid Expenses - Long-Term		125
Capitalized Implementation Costs	389,171
Investment in Equity Securities	8,080,000
Series A Preferred Stock
Stockholders’ Equity (Deficit)
Preferred Stock, value
Series B Preferred Stock
Stockholders’ Equity (Deficit)
Preferred Stock, value	1
Related Party
Current Liabilities:
Due to Officer – Related Party		$ 24,303	$ 9,611

Commitments and Contingencies (Details) - USD ($)								1 Months Ended					3 Months Ended				9 Months Ended		12 Months Ended
Commitments and Contingencies (Details) - USD ($)	May 12, 2025	Apr. 01, 2025	Mar. 31, 2025	Mar. 06, 2025	Nov. 30, 2024	Nov. 13, 2024	Mar. 01, 2024	Jun. 30, 2025	Apr. 30, 2025	Sep. 30, 2024	Mar. 31, 2024	Sep. 30, 2023	Sep. 30, 2025	Jun. 30, 2025	Mar. 31, 2025	Sep. 30, 2024	Sep. 30, 2025	Sep. 30, 2024	Dec. 31, 2024	Dec. 31, 2023	Mar. 05, 2025
Commitments and Contingencies [Line Items]
Compensation for services								$ 50,000						$ 506,819	$ 164,647				$ 125
BHHI common stock, value																			$ (351,405)
Other income													$ 30,800			$ 0	$ 73,450	$ 0
Shares issued (in Shares)													10,972,588				10,972,588		7,033,330	5,744,929
Fair market value per share (in Dollars per share)					$ 4	$ 4
Grant for the total cost					$ 5,000,000	$ 5,000,000
Price per share (in Dollars per share)	$ 4
Other Intangible Assets, Net																			$ 125
Share price (in Dollars per share)																			$ 125
Advertising and marketing expense													$ 182,216			160,270	$ 475,972	160,478	$ 172,989	$ 311,364
Outstanding amount													1,609,053				1,609,053		9,757,813	$ 6,797,652
Non-current prepaid expense in other assets																			125
Software expense													0
Non-current prepaid expense																			125
Consideration transaction	$ 225,000
Fair value measurement amount	2,942,136		$ 44,392												44,392
Capitalized implementation costs	76,671
Equity Classified Awards [Member]
Commitments and Contingencies [Line Items]
Unrecognized compensation cost													$ 4,500,000				4,500,000
Increase to stockholders' deficit																	471,466
Weighted average period													6 years 3 months
Share Based Liability [Member]
Commitments and Contingencies [Line Items]
Increase to the stock-based compensation liability		$ 72,277	$ 44,392
Software Development [Member]
Commitments and Contingencies [Line Items]
Stock consideration - expensed	$ 39,998	30,946
Fair value measurement amount		$ 41,331
Maintenance Services with Artemis [Member] \| Equity Classified Awards [Member]
Commitments and Contingencies [Line Items]
Software expense													$ 0				159,091
Non-current prepaid expense																			62
Increase to stockholders' deficit													0				159,029
Increase to capitalized implementation costs													0				312,500
Development Services Rendered [Member] \| Equity Classified Awards [Member]
Commitments and Contingencies [Line Items]
Non-current prepaid expense																			63
Increase to stockholders' deficit																	312,437
Common Stock [Member]
Commitments and Contingencies [Line Items]
Compensation for services														$ 5					$ 125
BHHI common stock, value
Additional shares issued (in Shares)	234,375														56
Shares issued (in Shares)					937,500	937,500													6,296,434	5,744,929
Shares granted (in Shares)														50,000					1,250,000
Outstanding amount													$ 116,669				116,669
Marketing Agreement [Member]
Commitments and Contingencies [Line Items]
Compensation for services											$ 100,000						$ 100,000		$ 100,000
Market capital											50,000,000
Additional shares issued (in Shares)							50,000										50,000
Share price (in Dollars per share)													$ 9				$ 9
Advertising and marketing expense													$ 33,333				$ 100,000
Outstanding amount													61,000				61,000		61,000
Broncos Sponsorship Agreement [Member]
Commitments and Contingencies [Line Items]
Marketing expenses																				$ 305,000
Other income																244,000		244,000	244,000
Technology Purchase Agreements [Member]
Commitments and Contingencies [Line Items]
Non-current prepaid expense																			63
Technology Purchase Agreements [Member] \| Common Stock [Member]
Commitments and Contingencies [Line Items]
Shares issued (in Shares)					312,500	312,500
SAAS Agreement [Member]
Commitments and Contingencies [Line Items]
Price per share (in Dollars per share)	$ 4
Consideration transaction	$ 25,000
EVEMeta [Member]
Commitments and Contingencies [Line Items]
Stock consideration - expensed					$ 1,250,000	$ 1,250,000
EVEMeta [Member] \| Common Stock [Member]
Commitments and Contingencies [Line Items]
Shares issued (in Shares)					312,500	312,500
EVEMeta [Member] \| Technology Purchase Agreements [Member]
Commitments and Contingencies [Line Items]
Shares granted (in Shares)					1,250,000	1,250,000
Artemis [Member]
Commitments and Contingencies [Line Items]
Stock consideration - expensed					$ 3,750,000	$ 3,750,000
First Tranche [Member] \| Marketing Agreement [Member]
Commitments and Contingencies [Line Items]
Compensation for services																	50,000		$ 50,000
Second Tranche [Member]
Commitments and Contingencies [Line Items]
Compensation for services									$ 50,000
Second Tranche [Member] \| Forecast [Member]
Commitments and Contingencies [Line Items]
Compensation for services									$ 50,000
Liability-Classified Awards [Member]
Commitments and Contingencies [Line Items]
Stock consideration - expensed	$ 116,669																39,998
Maximum [Member] \| Aforementioned [Member] \| Equity Classified Awards [Member]
Commitments and Contingencies [Line Items]
Increase to stockholders' deficit																	312,437
Maximum [Member] \| Broncos Sponsorship Agreement [Member]
Commitments and Contingencies [Line Items]
Reduction from payment of agreement										$ 305,000		$ 305,000
Minimum [Member] \| Aforementioned [Member] \| Equity Classified Awards [Member]
Commitments and Contingencies [Line Items]
Increase to stockholders' deficit																	159,029
Minimum [Member] \| Broncos Sponsorship Agreement [Member]
Commitments and Contingencies [Line Items]
Reduction from payment of agreement										$ 61,000		$ 61,000
IPO [Member]
Commitments and Contingencies [Line Items]
BHHI common stock, value																	1,234
Shares issued (in Shares)									29,305
Price per share (in Dollars per share)					$ 4	$ 4													$ 4
After the completion days				10 days
Share price (in Dollars per share)																			$ 4		$ 4
IPO [Member] \| Common Stock [Member]
Commitments and Contingencies [Line Items]
BHHI common stock, value																	101,867
IPO [Member] \| Marketing Agreement [Member]
Commitments and Contingencies [Line Items]
Compensation for services													$ 66,666
BHHI common stock, value											$ 200,000						$ 200,000
Additional shares issued (in Shares)											50,000

Stockholders’ Equity (Details) - USD ($)																	1 Months Ended							3 Months Ended						9 Months Ended		12 Months Ended
Stockholders’ Equity (Details) - USD ($)	Oct. 30, 2025	Jul. 30, 2025	Jul. 24, 2025	May 12, 2025	Apr. 30, 2025	Mar. 10, 2025	Mar. 07, 2025	Mar. 05, 2025	Nov. 30, 2024	Nov. 13, 2024	Jun. 14, 2024	Feb. 10, 2022	Dec. 31, 2020	Jul. 07, 2020	Dec. 21, 2019	Feb. 24, 2018	Nov. 28, 2025	Nov. 12, 2025	Jul. 31, 2025	Nov. 30, 2024	Oct. 31, 2024	Mar. 31, 2024	May 31, 2022	Sep. 30, 2025	Jun. 30, 2025	Mar. 31, 2025	Sep. 30, 2024	Jun. 30, 2024	Jun. 30, 2022	Sep. 30, 2025	Sep. 30, 2024	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020	Jan. 31, 2025	Feb. 22, 2022	Dec. 03, 2021
Stockholders’ Deficit [Line Items]
Common stock, shares authorized (in Shares)																								250,000,000						250,000,000		250,000,000	250,000,000
Common stock, par value (in Dollars per share)																								$ 0.0001						$ 0.0001		$ 0.0001	$ 0.0001
Preferred stock, shares authorized (in Shares)																								24,785,000						24,785,000		24,785,000
Preferred stock, par value (in Dollars per share)																								$ 0.0001						$ 0.0001		$ 0.0001	$ 0.0001
Preferred stock, shares issued (in Shares)																																82,096	82,096
Common stock, shares issued (in Shares)																								10,972,588						10,972,588		7,033,330	5,744,929
Common stock, shares outstanding (in Shares)																								10,972,588						10,972,588		7,033,330	5,744,929
Shares of common stock (in Shares)						221,250																									208,010
Cash proceeds																						$ 100,000							$ 322,164
Marketing agreement																																$ (351,405)
Retired shareholders total value
Fair market value per share (in Dollars per share)									$ 4	$ 4										$ 4
Fair market value of shares issued									$ 5,000,000	$ 5,000,000
Short-term loan																																$ 25,000
Offering price (in Dollars per share)																																$ 125
Shares payable																								$ 424						$ 424		$ 32,500	$ 251,056
Issuance of common stock								$ 5,900,000					$ 22																		$ 100,000	100,000
Offering costs																														761,422	5,000		2,000
Remaining offering cost																																307,296	307,296
Percentage of restricted stock vests												25.00%
Contra equity																								$ 22						$ 22		$ 76	$ 76
Shares of vested (in Shares)																														150,000		80,525	494,664
Forfeited unvested shares (in Shares)
Unamortized stock compensation																																$ 170,001	$ 340,001
Converted shares (in Shares)																																1,912,176
Preferred stock outstanding (in Shares)																																82,096	82,096
Acquire shares of common stock (in Shares)																			15,000
Conversion price (in Dollars per share)																			$ 0.942
Other expenses																														$ 133,331
Deferred offering costs																																$ 1,219,176	$ 610,835
Incurred offering costs																														131,922	295,019
Deferred offering costs																								$ 1,351,098						1,351,098
Offering costs																														1,236,098
Payments deferred cost																														$ 115,000
Shares issued																														3.00%		3.00%
Exercise price per share (in Dollars per share)																								$ 2.96						$ 2.96
Offering price																														100.00%		100.00%
Total value																														$ 130,980
Purchase of common stock (in Shares)																														1,950,000
Vested options for non-employees																								$ 140,224						$ 146,467
Vested options for employees																								161,845
Total cash proceeds																																$ 25,000
Offering of equity securities																															5,000
Offering costs																																608,341	610,835
Common stock value issued																								$ 1,097			$ 351,405			$ 1,097	351,405	14,554	$ 14,794
Lock-up provisions share (in Shares)																								312,500						312,500
Capitalized implementation costs																								$ 0						$ 312,500
Software expense																								$ 0
Restricted Stock Vests Percentage												25.00%
Gross proceeds																														$ 6,785,000
Additional fee incurred		$ 635,000
Fees amount		8,500
Percentage of common stock																														9.99%
Warrants issued (in Shares)																								4,000,000						4,000,000
Cash payment																								$ 9,575,000						$ 9,575,000		$ 50,649
Warrants offering cost																														1,106,389
Fair values																								$ 258,000						$ 220,200
PIPE Warrants [Member]
Stockholders’ Deficit [Line Items]
Acquire shares of common stock (in Shares)			15,923,567
Exercise price per share (in Dollars per share)			$ 0.817
PIPE Warrants shares (in Shares)
Expire term			5 years
Beneficially owned percentage																														4.99%
Fair value of warrants																														$ 12,392,578
Procceds from warrants																														$ 5,901,067
Placement Agent Warrants [Member]
Stockholders’ Deficit [Line Items]
Warrant exercised (in Shares)
H.C. Wainwright Warrants [Member]
Stockholders’ Deficit [Line Items]
Acquire shares of common stock (in Shares)																														536,093
Exercise price per share (in Dollars per share)																								$ 1.884						$ 1.884
Expire term																								5 years						5 years
Fair value of warrants																														$ 315,195
Warrant exercised (in Shares)
Cash payment																								$ 635,000						$ 635,000
Warrant [Member]
Stockholders’ Deficit [Line Items]
Shares of common stock (in Shares)																														44,250		44,250
Fair value of warrants																														$ 13,498,967
Forecast [Member]
Stockholders’ Deficit [Line Items]
Issuance of common stock					$ 25,000
Lock-up provisions share (in Shares)					6,250
Forecast [Member] \| Warrant [Member]
Stockholders’ Deficit [Line Items]
Exercise price per share (in Dollars per share)																	$ 0.817
Warrants shares (in Shares)																	500,000
Proceeds of warrants																	$ 408,500
Reclassification Common Stock [Member[
Stockholders’ Deficit [Line Items]
Common stock value issued																								$ 1,097						$ 1,097
Board of Directors [Member]
Stockholders’ Deficit [Line Items]
Common stock, shares authorized (in Shares)																																					56
Common stock, shares issued (in Shares)																																					56
Common Stock [Member]
Stockholders’ Deficit [Line Items]
Common stock, shares authorized (in Shares)																																						250,000,000	50,000,000
Common stock, par value (in Dollars per share)			$ 0.0001								$ 0.0001																											$ 0.0001	$ 0.0001
Common stock, shares issued (in Shares)									937,500	937,500										937,500												6,296,434	5,744,929
Common stock, shares outstanding (in Shares)																																6,296,434	5,744,929
Percentage of common stock outstanding shares																								10.00%						10.00%		10.00%
Reverse stock split (in Shares)																																81,462
Shares of common stock (in Shares)				234,375																						56
Marketing agreement
Retired shares of common stock (in Shares)																												208,010				208,010
Retired shareholders total value																												$ 425				$ 425
Shares granted (in Shares)																									50,000							1,250,000
Additional shares (in Shares)																																1,875
Issuance of common stock																																$ 25,000
Total cash proceeds																															576
Common stock value outstanding																											351,405				$ 351,405
Common Stock [Member] \| PIPE Warrants [Member]
Stockholders’ Deficit [Line Items]
Acquire shares of common stock (in Shares)			1,061.5711
Common Stock [Member] \| H.C. Wainwright Warrants [Member]
Stockholders’ Deficit [Line Items]
Warrants issued (in Shares)																								536,093						536,093
Common Stock [Member] \| Warrant [Member]
Stockholders’ Deficit [Line Items]
Converted shares (in Shares)																														17,517,203
Preferred Stock [Member]
Stockholders’ Deficit [Line Items]
Preferred stock, shares authorized (in Shares)																																						25,000,000	5,000,000
Preferred stock, par value (in Dollars per share)																																						$ 0.0001	$ 0.0001
Marketing agreement
Retired shareholders total value
Common and Preferred Stock [Member]
Stockholders’ Deficit [Line Items]
Reverse stock split																					1 for 2.43615
Malloy FRSPA [Member]
Stockholders’ Deficit [Line Items]
Offering price (in Dollars per share)													$ 0.0001			$ 0.0001																				$ 0.0001
Adjusted for the reverse stock split (in Shares)																																		1,102,411
Issuance of common stock																$ 401
Shares of restricted common stock (in Shares)													2			4,008,417
Percentage of restricted stock vests																25.00%
Malloy FRSPA [Member] \| Restricted Stock Agreements [Member]
Stockholders’ Deficit [Line Items]
Shares of restricted common stock (in Shares)													225,000
Leibovich FRSPA [Member]
Stockholders’ Deficit [Line Items]
Offering price (in Dollars per share)															$ 0.0001
Issuance of common stock															$ 312
Shares of restricted common stock (in Shares)															3,120,917
Percentage of restricted stock vests															25.00%
Shares of vested (in Shares)																																	858,327
Simpson FRSPA [Member]
Stockholders’ Deficit [Line Items]
Offering price (in Dollars per share)														$ 0.0001
Issuance of common stock														$ 179
Shares of restricted common stock (in Shares)														1,789,666
Percentage of restricted stock vests														25.00%
Shares of vested (in Shares)																														261,684	191,901	492,201	492,201
Stock-based Compensation - expensed																														$ 127,500
RSPAs [Member]
Stockholders’ Deficit [Line Items]
Offering price (in Dollars per share)													$ 0.0001																						$ 0.0001	$ 0.0001
Adjusted for the reverse stock split (in Shares)																																			207,918
Issuance of common stock																																			$ 76	$ 22
Shares of restricted common stock (in Shares)																																			756,000	225,000
Contra equity																								$ 61,880			61,594			61,880	$ 61,594	$ 22	$ 22
Shares of vested (in Shares)																							88,741									61,880	51,137
Forfeited unvested shares (in Shares)																							119,176
Restricted Stock Award [Member]
Stockholders’ Deficit [Line Items]
Shares of restricted common stock (in Shares)												279,129
Shares of vested (in Shares)																																209,347	139,565
Restricted Stock [Member]
Stockholders’ Deficit [Line Items]
Stock-based Compensation - expensed																																$ 170,000	$ 170,000
Kingswood [Member]
Stockholders’ Deficit [Line Items]
Net proceeds																														$ 789,200
Stock Options [Member]
Stockholders’ Deficit [Line Items]
Common stock, shares issued (in Shares)																								1,052,888						1,052,888
Shares of vested (in Shares)																														968,504
Stock Repurchased During Period, Shares (in Shares)																														897,112
Vested options for non-employees																														$ 830,477
Vested options for employees																														426,173
Restricted Stock Agreements [Member]
Stockholders’ Deficit [Line Items]
Shares of vested (in Shares)																								467,446	17,446	17,446
Stock-based Compensation - expensed																								$ 0			2,474			$ 0	9,505
Common Stock Awards [Member]
Stockholders’ Deficit [Line Items]
Shares of restricted common stock (in Shares)																														663,250,176
Shares of vested (in Shares)																								300,000						450,000
Fair value of warrants																								$ 478,200
Fair values																														$ 220,200
Grants shares (in Shares)																														300,000
Common Stock Awards [Member] \| Maximum [Member]
Stockholders’ Deficit [Line Items]
Date of grant (in Dollars per share)																								$ 1.72
Subsequent Event [Member]
Stockholders’ Deficit [Line Items]
Shares of common stock (in Shares)								1,475,000
Shares of common stock (in Shares)						221,250
Shares granted (in Shares)	175,000
Other expenses						$ 885,000		$ 5,900,000
Subsequent Event [Member] \| PIPE Warrants [Member]
Stockholders’ Deficit [Line Items]
Exercise price per share (in Dollars per share)																		$ 0.817
Warrants shares (in Shares)																		1,598,843
Proceeds of warrants																		$ 1,306,255
Subsequent Event [Member] \| Common Stock [Member]
Stockholders’ Deficit [Line Items]
Converted shares (in Shares)							29,660
Lock-up provisions share (in Shares)																										56
Conversion of stock (in Shares)																		7,327,378
IPO [Member]
Stockholders’ Deficit [Line Items]
Common stock, shares issued (in Shares)					29,305
Shares of common stock (in Shares)								1,475,000
Marketing agreement																														$ 1,234
Short-term loan																																$ 150,000
Maturity date																																Feb. 15, 2025
Offering price (in Dollars per share)								$ 4																								$ 4
Shares payable																																$ 7,500
Converted shares (in Shares)																														44,250
Other related expenses								$ 5,900,000
Other expenses																														$ 1,100,000
Net proceeds																														4,800,000
Deferred offering costs																								$ 0						0		$ 1,219,176
Incurred offering costs																								$ 0			24,906
Gross proceeds																														1,351,098
IPO [Member] \| Board of Directors [Member]
Stockholders’ Deficit [Line Items]
Common stock, shares authorized (in Shares)																										82,096
IPO [Member] \| Common Stock [Member]
Stockholders’ Deficit [Line Items]
Marketing agreement																														101,867
Adjusted for the reverse stock split (in Shares)																																6,250
IPO [Member] \| Subsequent Event [Member]
Stockholders’ Deficit [Line Items]
Other expenses								$ 5,900,000
Purchase of common stock (in Shares)						221,250
IPO [Member] \| Subsequent Event [Member] \| Common Stock [Member]
Stockholders’ Deficit [Line Items]
Shares of common stock (in Shares)								1,475,000
Gross proceeds								$ 4
Over-Allotment Option [Member]
Stockholders’ Deficit [Line Items]
Shares of common stock (in Shares)								1,475,000
Offering price (in Dollars per share)						$ 4
Issuance of common stock						$ 885,000
Other expenses																														95,800
Payments deferred cost																														1,061,800
Offering costs																														$ 190,980
Underwriter Warrants [Member]
Stockholders’ Deficit [Line Items]
Shares of common stock (in Shares)																														44,250
Exercise price per share (in Dollars per share)																								$ 4						$ 4
Stock Issuances [Member]
Stockholders’ Deficit [Line Items]
Common stock, shares issued (in Shares)					1,875																					1
Marketing agreement																														$ 200,000
Offering costs																											$ 312,296				312,296
Software expense																														$ 159,091
IPO share price (in Dollars per share)																								$ 4						$ 4
Business days																														10 days
Issued the shares (in Shares)																								50,000						50,000
Accrued interest					$ 7,500
Maturity date					Feb. 15, 2025
PIPE Offer [Member]
Stockholders’ Deficit [Line Items]
Offering costs		1,964,705	$ 1,964,705																											$ 1,964,705
Original Issue Discount [Member]
Stockholders’ Deficit [Line Items]
Original issue discount interest due																																30.00%
Percentage of common stock combined value																																30.00%
Maturity date																																Feb. 15, 2025
Original Issue Discount [Member] \| Forecast [Member]
Stockholders’ Deficit [Line Items]
Common stock, shares issued (in Shares)					1,875
Maturity date					Feb. 15, 2025
Plan Share Reserve [Member]
Stockholders’ Deficit [Line Items]
Common stock, shares issued (in Shares)																								2,250,000						2,250,000		2,250,000
Stock Incentive Plan [Member]
Stockholders’ Deficit [Line Items]
Purchase right of stock options reserved, number of shares (in Shares)																														1,950,000
BHHI [Member]
Stockholders’ Deficit [Line Items]
Shares of common stock (in Shares)																						29,094					135,911		132,243			6,250
Reverse stock split (in Shares)																						29,093
Amount of payment																																$ 280,000
Shares of payment (in Shares)																																81,462
Total cash proceeds																						$ 100,000
BHI [Member]
Stockholders’ Deficit [Line Items]
Shares of common stock (in Shares)																																135,856
BHI [Member] \| Common Stock [Member]
Stockholders’ Deficit [Line Items]
Retired shares of common stock (in Shares)																																208,010
Retired shareholders total value																																$ 576
BHI [Member] \| Leibovich FRSPA [Member]
Stockholders’ Deficit [Line Items]
Stock-based Compensation - expensed																																	195,057
BHI [Member] \| Simpson FRSPA [Member]
Stockholders’ Deficit [Line Items]
Stock-based Compensation - expensed																															$ 9	0	177,102
Unamortized stock compensation																								$ 42,500						$ 42,500
BHI [Member] \| RSPAs [Member]
Stockholders’ Deficit [Line Items]
Stock-based Compensation - expensed																																9,766	$ 14,063
BHI [Member] \| Restricted Stock [Member]
Stockholders’ Deficit [Line Items]
Stock-based Compensation - expensed																								42,500			$ 3
Mr. Malloy [Member]
Stockholders’ Deficit [Line Items]
Contra equity																																401
Mr. Leibovich [Member]
Stockholders’ Deficit [Line Items]
Contra equity																																$ 312
Mr. Simpson [Member]
Stockholders’ Deficit [Line Items]
Contra equity														$ 179
PIPE Offer [Member]
Stockholders’ Deficit [Line Items]
Other expenses		1,321,205
Gross proceeds		$ 15,000,000
Warrants offering cost																								$ 1,106,389						$ 1,106,389
Revere Securities, LLC [Member] \| Placement Agent Warrants [Member]
Stockholders’ Deficit [Line Items]
Acquire shares of common stock (in Shares)																														1,057,543
Exercise price per share (in Dollars per share)																								$ 0.942						$ 0.942
Expire term																								5 years						5 years
Fees amount			$ 1,171,205
Warrants issued (in Shares)			1,057,543
Fair value of warrants																														$ 791,194
Minimum [Member]
Stockholders’ Deficit [Line Items]
Vesting terms																														3 years
Options carry strike price (in Dollars per share)																														$ 0.38
Minimum [Member] \| Warrant [Member]
Stockholders’ Deficit [Line Items]
Exercise price per share (in Dollars per share)																								$ 0.59						0.59
Minimum [Member] \| Stock Options [Member]
Stockholders’ Deficit [Line Items]
Options carry strike price (in Dollars per share)																														0.576
Minimum [Member] \| Common Stock Awards [Member]
Stockholders’ Deficit [Line Items]
Date of grant (in Dollars per share)																														$ 0.73
Maximum [Member]
Stockholders’ Deficit [Line Items]
Vesting terms																														4 years
Options carry strike price (in Dollars per share)																														$ 0.6
Maximum [Member] \| Warrant [Member]
Stockholders’ Deficit [Line Items]
Exercise price per share (in Dollars per share)																								$ 0.78						0.78
Maximum [Member] \| Stock Options [Member]
Stockholders’ Deficit [Line Items]
Options carry strike price (in Dollars per share)																														$ 1
Series A Preferred Stock [Member]
Stockholders’ Deficit [Line Items]
Preferred stock, shares authorized (in Shares)																								200,000						200,000		200,000	200,000
Preferred stock, par value (in Dollars per share)																								$ 0.0001						$ 0.0001		$ 0.0001	$ 0.0001
Preferred stock, liquidation preference (in Dollars per share)																								$ 0.5						$ 0.5		$ 0.5
Preferred stock, shares issued (in Shares)
Reverse stock split																														1 for 2.43615		1 for 2.43615
Adjusted for the reverse stock split (in Shares)											1
Voting rights																														one
Preferred stock outstanding (in Shares)
Series A Preferred Stock [Member] \| Preferred Stock [Member]
Stockholders’ Deficit [Line Items]
Preferred stock, par value (in Dollars per share)											$ 0.0001
Marketing agreement
Retired shareholders total value
Adjusted for the reverse stock split (in Shares)											5.1287
Offering costs																								$ 1,964,705		1,176,800
Series B Convertible Preferred Stock [Member]
Stockholders’ Deficit [Line Items]
Shares of common stock (in Shares)																																1
Converted shares (in Shares)																														1
Artemis Stock Consideration [Member] \| Common Stock [Member]
Stockholders’ Deficit [Line Items]
Common stock, shares issued (in Shares)									937,500	279,129										937,500
EVEMeta Stock Consideration [Member]
Stockholders’ Deficit [Line Items]
Shares granted (in Shares)									1,250,000
Fair market value per share (in Dollars per share)									$ 4											$ 4
EVEMeta Stock Consideration [Member] \| Common Stock [Member]
Stockholders’ Deficit [Line Items]
Common stock, shares issued (in Shares)									312,500											312,500
Fair market value of shares issued																				$ 5,000,000
Series B Preferred Stock [Member]
Stockholders’ Deficit [Line Items]
Preferred stock, shares authorized (in Shares)																								15,000						15,000		15,000
Preferred stock, par value (in Dollars per share)																								$ 0.0001						$ 0.0001		$ 0.0001
Preferred stock, shares issued (in Shares)																								15,000						15,000
Preferred stock outstanding (in Shares)																								15,000						15,000
Convertible shares (in Shares)			15,923,567
Convertible Preferred Stock, par value (in Dollars per share)			$ 0.942
Fair value of warrants																														$ 19,108,280
Procceds from warrants																														$ 9,098,933
Series B Preferred Stock [Member] \| PIPE Warrants [Member]
Stockholders’ Deficit [Line Items]
Preferred stock, par value (in Dollars per share)			$ 0.0001
Warrants shares (in Shares)			15,923,567
Warrants issued (in Shares)			15,923,567
Series B Preferred Stock [Member] \| Preferred Stock [Member]
Stockholders’ Deficit [Line Items]
Marketing agreement
Retired shareholders total value
Acquire shares of common stock (in Shares)																			24,800,000
Series B Preferred Stock [Member] \| Subsequent Event [Member]
Stockholders’ Deficit [Line Items]
Conversion of stock (in Shares)																		6,902
Series B Preferred Stock [Member] \| Private Investment into Public Entity PIPE [Member]
Stockholders’ Deficit [Line Items]
Common stock, shares issued (in Shares)																								15,000						15,000
Common stock, shares outstanding (in Shares)																								15,000						15,000
Series B Preferred Stock [Member] \| PIPE Offer [Member]
Stockholders’ Deficit [Line Items]
Shares of common stock (in Shares)			15,000
Series B Convertible Preferred Stock [Member]
Stockholders’ Deficit [Line Items]
Converted preferred shares (in Shares)			15,000
PIPE Warrants shares (in Shares)			1,061.5711
Series B Convertible Preferred Stock [Member] \| PIPE Warrants [Member]
Stockholders’ Deficit [Line Items]
Convertible Preferred Stock, par value (in Dollars per share)			$ 1,000

Segment Reporting - Schedule of Operating Financial (Details) - Operating Segments [Member] - USD ($)	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2025	Sep. 30, 2024	Sep. 30, 2025	Sep. 30, 2024	Dec. 31, 2024	Dec. 31, 2023
Schedule of Operating Financial [Line Items]
Total Revenue				$ 55	$ 105	$ 366,438
Less: Significant and Other Segment Expenses
Cost of Sales				464	464	34,835
Advertising and Marketing	182,216	160,270	475,972	160,478	172,989	311,464
Legal and Professional	374,943	224,510	843,712	486,262	490,528	321,506
Selling, General and Administrative	713,415	113,566	1,595,027	457,362	626,901	1,099,576
Software Development	457	6,118	1,621	18,955	21,034	24,074
Stock-Based Compensation	344,569	44,974	700,140	137,006	179,766	556,222
Rent Expense	14,880		240,215		92	1,114
Interest Expense and Amortization of Debt Discount		(704,239)	(438,709)	(1,985,213)	2,179,122	2,769,208
Other Income					(384,047)	(79,113)
Foreign Currency Loss	14	616	(437)	766	1,775
Segment Net Loss	$ 2,540,636	$ (1,010,058)	$ (232,254)	$ (3,001,182)	$ (3,288,519)	$ (4,672,348)

Summary of Significant Accounting Policies - Schedule of Calculation for Both Basic and Diluted Net Loss Per Share (Details) - USD ($)	3 Months Ended						9 Months Ended		12 Months Ended
	Sep. 30, 2025	Jun. 30, 2025	Mar. 31, 2025	Sep. 30, 2024	Jun. 30, 2024	Mar. 31, 2024	Sep. 30, 2025	Sep. 30, 2024	Dec. 31, 2024	Dec. 31, 2023
Schedule of Calculation for Both Basic and Diluted Net Loss Per Share [Abstract]
Net Loss	$ 2,540,636	$ (1,705,217)	$ (1,067,673)	$ (1,010,058)	$ (956,963)	$ (1,034,161)	$ (232,254)	$ (3,001,182)	$ (3,288,519)	$ (4,672,348)
Weighted-average shares outstanding – Basic	10,829,664			5,688,797			9,786,460	5,664,529	5,697,212	5,594,621
Loss per share – Basic	$ 0.23			$ (0.18)			$ (0.02)	$ (0.53)	$ (0.58)	$ (0.84)
Loss per share – Diluted	$ 0.1			$ (0.18)			$ (0.02)	$ (0.53)	$ (0.58)	$ (0.84)

- Definition

The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482662/260-10-50-1

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (c)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-1

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (c)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-1

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-4

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 105
-SubTopic 10
-Name Accounting Standards Codification
-Section 65
-Paragraph 9
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479343/105-10-65-9

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 65
-Paragraph 17
-Subparagraph (d)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480336/718-10-65-17

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-6

Reference 8: http://www.xbrl.org/2003/role/exampleRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 52
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482635/260-10-55-52

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 60
-Name Accounting Standards Codification
-Section 65
-Paragraph 1
-Subparagraph (g)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147476176/805-60-65-1

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 323
-Name Accounting Standards Codification
-Section 65
-Paragraph 2
-Subparagraph (g)(3)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478666/740-323-65-2

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-3

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 15
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482635/260-10-55-15

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 40
-Name Accounting Standards Codification
-Section 65
-Paragraph 1
-Subparagraph (e)(4)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480175/815-40-65-1

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 40
-Name Accounting Standards Codification
-Section 65
-Paragraph 1
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480175/815-40-65-1

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 11
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-11

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 11
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-11

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 7
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-7

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482689/260-10-45-2

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 60B
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 10
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482689/260-10-45-10

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(25))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Topic 942
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(27))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Topic 944
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(23))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1

Reference 24: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 7
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482689/260-10-45-7

Reference 25: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 65
-Paragraph 4
-Subparagraph (f)(4)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481538/470-20-65-4

+ Details

- Definition

The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482662/260-10-50-1

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (c)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-1

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (c)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-1

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-4

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 105
-SubTopic 10
-Name Accounting Standards Codification
-Section 65
-Paragraph 9
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479343/105-10-65-9

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 65
-Paragraph 17
-Subparagraph (d)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480336/718-10-65-17

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-6

Reference 8: http://www.xbrl.org/2003/role/exampleRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 52
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482635/260-10-55-52

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 60
-Name Accounting Standards Codification
-Section 65
-Paragraph 1
-Subparagraph (g)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147476176/805-60-65-1

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 323
-Name Accounting Standards Codification
-Section 65
-Paragraph 2
-Subparagraph (g)(3)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478666/740-323-65-2

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-3

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 15
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482635/260-10-55-15

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 40
-Name Accounting Standards Codification
-Section 65
-Paragraph 1
-Subparagraph (e)(4)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480175/815-40-65-1

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 40
-Name Accounting Standards Codification
-Section 65
-Paragraph 1
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480175/815-40-65-1

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 11
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-11

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 11
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-11

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 7
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-7

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482689/260-10-45-2

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 60B
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(25))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Topic 942
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(27))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Topic 944
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(23))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 7
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482689/260-10-45-7

Reference 24: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 65
-Paragraph 4
-Subparagraph (f)(4)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481538/470-20-65-4

+ Details

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References

Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Topic 946
-SubTopic 830
-Name Accounting Standards Codification
-Section 55
-Paragraph 10
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479168/946-830-55-10

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Topic 220
-SubTopic 40
-Name Accounting Standards Codification
-Section 55
-Paragraph 4
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147476153/220-40-55-4

Reference 3: http://www.xbrl.org/2003/role/exampleRef
-Topic 220
-SubTopic 40
-Name Accounting Standards Codification
-Section 55
-Paragraph 21
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147476153/220-40-55-21

Reference 4: http://www.xbrl.org/2003/role/exampleRef
-Topic 220
-SubTopic 40
-Name Accounting Standards Codification
-Section 55
-Paragraph 14
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147476153/220-40-55-14

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(i))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(k)(2))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 825
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 28
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482907/825-10-50-28

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-4

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 480
-SubTopic 10
-Name Accounting Standards Codification
-Section S50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479857/480-10-S50-3

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 480
-SubTopic 10
-Name Accounting Standards Codification
-Section S45
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479887/480-10-S45-3

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 480
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 3A
-Subparagraph (24)(d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480244/480-10-S99-3A

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 105
-SubTopic 10
-Name Accounting Standards Codification
-Section 65
-Paragraph 9
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479343/105-10-65-9

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 65
-Paragraph 17
-Subparagraph (d)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480336/718-10-65-17

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-6

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 9
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-9

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 60
-Name Accounting Standards Codification
-Section 65
-Paragraph 1
-Subparagraph (g)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147476176/805-60-65-1

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 323
-Name Accounting Standards Codification
-Section 65
-Paragraph 2
-Subparagraph (g)(3)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478666/740-323-65-2

Reference 19: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(20))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Topic 323
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481687/323-10-50-3

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482765/220-10-50-6

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-3

Reference 24: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (b)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-1

Reference 25: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 40
-Name Accounting Standards Codification
-Section 65
-Paragraph 1
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480175/815-40-65-1

Reference 26: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 8
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-8

Reference 27: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 11
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-11

Reference 28: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 11
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-11

Reference 29: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 220
-Name Accounting Standards Codification
-Section 45
-Paragraph 7
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479105/946-220-45-7

Reference 30: http://www.xbrl.org/2003/role/disclosureRef
-Topic 944
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(18))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1

Reference 31: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.6-07(9))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1

Reference 32: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.6-09(1)(d))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3

Reference 33: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(i))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A

Reference 34: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(ii))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A

Reference 35: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iii)(A))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A

Reference 36: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iv))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A

Reference 37: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(5))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A

Reference 38: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(i))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B

Reference 39: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(A))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B

Reference 40: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(B))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B

Reference 41: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iv))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B

Reference 42: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(5))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B

Reference 43: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 60B
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B

Reference 44: http://www.xbrl.org/2003/role/disclosureRef
-Topic 205
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 7
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483499/205-20-50-7

Reference 45: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 230
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 28
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482740/230-10-45-28

Reference 46: http://www.xbrl.org/2003/role/disclosureRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 1A
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A

Reference 47: http://www.xbrl.org/2003/role/disclosureRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 1B
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B

Reference 48: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 65
-Paragraph 4
-Subparagraph (f)(4)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481538/470-20-65-4

Reference 49: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 942
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(22))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1

+ Details

Condensed Consolidated Statements of Operations And Comprehensive Income (Loss) (Unaudited) - USD ($)

3 Months Ended

9 Months Ended

12 Months Ended

Sep. 30, 2025

Sep. 30, 2024

Sep. 30, 2025

Sep. 30, 2024

Dec. 31, 2024

Dec. 31, 2023

Revenues:

Total Revenues

$ 55

$ 105

$ 366,438

Cost of Sales

Cost of Sales

464

34,835

Total Cost of Sales

464

34,835

Gross Profit (Loss)

(409)

(359)

331,603

Operating Expenses:

Advertising and Marketing

182,216

160,270

475,972

160,478

172,989

311,364

Legal and Professional

374,943

224,510

843,712

486,262

490,528

321,506

Selling, General and Administrative

713,416

113,566

1,595,027

457,362

626,901

1,099,576

Software Expense

14,880

240,215

Software Development

457

6,118

1,621

18,955

21,034

24,074

Stock-Based Compensation

344,569

44,974

700,140

137,006

179,766

556,222

Rent Expense

1,114

Total Operating Expenses

1,630,481

549,438

3,856,687

1,260,063

1,491,310

2,313,856

Other (Income) Expense:

Interest Expense and Amortization of Debt Discount

704,239

438,709

1,985,213

2,179,122

2,769,208

Other Income

(91,131)

(244,235)

(162,441)

(245,269)

(384,047)

(79,113)

Other Expenses

46,405

Other Expense – Stock-Based Compensation Liability

133,331

Foreign Currency (Gain) Loss

616

(437)

766

1,775

Net Unrealized Gain on Equity Securities

(4,080,000)

Total Other (Income) Expense, Net

(4,171,117)

460,620

(3,624,433)

1,740,710

1,796,850

2,690,095

Income (Loss) from Continuing Operations Before Income Taxes

2,540,636

(1,010,058)

(232,254)

(3,001,182)

(3,288,519)

(4,672,348)

Provision for Income Taxes

Net Income (Loss)

2,540,636

(1,010,058)

(232,254)

(3,001,182)

(3,288,519)

(4,672,348)

Other Comprehensive Loss, Net of Tax

Foreign Currency Translation Adjustment

Total Other Comprehensive Loss

Total Comprehensive Income (Loss)

$ 2,540,636

$ (1,010,058)

$ (232,254)

$ (3,001,182)

$ (3,288,519)

$ (4,672,348)

Net Income (Loss) per Common Share – Basic (in Dollars per share)

$ 0.23

$ (0.18)

$ (0.02)

$ (0.53)

$ (0.58)

$ (0.84)

Net Loss per Common Share – Diluted (in Dollars per share)

$ 0.1

$ (0.18)

$ (0.02)

$ (0.53)

$ (0.58)

$ (0.84)

Weighted Average Shares Outstanding – Basic (in Shares)

10,829,664

5,688,797

9,786,460

5,664,529

5,697,212

5,594,621

Weighted Average Shares Outstanding – Diluted (in Shares)

26,087,846

^[1]

5,688,797

^[1]

9,786,460

^[1]

5,664,529

^[1]

5,697,212

5,594,621

Net Income (Loss) per Common Share – Diluted (in Dollars per share)

$ 0.1

$ (0.18)

$ (0.02)

$ (0.53)

$ (0.58)

$ (0.84)

Tournament Revenues

Revenues:

Total Revenues

$ 366,333

Live-streaming Services

Revenues:

Total Revenues

$ 55

$ 105

[1]	Only noted for the periods in which the result is not anti-dilutive.

Offerings - Offering: 1	Nov. 25, 2025 USD ($) shares
Offering:
Fee Previously Paid	false
Other Rule	true
Security Type	Equity
Security Class Title	Common Stock, par value $0.0001 per share
Amount Registered \| shares	718,957,784
Proposed Maximum Offering Price per Unit	0.00
Maximum Aggregate Offering Price	$ 0.00
Fee Rate	0.01381%
Amount of Registration Fee	$ 0.00
Offering Note	Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the “Securities Act”), there are also being registered an indeterminable number of additional securities as may be issued resulting from stock splits, stock dividends, anti-dilution provisions or similar transactions. Relates to common stock, $0.0001 par value per share, of Brag House Holdings, Inc., a Delaware corporation (“Brag House”), issuable to holders of common stock, no par value per share, of House of Doge Inc., a Texas corporation (“House of Doge”), in the proposed merger of Brag House Merger Sub Inc., a Delaware corporation and a direct, wholly owned subsidiary of Brag House, with and into House of Doge, with House of Doge surviving the merger as a wholly owned subsidiary of Brag House. The amount of common stock of Brag House to be registered includes the estimated maximum number of shares of common stock of Brag House that are expected to be issued (or become issuable) pursuant to the merger, without taking into account the effect of a reverse stock split of common stock of Brag House, assuming an estimated pre-split exchange ratio (which is subject to adjustment prior to the closing of the merger) of approximately 1.77351 shares of common stock of Brag House for each outstanding share of common stock of House of Doge. Calculated in accordance with Rule 457(f)(2) under the Securities Act. House of Doge is a private company, no market exists for its securities and it has an accumulated capital deficit. Therefore, the proposed maximum aggregate offering price for the shares expected to be issued pursuant to the merger is one-third of the aggregate par value of the House of Doge securities expected to be exchanged in the proposed merger. As House of Doge’s common stock has no par value, however, this value is $0.00.

Submission	Nov. 25, 2025
Submission [Line Items]
Central Index Key	0001903595
Registrant Name	BRAG HOUSE HOLDINGS, INC.
Form Type	S-4
Submission Type	S-4
Fee Exhibit Type	EX-FILING FEES
Offering Table N/A
Offset Table N/A	N/A
Combined Prospectus Table N/A	N/A

Fair Value Measurements - Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details) - Fair Value, Recurring [Member] - USD ($)	Sep. 30, 2025	Dec. 31, 2024
Fair Value Measurements - Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details) [Line Items]
Investment in Equity Securities	$ 8,080,000
Level 1 [Member]
Fair Value Measurements - Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details) [Line Items]
Investment in Equity Securities	8,080,000
Level 2 [Member]
Fair Value Measurements - Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details) [Line Items]
Investment in Equity Securities
Level 3 [Member]
Fair Value Measurements - Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details) [Line Items]
Investment in Equity Securities

Income Taxes - Schedule of Net Deferred Tax Assets, Liabilities (Details) - USD ($)	Sep. 30, 2025	Dec. 31, 2024	Dec. 31, 2023
Schedule of Net Deferred Tax Assets, Liabilities [Abstract]
Net operating loss carryforwards		$ 2,769,080	$ 2,042,884
Stock-based compensation		646,033	635,864
Capitalized research and development - Sec 174		100,251
Total deferred assets		3,515,364	2,678,748
Valuation allowance		(3,515,364)	(2,678,748)
Net deferred tax assets	$ 1,044,912

Fees Summary	Nov. 25, 2025 USD ($)
Fees Summary [Line Items]
Total Offering	$ 0.00
Total Fee Amount	0.00
Net Fee	$ 0.00

Fair Value Measurements (Details) - USD ($)					1 Months Ended		3 Months Ended		9 Months Ended
Fair Value Measurements (Details) - USD ($)	Sep. 02, 2025	Jul. 24, 2025	May 12, 2025	Mar. 10, 2025	Jul. 31, 2025	May 12, 2025	Jun. 30, 2025	Mar. 31, 2025	Sep. 30, 2025	Sep. 30, 2024	Dec. 31, 2024
Fair Value Measurements [Line Items]
Fair value measurement			$ 2,942,136			$ 2,942,136		$ 44,392
Stock-based compensation liability			116,669			72,277
Existing stock-based compensation liability			$ 116,669			$ 116,669		44,392
Capitalized implementation costs									41,331
Software expense							$ 41,331	$ 35,340	$ 30,946
Shares issued (in Shares)				221,250						208,010
Warrants share (in Shares)									4,000,000
Acquire shares of common stock (in Shares)					15,000
Exercise price per share (in Dollars per share)		$ 0.942
Warrants exercise price per share (in Dollars per share)	$ 0.0001
Investment in equity securities									$ 8,080,000
PIPE Warrants [Member]
Fair Value Measurements [Line Items]
Existing stock-based compensation liability									72,277
Acquire shares of common stock (in Shares)		15,923,567
Pre-Funded Warrants [Member]
Fair Value Measurements [Line Items]
Invested warrants	$ 4,000,000
Purchase price per warrant share	$ 1
Class B Common Stock [Member]
Fair Value Measurements [Line Items]
Warrants share (in Shares)	1
Fair Value of Assets Acquired	$ 4,000,000
Placement Agent Warrants [Member]
Fair Value Measurements [Line Items]
Acquire shares of common stock (in Shares)		1,057,543
Issuance of Common Stock (in Shares)		1,057,543
H.C Wainwright [Member]
Fair Value Measurements [Line Items]
Warrants share (in Shares)		536,093
Acquire shares of common stock (in Shares)		536,093
Exercise price per share (in Dollars per share)		$ 1.884
Series B Preferred Stock [Member] \| PIPE Warrants [Member]
Fair Value Measurements [Line Items]
Warrants share (in Shares)		15,923,567
Class B Common Stock [Member]
Fair Value Measurements [Line Items]
Warrants share (in Shares)	1
Investment in equity securities									$ 8,080,000
PIPE Offering [Member] \| Series B Preferred Stock [Member]
Fair Value Measurements [Line Items]
Shares issued (in Shares)		15,000

Condensed Consolidated Statements of Changes in Stockholders’ Equity (Deficit) (Unaudited) (Parentheticals) - USD ($)	3 Months Ended
	Sep. 30, 2025	Mar. 31, 2025
Preferred Stock \| Series A Preferred Stock
Offering Costs	$ 1,964,705	$ 1,176,800

Related Party Transactions (Details) - USD ($)	9 Months Ended		12 Months Ended
Related Party Transactions (Details) - USD ($)	Sep. 30, 2025	Sep. 30, 2024	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Related Party Transactions [Line Items]
Account balance			$ 43,563
Cash	$ 9,575,000		50,649
Deferred compensation			46,811
Payables	424		32,500	$ 251,056
Repayments of Notes Payable	399,126	$ 25,000	25,000
Reimbursable expenses	$ 0		24,303
Lavell Juan Malloy, II [Member]
Related Party Transactions [Line Items]
Outstanding balance					$ 43,563
Related Party [Member]
Related Party Transactions [Line Items]
Reimbursable expenses			24,303	9,611
Payables			51,712	$ 9,611
Repayments of Notes Payable			$ 37,020

Segment Reporting (Details)	9 Months Ended
Segment Reporting (Details)	Sep. 30, 2025 Integer
Segment Reporting [Abstract]
Operating segment	1

Income Taxes (Details) - USD ($)	9 Months Ended		12 Months Ended
Income Taxes (Details) - USD ($)	Sep. 30, 2025	Sep. 30, 2024	Dec. 31, 2024	Dec. 31, 2023
Income Taxes [Abstract]
Other current liability	$ 7,373	$ 70,049	$ 95,000
Federal net operating loss carry-forwards			9,676,887	7,210,359
State net operating loss carry-forwards	$ 16,514,918		$ 11,337,446	8,133,984
Percentage of taxable income			80.00%
Valuation allowance increased			$ 836,616	$ 1,046,842

Document And Entity Information	9 Months Ended
Document And Entity Information	Sep. 30, 2025
Document Information Line Items
Entity Central Index Key	0001903595
Document Type	S-4
Entity Registrant Name	BRAG HOUSE HOLDINGS, INC.
Entity Incorporation, State or Country Code	DE
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Amendment Flag	false

Investments (Details) - USD ($)	3 Months Ended	9 Months Ended
Investments (Details) - USD ($)	Sep. 30, 2025	Sep. 30, 2025	Sep. 02, 2025	Dec. 31, 2024	Sep. 30, 2024
Investments [Line Items]
Exercise price (in Dollars per share)	$ 2.96	$ 2.96
Purchased warrants (in Shares)	4,000,000	4,000,000
Share price (in Dollars per share)	$ 1	$ 1			$ 0.73
Investments and cash	$ 4,000,000	$ 4,000,000
Investments carrying value	8,080,000	8,080,000
Unrealized gain on equity securities	4,080,000	4,080,000
Class B Common Stock [Member]
Investments [Line Items]
Purchased warrants (in Shares)			1
Investments carrying value	$ 8,080,000	$ 8,080,000
Class B Common Stock [Member] \| Securities Purchase Agreement [Member]
Investments [Line Items]
Exercise price (in Dollars per share)	$ 0.0001	$ 0.0001
CleanCore'S [Member] \| Minimum [Member]
Investments [Line Items]
Beneficial ownership percentage	4.99%	4.99%
CleanCore'S [Member] \| Maximum [Member]
Investments [Line Items]
Beneficial ownership percentage	9.99%	9.99%

Debt - Schedule of Convertible Debt (Details) - USD ($)	Dec. 31, 2024	Dec. 31, 2023
Schedule of Convertible Debt [Abstract]
Outstanding Principal	$ 5,722,511	$ 4,527,228
Unamortized Debt Issuance Costs
Unamortized Debt Discount – Shares Payable
Unamortized Debt Discount – Original Issue Discount
Convertible Debt, Net	$ 5,722,511	$ 4,527,228